Simulation, Models, and Refactoring of Bacteriophage T7 by Kosuri, Sriram
Simulation, Models, and Refactoring of Bacteriophage T7 
Gene Expression
by
Sriram Kosuri
B.S. Bioengineering
University of California, Berkeley, 2001
SUBMITTED TO THE DEPARTMENT OF BIOLOGICAL ENGINEERING IN 
PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF 
DOCTER OF SCIENCE IN BIOLOGICAL ENGINEERING
AT THE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
JANUARY 2007
©2006 Sriram Kosuri. Some rights reserved.
Licensed under the Creative Commons Attribution 2.5 License
The author hereby grants to MIT permission to reproduce and to distribute publicly paper 
and electronic copies of this thesis document in whole or in part in any medium known or 
hereafter created
Signature of Author: ______________________________________________________
Division of Biological Engineering
January 23, 2007
Certified by: _____________________________________________________________
Drew Endy, Ph.D.
Assistant Professor of Biological Engineering
Thesis Supervisor
1
This thesis has been accepted by a committee of the Biological 
Engineering Division as follows:
Professor Bruce Tidor   ___________________________________
Professor of Biological Engineering
Professor of Electrical Engineering & Computer Science
Thesis Committee Chairman
Professor Drew Endy    ___________________________________
Cabot Assistant Professor of Biological Engineering
Thesis Adivisor
Professor Douglas Lauffenburger  ___________________________________
Whitaker Professor of Biological Engineering
Professor of Chemical Engineering
Professor of Biology
Dr. Tom Knight    ___________________________________
Senior Research Scientist
Computer Science and Artificial Intelligence Laboratory
Professor Ian Molineux   ___________________________________
Professor of Molecular Genetics and Microbiology
University of Texas, Austin
2
Abstract
 Our understanding of why biological systems are designed in a particular way 
would benefit from biophysically-realistic models that can make accurate predictions on 
the time-evolution of molecular events given arbitrary arrangements of genetic 
components.  This thesis is focused on constructing such models for gene expression 
during bacteriophage T7 infection.  T7 gene expression is a particularly well suited model 
system because knowledge of how the phage functions is thought to be relatively 
complete.  My work focuses on two questions in particular.  First, can we address 
deficiencies in past simulations and measurements of bacteriophage T7 to improve 
models of gene expression?  Second, can we design and build refactored surrogates of T7 
that are easier to understand and model?
 To address deficiencies in past simulations and measurements, I developed a new 
single-molecule, base-pair-resolved gene expression simulator named Tabasco that can 
faithfully represent mechanisms thought to govern phage gene expression.  I used 
Tabasco to construct a model of T7 gene expression that encodes our mechanistic 
understanding.  The model displayed significant discrepancies from new system-wide 
measurements of absolute T7 mRNA levels during infection.  I fit transcript-specific 
degradation rates to match the measured RNA levels and as a result corrected 
discrepancies in protein synthesis rates that confounded previous models.  I also 
developed and used a fitting procedure to the data that let us evaluate assumptions related 
to promoter strengths, mRNA degradation, and polymerase interactions.
 To construct surrogates of T7 that are easier to understand and model, I began the 
process of refactoring the T7 genome to construct an organism that is a more direct 
representation of the models that we build.  In other words, instead of making our models 
evermore detailed to explain wild-type T7, we started to construct new phage that are 
more direct representations of our models.  The goal of our original design, T7.1, was to 
physically define, separate, and enable unique manipulation of primary genetic elements.  
To test our initial design, we replaced the left 11,515 bp of the wild-type genome with 
12,179 bp of engineered DNA. The resulting chimeric genome encodes a viable 
bacteriophage that appears to maintain key features of the original while being simpler to 
model and easier to manipulate.  I also present a second generation design, T7.2, that 
extends the original goals of T7.1 by constructing a more direct physical representation of 
the T7 model.  
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Chapter 1.  Introduction
Chapter 1.1.  Overview
 The development of natural biological organisms provides a stunning example of 
how genetically-identical organisms that have inherent chemical and environmental 
variation can arrive at complex, deterministic outcomes.  The precision and 
reproducibility of development imply reproducible molecular and cellular events 
governed by their evolved genome designs.  The ability to produce accurate model-based 
predictions of these molecular and cellular events given arbitrary arrangements of genetic 
components would allow us to explore why biological systems might be designed in a 
particular way, and help us build novel, intentional, and useful biological organisms 
[Carlson R, 2001].  However, making reliable computational model-based predictions 
remains very difficult [Endy & Brent, 2001].  What remains unclear is what information 
we are missing, and to what detail do we have to understand it in order to construct 
predictive molecular models of biological systems [Sharp, 2000].  
 Our lack of accurate model-based predictions may be due to several reasons.  For 
example, our models may be incomplete, missing details that are important in system 
function.  Also, since models typically are for small subsystems within organisms, the 
proper boundaries and interfaces between these subsystems and the organism as a whole 
are poorly defined.   We also lack precise experimental data describing the physical state 
of our system over time, and when we attempt to model the dynamic behavior of the 
system, make use of limited modeling frameworks that are often poor approximations for 
the inside of a cell.  Not surprisingly, as our models increase in size and complexity, their 
utility in helping us to predict the behavior that results from novel perturbations is 
limited.  
 This thesis is focused on trying to understand the program of gene expression 
during the development of bacteriophage T7.  T7 is particularly well suited as a model 
system for the development of an entire organism because knowledge of how the phage 
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functions is thought to be relatively complete.  My work focuses on two questions in 
particular.  First, can we address deficiencies in past simulations and measurements of 
bacteriophage T7 to improve past models of gene expression during development?  
Second, can we design and build refactored surrogates of T7 that are easier to model and 
understand?
 The remainder of this chapter introduces bacteriophage T7 and past efforts to 
construct models of T7 development.  Chapter 2 introduces a new simulator I developed 
called Tabasco that allows us to explicitly encode gene expression mechanisms 
commensurate with our putative understanding of T7 biology.  Chapter 3 describes our 
efforts to build detailed models of T7 gene expression using Tabasco and analyze the 
models with respect to new system-wide measurements of mRNA levels.  In Chapter 4, I 
present our work on refactoring the T7 genome in order to construct a self-replicating 
developmental system that is easier to understand.  Finally, Chapter 5 describes ongoing 
extensions of this work and where it stands in relation to my original goals.
Chapter 1.2.  Background
 Bacteriophage T7 (T7) is an obligate lytic phage that infects Escherichia coli 
[Dunn & Studier, 1983; Studier & Dunn, 1983].  T7 was twice isolated from Ward 
MacNeal’s ‘standard anti-coli-phage’ mixture [Demerec & Fano, 1945; Delbrück, 1946]. 
MacNeal’s ‘mixture’ may have been cultured in series – T7 was the only identifiable 
isolate [Studier, 1979].  One of the two original T7 isolates was reportedly chosen for 
future use and master cultures of ‘wild-type’ T7 have been maintained since.  Genetics, 
and then biochemistry, enabled the discovery and characterization of some of the 
individual elements that participate in T7 development [Molineux, 2005]. Sequencing of 
the T7 genome revealed additional elements [Dunn & Studier, 1983], not all of which 
have obvious functions [Chan et al., 2005]. 
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Chapter 1.2.1.  Discovering the Parts of T7
 T7 is a good model system for learning what fraction of the functional 
information encoded on the genome of a natural biological system has been discovered, 
and how much of what is unknown is likely to matter.  For example, the T7 protein 
coding domains were first characterized by the isolation and analysis of randomly 
generated amber mutants. Nineteen genes were identified by mapping mutants that 
disrupt T7 DNA synthesis, particle maturation, and lysis [Studier, 1969; Hausmann & 
Gomez, 1967; Hausmann & LaRue, 1969].  Two additional genes, T7 DNA ligase and 
protein kinase, were isolated via loss of function and deletion, respectively [Masamune et 
al., 1971;Ritchie & Malcolm, 1970]; the genetic analysis of ligase and kinase mutants 
was carried out using mutant host strains that do not support the growth of ligase or 
kinase defective phage [Studier, 1973a].  As many as 30 T7 proteins were observed by 
pulsing phage- infected cells with radioactive amino acids [Studier & Maizel, 1969; 
Studier, 1973b].  Further experiments, such as electrophoretic mobility shifts of amber 
mutants, provided evidence for as many as 38 T7 proteins [Studier, 1981].  Sequencing of 
the genome confirmed the previously constructed genetic maps [Dunn & Studier, 1983].  
But, analysis of the complete genome sequence also revealed that the set of protein 
coding domains found via mutagenesis, screening, and mapping was not exhaustive, and 
that additional unidentified open reading frames occupied most of the remainder of the 
genome.  Some of these unidentified open reading frames can be labeled as putative 
protein coding domains based on the inferred strengths of adjacent upstream ribosome 
binding sites.  In all, up to 57 genes encoding 60 potential proteins have been found or 
postulated [Molineux, 2005].  However, only 35 of these 60 proteins have at least one 
known function.  And, of the 25 non-essential proteins, only 12 are conserved across the 
family of T7-like phage [Molineux, 2005].  Can we ignore these uncharacterized proteins 
in our models?  Should we edit the genome to get rid of them [Chan et al., 2005]?  
 As a second example of where our knowledge stands, the E. coli RNA polymerase 
promoters on the T7 genome (A0, A1- 3, B, C, and E) were first mapped by in vitro 
transcription studies [Davis & Hyman, 1970; Minkley & Pribnow, 1973; Golomb & 
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Chamberlin, 1974a, b; Niles & Condit, 1975; McAllister & McCarron, 1977; Stahl & 
Chamberlin, 1977; Kassavetis & Chamberlin, 1979; Panayotatos & Wells, 1979] and 
subsequently confirmed by sequencing [Oakley & Coleman, 1977; Boothroyd & 
Hayward, 1979; Rosa, 1979; Rosa, 1981a; Rosa, 1981b; Osterman & Coleman; Carter & 
McAllister, 1981; Dunn & Studier, 1983].  Results of in vitro transcription reactions 
using T7 genomic DNA as template agreed with the available in vivo transcription data 
[Studier, 1973a; Summers et al., 1973; McAllister & Wu, 1978; McAllister et al., 1981].  
However, the cloning of random sections of the T7 genome into a plasmid that selected 
for transcription activity from the cloned fragment identified other possible promoters 
[Studier & Rosenburg, 1981].  Sequence analysis of the cloned sections identified ~10 
regions with similarity to known promoters (the identifiable sites are labeled with an S1-
S6 in our own annotations); footprinting assays identified two additional promoters (these 
promoters are labeled F1 and F2 in our own annotations) [Dunn & Studier, 1983; http://
web.mit.edu/endy/www/ncbi]. But, any contribution of these putative promoters to wild-
type T7 infection is not now defined.  As with some of the T7 genes, should we ignore 
these promoters in our models?  Should we delete them from the T7 genome?  Is there 
other information encoded on the wild-type T7 genome that we should include in our 
models, ignore, or actively remove [Chan et al., 2005]? 
Chapter 1.2.2.  Putting the Parts Together
 The experimentalists who originally discovered much of how T7 works developed 
the best descriptive, system-level models for T7 infection.  Their models were made by 
integrating knowledge of the individual parts and mechanisms that act during infection, 
from genome entry to phage particle formation [Studier & Dunn, 1983].  Two features 
specific to T7 biology made the construction of their system-level models easier.  First, 
compared to other phage, T7 is relatively independent of complex host physiology.  For 
example, T7 encodes phage-specific RNA and DNA polymerases, and mRNA and protein 
synthesis of  host genes is shut down during the first ~6 minutes of T7 infection.  Second, 
RNA polymerase pulls most of the T7 genome into the newly infected cell [Zavriev & 
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Shemyakin, 1982; Garcia & Molineux, 1995].  Polymerase mediated genome entry is a 
relatively slow process that results in the direct physical coupling of gene expression 
dynamics to gene position.  For example, a gene cannot be expressed until its coding 
domain enters the newly infected cell [Chan et al., 2005]. 

Chapter 1.2.3.  Models of Bacteriophage T7 Infection 
 Building on this work, Drew Endy with John Yin (UW Madison) and Ian 
Molineux (UT Austin) constructed a model that enables computer-based simulation of T7 
development at the ‘molecular level’ [Endy et al., 1997].  Here, molecular level means 
that the model captures the expression of individual genes and the interactions among 
distinct biochemical species such as proteins, mRNA, amino acids, nucleotides, etc.  The 
model starts with a single phage particle bound to a single host cell and follows T7 
infection up to intracellular progeny production.  The model was built using a best-faith 
effort at encoding the current scientific understanding of how T7 actually works. Any 
estimated parameter values were chosen independent of system-level model behavior.
Chapter 1.2.4.  How Good is the Model?
 Endy’s model provides a reasonable estimate of many aspects of gene expression, 
but several significant discrepancies remained.  For example, Figure 1-1 shows the 
observed and computed rates of protein synthesis during T7 infection. The computed time 
of first synthesis is correct for most proteins, suggesting that the models for T7 genome 
entry are good, but that the computed synthesis profiles for a few proteins continue 
beyond the data (e.g., gp1, the T7 RNA polymerase).
 Endy and colleagues then implemented a general form of the T7 simulation that 
can compute the expected growth dynamics for any permutation of the genetic elements 
that comprise the wild-type T7 genome [Endy et al., 2000].  Using the new simulator, 
they computed the expected effects of repositioning each of the essential T7 genes at all 
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possible positions within an array of 72 moveable genetic elements.  The simulations 
predicted that moving gene 1, encoding the T7 RNA polymerase, immediately 
downstream of its natural position would produce a mutant phage that grows faster than 
the wild type under laboratory conditions [Figure 1-2].  The prediction was based on the 
observation that moving gene 1 to its new position would create a weak T7 autogene 
[Dubendorff & Studier, 1991], and that modest self-expression of the T7 RNA 
polymerase would accelerate phage infection.  In order to test the prediction, they 
constructed a series of ectopic gene 1 strains in the lab and, upon characterization, found 
that all the ectopic phage grew slower than the wild type [Endy et al., 2000].
 Disagreement between model-based predictions and the observed system behavior 
could have occurred for at least three reasons.  First, past computational approaches to 
14
Figure 1-1. Observed and computed rates of phage T7 protein synthesis. (a) 
Experimental data.  35S pulse-chase protein synthesis gel for wild-type T7 infection. (b) 
Simulation output. Comparison of observed and computed T7 protein synthesis rates 
reveals that during an actual phage infection, synthesis of the T7 proteins gp1, gp1.3, gp2.5 
and gp5 is down regulated by an unknown mechanism(s) [Endy & Brent, 2001].
modeling T7 gene expression 
could have been inappropriate.  
For example, studies suggest that 
noise in gene expression for a 
system may lead to variation in 
system behavior [Arkin et al., 
1998].  If gene expression noise is 
significant during T7 development, 
the creation of the weak autogene 
in the predicted faster-than-wild-
type gene 1 strain, could lead to 
stochastic differences in phenotype 
[Thattai & van Oudenaarden, 
2001].  For example, one sub-
population could produce the 
autogene behavior, while a second 
sub-population of cells produces 
slower-than-wild type infections, 
and the resulting observed 
population average growth rate is 
slower than wild type.  Second, the 
resolution of past models may 
have been insufficient.  Past 
models were constrained by 
simulation technologies, and thus 
were unable to explicitly represent 
mechanisms that are thought to govern gene expression.  For example, polymerase-
mediated entry of the genome was modeled as a constant rate process, rather than as a 
result of transcription of the genome.  Incorrect representation of such processes can 
mask problems with the models that would be made clear by explicit simulation.  Third, 
models for T7 development could be incomplete or wrong.  For example, unknown 
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Figure 1-2.  (a) Simulation results showing the 
expected phage T7 growth rate as a function of the 
position of gene 1, encoding T7 RNA polymerase, on 
(b) the T7 genome.  (c) A mutant T7 genome in which 
all the T7 genetic elements are permuted [Endy et al., 
2000].
genetic elements and regulation mechanisms may play a role in the shutdown of class I 
and II protein synthesis that the models failed to account for.  Using models that do not 
account for unknown processes could debase any predictions of the models.   
 In this thesis, I have attempted to address these problems.  I developed a  new 
gene expression simulator named Tabasco in order to allow stochastic simulation of the 
mechanisms thought to govern phage gene expression [§2].  I used Tabasco to make a 
model of phage gene expression that more directly encodes our understanding of T7 gene 
expression [§3].  In addition, I coupled this model with comparisons to new system-wide 
measurements of T7 mRNA levels during development to better evaluate the model’s 
validity.  Finally, I began the process of refactoring the T7 genome to construct an 
organism that is a more direct representation of the models that we build [§4].
16
Chapter 2.  Tabasco
Chapter 2.1.  Introduction
 Mechanistic models for gene expression are quite detailed and are continuously 
improving.  For example, kinetic studies of promoter initiation and single molecule 
studies of processive protein movements on DNA give us mechanistic understanding of 
gene expression at an unprecedented level of detail [for review, Bai et al., 2006].  Those 
interested in studying the consequences of this understanding on system-level behavior 
would benefit from the ability to integrate these detailed biophysical models into system-
level simulation.  Currently available simulation techniques are sufficient to study the 
expression from a single operon, but become computational infeasible if the system is of 
much greater complexity [Arkin, 1998]. 
There are many approaches for encoding systems of biochemical reactions into a 
mathematical framework.  One common approach is to consider the chemical species 
involved in the reactions as a continuous function of time, for example by expressing the 
reactions as a set of coupled ordinary differential equations (ODEs) [§2.2.1].  Another 
approach is to explicitly account for each member of a species, for example by using 
stochastic simulation algorithms [§2.2.2].  Stochastic simulation algorithms have some 
theoretical advantages over continuous formulations.  For example, the accuracy of ODE 
simulations can break down when the numbers of any particular reactant in a system are 
low [Samoilov & Arkin, 2006].  In this situation, an individual reaction event can make a 
large difference to the likelihood that other reactions will occur, and so the precise order 
and timing of reaction events matters.  Almost any reaction involving a single copy of a 
gene will have this problem.  
Both stochastic and continuous formulations, however, share the problem of the 
so-called “combinatorial explosion” of individual species and states in a complex system. 
For example, the spatial and temporal control of the  gene endo16 expression during S. 
purpuratu development is controlled by a 2300 bp sequence [Yuh & Davidson, 1996].  
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This control sequence contains 33 sites that bind 15 distinct proteins [Yuh et al., 2001].  
Simulating this system requires enumerating the possible states of the DNA with proteins 
bound, which in the case of the regulatory region of endo16 exceeds 1013 distinct species 
-- far more species than copies of the individual DNA, proteins, and/or complexes in an 
individual cell.  Explicitly enumerating this number of distinct species is currently 
computationally intractable.  
 Several groups have addressed the combinatorial explosion problem specifically 
with respect to protein complex formation [Morton-Firth & Bray 1998; Andrews & Bray, 
2004; Lok & Brent 2005].  The simulators designed by these groups (single-molecule 
simulators) track individual molecules and what they are bound to, so that the only   
complexes formed at any given time are enumerated, and not all possible states.  The 
rules for moving from one state to another are simplified by defining classes of 
complexes that undergo the same set of reactions, with reaction rates modulated by the 
presence or absence of individual components.  For example, in the yeast pheromone 
response pathway, Ste5, a scaffolding protein, can form over 25,000 distinct complexes 
with other proteins, far exceeding the 5000 complexes estimated to be in the cell at any 
time [Endy & Brent, 2001; Bardwell et al., 1996].  Using their single-molecule simulator, 
Moleculizer, Lok and Brent were able to enhance the efficiency of simulating the 
pathway many fold by in part reducing the number of initial species specified and 
generating them dynamically as needed [Lok & Brent, 2005].
 Current single-molecule simulators deal well with binding and unbinding within 
complexes.  However, they do not deal well with situations in which the elements of the 
complex are processive (i.e., complexes move along many binding states) or when the 
number of binding states is large.   For example, simulating a single RNA polymerase 
transcribing a 3,000-base pair gene would require a DNA molecule of over 3,000 
different states with enumerated rules for the transitions from one base to the next.  In 
order to simulate detailed models of gene expression, I developed, with Jason Kelly, a 
single-molecule stochastic simulator, Tabasco, which explicitly deals with reactions 
specific to gene expression such as the initiation, elongation and termination of RNA 
transcripts and polypeptide chains and interactions between polymerases [Kosuri S, 
Kelly, JR, Endy D, in preparation]. 
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 Our motivations for creating Tabasco stem from our interest in simulating the 
dynamics of bacteriophage T7 gene expression during phage infection.  Past attempts at 
constructing models of T7 infection used ODEs to simulate gene expression dynamics, 
which prevented representation of the details of transcription and entry [Endy et al, 1997, 
2001].  For example, the E. coli RNA polymerase initiates expression of early T7 genes, 
including T7 RNA polymerase.  T7 RNA polymerase first initiates transcription behind 
already transcribing E. coli RNA polymerase molecules.  E. coli RNA polymerase has a 
~45 nucleotide per second elongation rate; T7 RNA polymerase has a ~250 nucleotide 
per second elongation rate.  What happens when a T7 RNA polymerase molecule catches 
up to an E. coli RNA polymerase?  The transition from E. coli to T7 RNA polymerase 
mediated genome entry will impact the timing of expression across the genome; cell-cell 
variation in the entry transition will limit the precision by which T7 can control infection.  
Using Tabasco, we are able to explore the dynamics of gene expression during T7 
development at single-base resolution.  The increased resolution of these computational 
models allows for direct evaluation of assumptions concerning polymerase interactions, 
transcriptional coupling to genome entry, and stochastic fluctuations on T7 development. 
Chapter 2.2.  Background
Chapter 2.2.1.  Mathematical Models of Gene Expression
 The history of mathematical and biophysical models of gene expression began at 
the very start of our understanding of the molecular nature of genetic information [Luria 
& Delbrück, 1943].  I will focus this section primarily on the development of biophysical 
models of the transcriptional control of prokaryotic gene expression through experiments 
and the parallel development of mathematical models.  
 In 1961, Francois Jacob and Jacques Monod showed through a series of 
experiments and logical formulations that the control of β-galactosidase expression is 
dependant upon negative regulation by lac repressor (Jacob & Monod, 1961).  
Furthermore they hypothesized that these interactions depend upon a secondary 
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messenger, which acted as a temporary intermediary between the genetic code and 
protein synthesis by the ribosomes.  Sydney Brenner, Monod, and Matthew Meselson 
experimentally verified the existence of this messenger RNA (mRNA) soon afterwards, 
which solidified the “central dogma” of biology [Brenner et al., 1961].  Work on the lac 
system has since continued, leading to such discoveries as the notion of the operon as a 
module of control for genetic systems, positive control of gene expression, and 
technologies such as DNA sequencing [reviewed in Muller-Hill, 1996].  
 Soon afterwards, Stuart Kauffman constructed some of the earliest mathematical 
models of gene expression in order to study how large-scale biological systems might be 
organized [Kauffman, 1969].  Kauffman treated the expression state of each gene as a 
binary variable (on/off), whose output is dependent upon some Boolean function of its 
inputs.  Others, such as René Thomas, formalized these studies and extended them to 
include delays that represented times between initial signal and output protein production 
[Thomas, 1973; Thomas et. al., 1976].  Also around this time, Michael Savageau began to 
study feedback control in genetic systems using ordinary differential equations 
[Savageau, 1974; 1975; §2.2.2].  Savageau’s approach was to model gene expression as a 
system of chemical species governed by synthesis and degradation terms that were 
dependent upon power-law relationships with other species.  These studies formed the 
basis for the mathematical modeling of gene expression using coupled sets of differential 
equations.
 Alongside these mathematical studies, experiments attempting to understand the 
biophysical process of transcription initiation were ongoing.  For example, two regions, 
the Pribnow box and the –35 region, located 10 and 35 bases from the transcription start 
respectively, were found to be conserved in E. coli promoter regions and thought to 
function as the DNA binding site for RNA polymerase [Pribnow, 1975; Gilbert, 1976].  
This information was brought together into what was called the “bipartite model” for 
promoter initiation.  In this model, sequence specific binding was in fast equilibrium 
relative to the slower process of DNA open complex formation, which together 
determined the initiation rate of the polymerase [McClure, 1982].  In addition, details 
were uncovered on the abortive initiation of polymerases, which showed that polymerase 
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seem to start, abort, and then restart a number of times before the formation of a 
productive elongation complex [Johnston & McClure, 1976; Cech et. al., 1980].
 Based on these new biophysical models, a new class of mathematical models was 
emerging.  Shea and Ackers’ work on modeling the gene regulation of the bacteriophage 
lambda OR control region created a framework based on statistical mechanics [Ackers et. 
al., 1982; Shea & Ackers, 1985].  They postulated that since the binding of operators to 
DNA was very fast when compared to downstream processes such as transcription 
initiation, a probabilistic model of binding could be created based on proportionality of 
the equilibrium binding constants of proteins to the DNA.
 The importance of the Shea-Ackers’ model was not fully appreciated until work 
on understanding the role of random fluctuations in biochemical systems began.  Though 
the phenomenon of cell-cell variation in the bacterial response to chemical stimuli has 
been apparent for some time, little progress was made in trying to mathematically model 
it [Luria & Delbrück, 1943; Chock & Stadtman, 1977; Goldbeter & Koshland, 1981].  
However, a number of improvements allowed for the development of stochastic 
simulations that could probe such behavior.  First, the development of exact stochastic 
simulation algorithms (SSAs), when coupled to increases in computational power, 
allowed for the efficient simulation of random fluctuations in larger chemical systems 
[Gillespie, 1976, 1977; §2.2.2].  In addition, the Shea-Ackers model allowed for the 
treatment of fast DNA-binding reactions as being in equilibrium, easing the 
computational burden.  Adam Arkin and Harley McAdams showed that stochastic effects 
can be successfully modeled using these new simulation tools, and that cell-cell variation 
due to uncertainty in the timing of individual reaction events might qualitatively impact 
developmental pathways [McAdams & Arkin, 1997; Arkin et. al., 1998].  Several groups 
have subsequently experimentally and theoretically explored the effects of stochastic 
variation on gene expression [Thattai & van Oudenaarden, 2001; Ozbdak et al., 2002; 
Elowitz et al., 2002; Paulsson, 2004; Rosenfeld et al., 2005; Pedraza et al., 2005; Kaern et 
al., 2005; Mettetal et al., 2006].
 Most mathematical models of gene expression still lag behind our experimental 
understanding of gene expression.  For example in vitro single-molecule studies revealed 
that pauses and arrests of E. coli RNA polymerase transcribing along DNA occur often, 
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and that pausing is a step in the route towards termination [Forde et. al., 2002; Adelman 
et. al., 2002; Skinner et al., 2004].  However, such mechanisms are difficult to account for 
with current simulators.  In another example, interactions between transcribing 
polymerases on the genome are known to affect gene expression [Adhya & Gottesman, 
1982; Horowitz & Platt, 1982; Nomura et al., 1985; Epshtein et al., 2003].  Again, 
simulating interaction of transcribing polymerases is difficult.  In both cases, the near 
base-pair resolution needed to analyze these models is difficult because of the large 
number of species that need to be enumerated in such a detailed simulation.
Chapter 2.2.2.  Stochastic Simulation
 Simulating the time course of a set of coupled chemical reactions is often carried 
out using ordinary differential equations.  This approach to representing biological 
systems approximates all species as continuous functions of time.  However, in some 
cases, the continuous approximation breaks down.  When individual reaction events 
cause large changes in the probability of future reactions, the precise order and timing of 
reaction events matters.  Variation in the timing of individual reactions due to thermal 
fluctuations can produce variation in system behavior that is not accounted for in 
deterministic formulations.  For example, variation can be large when there are low 
numbers of any individual reactants, as in the case of single-copy genomic DNA.  
Stochastic formulations, on the other hand, are able to account for this variation by 
treating all species as discrete variables and reaction rates as probabilities per unit time 
(i.e., propensities).  Solving these stochastic formulations analytically is very difficult and 
practically impossible except for the most simple of systems [e.g., Thattai & van 
Oudenaarden, 2001].  Thus, the most common approach is to use computational methods 
developed by Dan Gillespie in the 1970’s to approximate solutions [Gillespie, 1976, 
1977]. 
 Gillespie’s stochastic simulation algorithm (SSA) allows for exact simulation of a 
system of elementary chemical reactions [Gillespie, 1976].  For each reaction, the SSA 
generates a tentative execution time by mapping a randomly generated number to the 
reaction time’s probability density function (PDF).  In the case of an elementary chemical 
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reaction, the reaction time’s PDF is defined as an exponential distribution with 
characteristic time proportional to the inverse of the reaction’s propensity.  A reaction 
propensity is related to the macroscopic rate constant of the reaction and is also 
dependent upon the number of reactant molecules and cell volume.  In a system of 
reactions, the algorithm first executes the reaction with the earliest tentative reaction time, 
and updates the copy numbers of the reactant and product species.  The overall simulation 
time is then incremented by the tentative reaction time,  and the propensities of all the 
reactions are recalculated.  This process is repeated and, in this manner, one potential 
time course of the system is generated.  When averaged over many runs, the distribution 
created is equivalent to the analytical solution obtained through the chemical master 
equation, which describes all the probabilistic states of the system [Gillespie, 1977].
 Subsequently, there have been improvements  to Gillespie’s SSA that help increase 
the computational efficiency, such as Gibson and Bruck’s accelerations to the Gillespie’s 
SSA in the Next Reaction Method (NRM) [Gibson & Bruck, 2000].  First, instead of 
recalculating all reaction propensities and times, the NRM efficiently transformed them 
from one cycle to the next.  Second, the NRM created a data structure, called the reaction 
graph, in order to only update those reactions whose substrates’ copy numbers have 
changed after any particular reaction has occurred.  Third, more efficient data structures, 
priority queues, were used to search for the first reaction.  Finally, Gibson and coworkers 
outlined the use of the NRM to model a series of reactions that have identical exponential 
propensities (e.g., polymerization) as a single reaction described by the gamma 
distribution. 
Chapter 2.3.  Results
Chapter 2.3.1.  Features and Structure of Tabasco
 Tabasco is a stochastic simulator that tracks individual molecules of DNA and 
associated proteins at single base-pair resolution.  By defining logical rules of 
23
transcription and translation that govern initiation, elongation, termination, and 
interactions of polymerases, ribosomes, and proteins at the start of simulation, Tabasco is 
able to dynamically update the state of the system and generate the appropriate reactions 
[Fig 2-1].  For example, if a polymerase transcribes over another protein’s DNA-binding 
site, the simulator makes the site unavailable for binding other proteins until the 
polymerase is no longer overlapping the binding site.  Tabasco makes use of a Gibson-
accelerated Gillespie stochastic simulation algorithm (SSA) to compute the reaction event 
timing and the resultant time-evolution of the genetic system [Gibson & Bruck, 2000]. 
 Tabasco’s structure confers a number of advantages [Figure 2-2; Methods].  First, 
tracking the state of individual molecules on DNA eliminates the need to enumerate all 
the possible states of polymerases and proteins associated with the DNA.  Second, 
protein-protein interactions that may occur on DNA, such as collisions between different 
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Figure 2-1. Structure of Tabasco Simulator.  A simplified flow diagram of gene 
expression shows how Tabasco transitions from tracking individual molecules (Single 
Molecule Resolution) to grouping them into species (Species Level Resolution).  The 
arrows represent reactions that can occur (process labeled in blue).  See §2.5.2 for an 
explanation of 
polymerases or between polymerases and other proteins, can be accounted for and 
simulated based on explicitly defined rules.  Third, Tabasco allows us to consider and 
integrate a very large number of factors that may influence the rate of RNA 
polymerization for any particular gene, such as the binding of multiple transcription 
factors or the contribution of RNA polymerases that initiated transcription at a promoter 
connected to an upstream gene.  Fourth, Tabasco can be used to visualize the location and 
progress of the polymerases transcribing DNA.  Two advantages of Tabasco that are 
particularly relevant to T7 are that the simulator allows one to define multiple 
polymerases with different characteristics (such as transcription speed) and that Tabasco 
tracks the time course of the entry of the T7 genome, allowing us to see how the stage of 
entry changes the dynamics of gene expression [see movie at http://openwetware.org/
wiki/Tabasco; §3]. 
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Figure 2-2. Advantages of Single Molecule Resolution.  Tracking individual molecules 
of DNA at a base-pair resolution allows for enumeration of mechanisms that were 
previously not examinable through simulation.  For example, when a traversing 
polymerase passes over a genetic element such as a protein-DNA binding site, the 
binding site is inactivated and prevented from binding a protein until the polymerase 
completely passes over (a).  Activation of genetic elements by entry of DNA into the cell 
(b) and inter-polymerase interactions (c) can be directly simulated as well.  Finally, in 
complex genetic environments (d), a priori transcription levels for each protein need not 
be calculated, for they are generated implicitly (Promoter arrows with different sizes and 
colors represent different activities and polymerase specificities, respectively).  
 While treating DNA with single-molecule and single base-pair resolution provides a 
number of advantages, treating RNA and protein species at the same resolution is both 
unnecessary and computationally expensive because of the large number of RNA 
molecules compared with DNA.  To increase computational efficiency Tabasco 
transitions from single-molecule simulation, where individual molecules and their states 
are tracked, to species-level simulation for RNA and protein molecules, akin to traditional 
SSAs.  Only those RNA molecules that are still attached to transcribing RNA 
polymerases are treated as single molecules.  As each coding domain on an RNA 
molecule is completed, it becomes part of the species-level simulation.  In essence, each 
of the coding domains is treated separately as a species, and ribosomes that initiate 
translation on a coding domain are assumed not to interfere with one another [§2.4].  
Translation is treated as a series of single amino acid polymerization steps, with the 
number of steps depending on the length of the coding domain.  This gives a more 
accurate distribution of times for protein production than treating the whole elongation 
process as a single step.  Based on the work of Gibson and Bruck, we model these steps 
in aggregate using the gamma distribution [Gibson & Bruck, 2000; Figure 2-3].  Protein 
interactions are all treated at the species-level.
Chapter 2.3.2.  Simple Gene Expression Models
 As an initial test, Tabasco was used to simulate expression of a 1000 amino acid 
protein and compared against results from a standard species-level SSA [Figure 2-4].  
The structure of the Gillespie-based species-level SSA is comparable to the Tabasco 
structure, except that processive movements on the DNA are treated as a lumped, single-
step reaction sampled from an exponential distribution [Figure 2-1; Figure 2-6].  Care 
was taken to make the simulations as close as possible for comparison; some differences 
were unavoidable, but they were insignificant [Table 2-1; §2.5.5.2; §7.3.1].  In the steady 
state, both simulators produce similar results.  However, a difference arises in the pre-
steady state kinetics of the system.  The species-level simulation first starts producing 
protein by ~30 seconds.  This is unrealistic; RNA polymerase transcribes at an average 
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rate of 40 bp per second, so production of a 3,000 bases of messenger RNA should take 
~75 seconds.  Even if a ribosome follows directly behind the RNA polymerase, protein 
production should not take less time than RNA production.  Tabasco produces protein 
only after a more realistic ~100 seconds.
 The discrepancy in time to the first protein production between the species-level 
and Tabasco simulators occurs for two reasons [Gibson & Bruck, 2000].  First, since the 
RNA polymerase and ribosome elongation steps in the species-level simulation are 
treated as single exponential elementary reactions, 63% of the reactions happen earlier 
than the average reaction time.  The second reason, which is more substantial, is that 
SSAs assume that the reactions are Markov, i.e., reaction timings do not depend on 
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Figure 2-3. Differences in single-step and multi-step elongation processes.  
Treating elongation of polymerase on DNA along 50 bases as a one step elongation 
process versus a chain of individual reaction steps gives the same average 
elongation time, but has marked differences in the distribution of those elongation 
times.  The process shown here is either a single 1 second elongation step (red) or 
fifty 1/50 second elongation steps (blue).  Each histogram is the distribution of 
resulting times from 20,000 independent simulations.  
history.  In an SSA that treats elongation as a single step, a ribosome has a chance of 
entering the elongating state, and a chance of leaving it; the greater the number of 
ribosomes that have entered elongation, the greater the chance that a protein will be 
completed.  Thus, there is a chance that a protein will be completed in a very short time 
after elongation begins; especially if many ribosomes enter an elongating state before 
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Figure 2-4. Comparison of Tabasco to species-level simulations for a simple gene.  I 
simulated expression of a 1000 amino acid protein using Tabasco (blue) and a standard 
species level simulator (red), where the processes of elongation (transcription and 
translation) were lumped into single steps.  While the steady-state averages are quite similar 
(a-b), the pre-steady state kinetics are quite different (c).  The distribution of times  to 
produce the first protein for all the simulations is shown in (d).  The species-level simulator 
generates unrealistic times to produce a protein of this size; elongation of the polymerase 
alone should take ~75 seconds (see text).  The data shown are averages of 500 simulations.
ever leaving the elongating state.   The fact that Tabasco treats each elongation reaction as 
a series of elongation steps alleviates both of these problems.  These improvements 
provide a more realistic timing for simulation of pre-steady state kinetics of protein 
production that are important during dynamic phenomena such as signal transduction or 
embryonic development.  
Chapter 2.3.3.  Polymerase Interactions
 The specific system I have chosen to study using Tabasco is bacteriophage T7.  
During bacteriophage T7 infection, the E. coli RNA polymerase initiates expression of 
early T7 proteins, including T7 RNA polymerase [Studier & Dunn, 1983].  T7 RNA 
polymerase first initiates transcription behind already transcribing E. coli RNA 
polymerase molecules.  At 37˚C, E. coli RNA polymerase transcribes at ~45 bp per 
second; T7 RNA polymerase transcribes at ~250 bp per second [Garcia & Molineux, 
1995].  Thus it is almost inevitable that the T7 RNA polymerase will collide with E. coli 
RNA polymerases ahead of it.  
 Tracking the DNA at a single-molecule level allows us to simulate how protein 
output might change as a result of the assumptions made on the outcome of RNA 
polymerase collisions [Adhya & Gottesman, 1982; Horowitz & Platt, 1982; Nomura et 
al., 1985; Epshtein et al., 2003].  Figure 2-5 shows the results of simulation of a simple 
genetic system where two different polymerases transcribe the same piece of DNA, 
mimicking the layout of the T7 genetic architecture.  The simulations describe three 
possible outcomes of collision: (1) the downstream polymerase in the collision 
terminates, (2) the upstream polymerase terminates, or (3) the upstream polymerase 
follows at the speed of the downstream polymerase.  Each assumption leads to different 
levels of steady state protein production.  For example, in cases where the upstream 
polymerase terminates upon the collision of polymerases, most of the T7 polymerases 
will prematurely terminate because they will catch up with a slower, previously 
transcribing host polymerase.  In this case, the resulting gene expression levels are 
similar to the situation where there is no T7 polymerase at all. 
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Chapter 2.3.4.  Genome-scale Models – Bacteriophage T7
 In order to test the effectiveness of using Tabasco on larger, more biologically 
realistic systems, I simulated gene expression during bacteriophage T7 infection.  The 
39,937 base-pair genome, as represented by the simulation, contains 52 coding domains, 
22 host and phage promoters, two transcriptional terminators, and three distinct 
transcriptional feedback loops for each infecting phage molecule [Dunn & Studier, 1983]. 
30
Figure 2-5. Simulating models for inter-polymerase interactions.  Average steady-
state protein levels of simulations of the DNA molecule with promoters for different 
polymerases (T7 and E. coli RNA polymerases) that are expected to interact on the DNA 
as they transcribe.  The T7 RNA polymerase is ~5 times faster than the E. coli RNA 
polymerase.  Shown above are the results of simulations where different assumptions are 
used as to the nature of the interaction that occurs between the polymerases upon 
collision.  The ‘Downstream falloff’ model specifies that the downstream polymerase 
upon a collision between two transcribing polymerases will fall terminate transcription 
and release from the DNA.  The ‘Upstream falloff’ model describes the opposite 
situation when the upstream polymerase falls off.  Finally, the ‘Traffic jam’ model is 
when the upstream polymerase follows the downstream polymerase at the speed of the 
downstream polymerase.  The ‘Only T7’ and ‘Only E. coli’ are controls that show 
expression without  E. coli and T7 RNA polymerase, respectively. 
Because there are relatively few transcriptional terminators and many promoters, the rate 
of transcription  of individual genes in this system depends on the rates of transcription of 
the upstream genes, as well as the presence of different polymerases.  In the case of T7, 
there is a further complication in that not all genes are available for transcription at once, 
since the entry of the T7 genome is a relatively slow process. 
 Tracking the development of T7 from entry to the end of gene expression is thus a 
good test for simulation of genomic level models in Tabasco.  Using realistic parameter 
sets, I simulated the simultaneous infection of three phage into a single cell [§2.5.5.3].  
Jason Kelly and I developed a method to visualize the results of these simulations that 
allows graphical display of Tabasco output [see http://openwetware.org/wiki/Tabasco].  
 Simulation of a full scale genomic model of T7 gene expression during infection on 
a single AMD Athlon MP 2100+ 1.8 GHz processor takes on the between 1-2 hours for 
30 minutes of simulated infection time.  For the first time, we are able to simulate gene 
expression at single base resolution for all gene expression in a particular organism 
during development.  In particular, we can explore specific hypothesis of polymerase 
interactions, stochastic gene expression, and coupling of entry and transcription.  
Chapter 2.4.  Discussion
 I designed and built Tabasco in response to the inability of currently available 
simulation tools to represent biophysical mechanisms at a level of resolution 
commensurate with our understanding.  Tabasco allows simulation of T7 genome scale 
models of gene expression at single base-pair resolution.  Previous tools required either 
modeling smaller systems at increased resolution, or simplifications and assumptions of 
the biophysical models that result in less accuracy.  For example, Tabasco’s implemention 
of a Gibson-accelerated Gillespie SSA allowed us to bypass standard simplifications that 
are often made for promoter binding and initiation [Shea & Ackers, 1985].  I have shown 
here that the increased resolution provides more accurate pre-steady state kinetics of gene 
expression, gives us the ability to test models of polymerase and protein interactions on 
the DNA, and allows us to fully simulate the dynamics of gene expression during 
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development of bacteriophage T7.  
 Executables, source code, documentation, and usage notes for Tabasco are freely 
available, and should facilitate future extensions on the current design [http://
openwetware.org/wiki/Tabasco].  While requiring significant processing power, Tabasco 
is computationally tractable in regimes where the effects of perturbations are highest; i.e., 
when the number of DNA molecules in the system is low.  The simulator should be a 
good base to further study interactions on DNA that lead to transcription and translation.  
For example, Tabasco should provide a platform to explicitly simulate hypotheses how 
many transcription factors can interact to direct eukaryotic gene expression, such as in 
control of endo16 expression [Yuh et al., 2001]
 There are many other tools for stochastic simulation available; Tabasco specifically 
enables simulation of high-resolution models of gene expression.  Other single molecule 
simulation tools, such as StochSim and Moleculizer, are available and primarily focus on 
binding and activation of protein complexes in signaling.  In addition, others have been 
working on increasing the efficiency of the SSA without significantly sacrificing accuracy 
[Rao & Arkin, 2003; Gillespie & Petzold, 2003; Cao et al., 2005].  Finally, I am helping 
to construct a simulator that uses rule-based logic like Tabasco to simulate proteoglycan 
formation and modification (§5.1).  As our models for system level behavior become 
more encompassing, future work will require combining the efficiencies gained from 
these individual simulators to create more general tools for high-resolution models of 
system behavior.
Chapter 2.5.  Methods
Chapter 2.5.1.  Overall Structure and Gillespie Integration Simulator 
Structure
Tabasco implements a modified version of the Next Reaction Method (NRM) 
[§2.2.2; Gibson & Bruck, 2000].  Briefly, at the start of the NRM, the reactions are 
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defined and their tentative time of next execution is calculated and stored within a priority 
queue containing all the defined reactions.  The priority queue sorts these reactions 
efficiently to allow quick searches for the minimum tentative time.  The reaction with the 
next tentative reaction time relative to the current simulation time is executed, any 
tentative reaction times that are affected by the current reaction’s execution are updated, 
and the priority queue structure is reordered to reflect the new times.  The process is 
repeated to compute the time evolution of the system.
The NRM uses a dependency graph to determine which reactions are affected by 
any particular reaction’s execution.  In the NRM, the dependency graph is calculated a 
priori, and remains unchanged throughout the simulation.  However, since Tabasco 
creates reactions and complexes at the single-molecule level dynamically during 
simulation, a static dependency graph and priority queue will not work.  In order to solve 
this problem, Tabasco contains two specialized reactions per DNA molecule within the 
priority queue and dependency graph that are used to track a set of dynamically generated 
reactions.  These reactions are placeholders for all the dynamically generated 
transcriptional and translational events that occur at the single-molecule level.  The 
placeholder reactions have tentative reaction times that are equal to the minimum 
tentative reaction time of set of dynamically generated reactions the placeholder is 
tracking.  These placeholder reactions are described below [§2.4.2].
Chapter 2.5.2.  Transcription and Translation
 There are two specialized placeholder reactions within the priority queue in the 
NRM that are used to track DNA-protein complexes and RNA-ribosome complexes at 
the single-molecule level.  The DNA-protein complex reaction tracks the position and 
state of polymerases, or other proteins, as they traverse the DNA.  The RNA-ribosome 
complex reaction tracks the state of those ribosomes elongating along mRNAs that are 
still being transcribed by RNA polymerases.  Here state refers to whether the polymerase 
or ribosome is just bound, initiating, or elongating, as well as the time they will next 
perform an action such as termination or elongation.  All the complexes, and the events 
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that they may generate, are stored in a different priority queue contained within these 
specialized reactions.  The minimum tentative reaction time for any of the complexes to 
change state or position is used as the tentative time for the entire placeholder reaction in 
the NRM.  
 It is within these specialized entries that the logic of transcription and translation is 
encoded.  In the simulation, polymerases bind free promoters to form a protein-DNA 
complexes, which are stored within the specialized NRM entry.  These bound complexes 
can then either form an initiation complex or fall off the DNA.  Once an initiation 
complex is formed, the polymerase can undergo abortive initiation steps, or it can begin 
transcription.  The promoter is not freed until the footprint of the polymerase has left the 
entire promoter region.  If two elongating polymerases collide, they act according to the 
polymerase interaction model chosen at the start of simulation.  Upon arriving at a 
transcriptional terminator, a polymerase will either continue transcribing or terminate 
depending on a stochastic decision that is weighted by the termination efficiency.  
Polymerases that reach the end of a particular piece of DNA also terminate transcription.  
In addition, transcribing polymerases that are on functional protein binding sites such as 
other promoters, block binding of the site by other proteins until the polymerase footprint 
clears the site.  
 Transcribing RNA polymerases produce mRNA, which must be tracked by 
Tabasco.  I used two classes to represent ribosome binding sites (RBSs) on the genome, 
Nascent RBSs and Mature RBSs, to differentiate when mRNA is tracked at the single-
molecule level or the species-level, respectively.  The Nascent and Mature RBSs both 
represent a single RBS on the DNA, and the two are distinguished here in order to deal 
with the computational structure of Tabasco.  When an RNA polymerase first transcribes 
an RBS, a Nascent RBS is created.  If, for example, a RNA polymerase prematurely 
terminates before reaching the translation stop of the Nascent RBS, the mRNA and the 
ribosomes translating it must be deleted from the simulation as well.  Thus, while the 
coding sequence is still being transcribed, we must treat all translation events at the 
single-molecule level as well.  Once the polymerase arrives at the corresponding 
translation termination site, the Nascent RBS is converted to a Mature RBS which is 
tracked at the species-level.   
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 Translation occurs in three steps.  First, ribosomes can bind either Nascent or 
Mature RBSs.  There is an initial reaction to form the Initiation Complex.  Second, these 
initiation complexes are converted to Elongation Complexes and an RBS (Nascent or 
Mature) at a rate dependent upon the speed of the ribosome and the length the ribosome 
must travel to clear the ribosome binding site.  This reaction is treated as a single step, 
however the distribution of times are chosen from the gamma distribution, in order to 
represent a series of exponential reactions.  Third, the Elongation Complex then forms a 
finished protein and a free ribosome at a rate proportional to the remaining length of the 
open reading frame.  This reaction also is represented using the gamma distribution.  
Chapter 2.5.3. DNA entry
 In order to simulate mechanisms of bacteriophage T7 entry into the cell, we used a 
two-step DNA entry model.  First, DNA can enter at a constant rate, up to a certain site, 
which is meant to represent a molecular motor based entry of phage DNA.  Second, 
RNA polymerases have been implicated as molecular motors that drive phage DNA entry 
[Zavriev & Shemyakin, 1982; Garcia & Molineux, 1995].  In Tabasco, RNA polymerases 
that reach the end of the DNA that has not yet entered the cell cause DNA internalization 
at the rate of polymerization.  These mechanisms were added to Tabasco, because they 
are thought to govern bacteriophage T7 entry.
Chapter 2.5.4.  Simulation, Data Output, Visualization, Code
 Tabasco is written in Java® 1.4. The input file to the simulator is an XML file that 
describes and parameterizes the relevant genetic elements, initial conditions, and any 
other reactions that occur.  The visualization is created by producing images that are then 
merged using Quicktime® to create a movie.  The source code, executables, along with 
documentation and instructions for use, are available online at http://openwetware.org/
wiki/Tabasco
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Chapter 2.5.5.  Parameterization
 All constants used are provided for completeness.  For a discussion on the sources 
and/or derivations of the constants used, see Chapter 3.  
Chapter 2.5.5.1.  Gamma versus Exponential distribution
 The distribution of expected times for a reaction to occur in a stochastic simulator 
depends on the underlying model [Figure 2-3].  Elementary chemical reactions will 
follow an exponential distribution in arrival times.  However, this is not true of non-
elementary reactions.  Treating an imaginary elongation process as one step versus 50 
individual steps has significant consequences.  To obtain the distribution time for the two 
cases, I use uniformly-distributed pseudorandom numbers and transform them into 
exponential- or gamma-distributed random numbers.  The exponential distribution is used 
for the single step representation.  Exponentially distributed numbers are calculated by 
simply taking the negative natural log of a uniformly-distributed pseudorandom number.  
A series of exponentially distributed arrival times, as in the case of the multi-step 
elongation process, is given exactly by the gamma distribution.  Gamma distributed 
numbers are calculated from uniformly-distributed pseudorandom numbers by an 
implementation of the rejection method [Press et al., 1992].  Pseudorandom numbers are 
generated from Java’s implementation (java.util.Random) of a linear congruential 
pseudorandom number generator with a 48-bit seed [Knuth, 1997].
Chapter 2.5.5.2.  Simple Gene Expression model
 I simulated two models of a promoter driving expression of a coding domain.  
The first model, termed single-molecule simulation, used the described Tabasco simulator 
to account for each reaction step during transcription and translation.  The model uses the 
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schemes shown in Figures 2-1 and 2-6a.  The second model, termed the species-level 
simulation, treats transcriptional and translational elongation as a single step as shown in 
Figure 2-6b.    The main parameters used in both models are shown in Table 2-1.  
Constants were adjusted slightly to account for small differences in model structure to 
give equal steady state values of mRNA and protein levels.  Finally, the input files for the 
simulations can be found in the Appendix [§7.3.1].  
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Constant Tabasco Species-
Level
kon (M-1s-1). 4e7 4e7
koff (s-1). 4 4
kiniton (s-1). 1.2 1.2
% runoff 0 N/A
krecyc (s-1). 0 N/A
kelong (s-1) 0.23 0.23
kprot (s-1) 0.645* 0.645
kribon (M-1s-1) 1.15e4 1.15e4
kclear (s-1). 0.14* 0.1308
rib elongation (s-1) 20 20
mRNA deg (s-1). 2.5e-3 2.5e-3
protein deg (s-1) 7e-4 7e-4
Table 2-1.  Constants used in simple 
gene expression model.  The two models 
tested used the both a species-level SSA 
and Tabasco to represent gene expression 
for a simple system shown in Figure 2-6.  
The Tabasco constants for kprot and 
kclear were adjusted to ensure the steady-
state levels of mRNA and protein were 
equivalent in both simulations.  The 
constants do not exactly match because of 
small variations in the structure of the 
simulator.
(a)
(b)
Figure 2-6.  Different models representing gene 
expression.  We can represent a simple model for 
gene expression differently based on the simulator.  
The Tabasco simulator treats expression at the 
molecular level.  The molecular-level Tabasco-based 
simulation uses the general schematic used in Figure 
2-1, and transcription initiation as shown in (a).  The 
species-level simulation uses the schematic shown 
in (b).  Care was taken to make sure the constants 
were equivalent in both simulations.  
Chapter 2.5.5.3.  Polymerase Interactions & Bacteriophage T7
 The simulations for the polymerase interactions and bacteriophage T7 used 
parameters that can be found in the input files in the Appendix [§7.3.2].  The parameters 
used were based on the derivations described in the next chapter [§3.6].  However, in 
general, the exact values of the constants are ancillary to this section, which is to show 
that Tabasco is able to simulate processes such as polymerase interactions and entire 
genetic systems such as T7.
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Chapter 3.  Models
Chapter 3.1.  Introduction
Biological systems are physical systems that replicate themselves faithfully.  The 
precision and reproducibility of biological behaviors such as development imply 
reproducible molecular events that govern their processes.  However, precise knowledge 
of an entire biological system with all the numbers, interactions, and dynamics of 
individual components does not exist.  Through genetics, we have information on 
identity, essentiality, and connectivity of some of the components of biological systems.  
Biochemistry provides detailed kinetics on individual components of these pathways.  
Sequencing and modern bioinformatics give us further information on identifying 
uncharacterized components and the components’ evolutionary relationships.  However, 
few successful examples exist for combining this knowledge to construct accurate, 
biophysically realistic models of entire organisms [Endy & Brent, 2001].  Such models 
could be used to make model-based predictions to explore questions such as why a 
particular organism is designed the way it is, and give us better substrate from which to 
engineer future biological systems.
 Bacteriophage T7 is a convenient organism from which to develop such system-
level models for several reasons [§1.2].  First, T7 is well studied.  The genome has been 
sequenced, annotated, and many important factors involved in RNA processing, DNA 
replication, and protein expression have been described in detail [Dunn & Studier, 1983; 
Studier & Dunn, 1983].  Second, compared to other pathogens, T7 is relatively 
independent of host physiology.  T7 encodes phage-specific RNA and DNA polymerases, 
inhibits transcription and translation of most host genes early in infection, and degrades 
most of the host genome. Third, transcription and replication of the T7 genome are 
mostly independent processes, thus simplifying analysis of gene expression [Zhang & 
Studier, 2004].  Fourth, complete internalization of the T7 genome takes under 10 min at 
30˚C, or about one third of the latent period [Zavriev & Shemyakin, 1982; Garcia & 
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Molineux, 1995].  As genes obviously cannot be transcribed before they leave the phage 
capsid and enter the cell, the slow entry of the T7 genome also provides a direct 
mechanism for regulating the timing and levels of gene expression.  Based on their 
spatial location and temporal expression patterns, T7 genes are divided into three classes, 
which also correlate with the gene’s function [Studier, 1972].  Class I genes (genes 0.3 to 
1.3) are expressed first and mostly transcribed by the E. coli RNA Polymerase.  The class 
II genes (genes 1.4 to 6.3) followed by the class III genes (genes 6.5 to 19.5) are 
expressed next and mostly transcribed by the T7 RNA polymerase.  
Previous modeling efforts encoded the aggregate knowledge of T7 biology to 
make computer simulations of an entire biological organism [Buchholtz & Schneider, 
1987; Endy et al., 1997].  These simulations provided encouraging results, but also 
showed a number of troubling inconsistencies with experimental measurements. Using 
the model to predict the effects of gene repositioning led to failures in certain predictions 
of phage growth [Endy et al., 2001].  For example, protein synthesis of most class I and II 
genes was observed to spike and then fall-off as infection proceeded, whereas the model 
predicted sustained expression.  The model assumed that T7 mRNA was stable based on 
previous measurements that showed that the total cellular RNA lifetime is greater than 20 
minutes during infection [Summers, 1970].  However, individual transcript degradation 
could be obscured in such bulk mRNA measurements and perhaps is the cause for drop-
off in protein synthesis rates.
This chapter describes our work to revisit these original models, specifically 
focusing on the program of gene expression during T7 infection [Keller et al., in 
preparation].  To do this work, I developed and used a new simulator, Tabasco, to explore 
in greater detail mechanisms that are thought to govern phage gene expression [§2].  I 
coupled this analysis with Heather Keller’s real-time RT-PCR measurements of the 
absolute RNA levels over the course of infection for 21 of the 56 known T7 genes.  The 
measurements strongly indicate that T7 mRNA is decaying during infection.  I used the 
model to estimate degradation rates and show that the resultant mRNA profiles correct 
the previous discrepancies in protein synthesis rates. I use the quantitative mRNA 
measurements to further constrain different assumptions in the model, and discuss what 
challenges lie ahead.
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Chapter 3.2.  Background on T7 Gene Expression
Chapter 3.2.1.  General
 Bacteriophage T7 is an obligate lytic phage that infects B strains of E. coli [Dunn 
& Studier, 1983; Studier & Dunn, 1983].  The initial genetic studies of T7 found 19 genes 
to be essential for the viability of the phage, which were numbered 1-19.  Further screens 
and eventually the sequencing of the DNA revealed more genes, which were numbered 
appropriate to their locations relative to the original 19.  In total, the 39,937 base pair (bp) 
genome encodes 56 genes predicted to specify 60 proteins, of which 45 have been 
observed by polyacrylamide gel electrophoresis.  These genes are separated into three 
classes called early (class I), middle (class II), and late (class III), depending on their 
location on the genome.  To clarify the naming conventions, the genes are simply written 
as gene 1 or gene 0.3.  The protein products are labeled gp1 or gp0.3 (for gene product 
0.3).  Promoters specific to the E. coli RNA polymerase (RNAP) are labeled with a 
capital letter sometimes followed by a number such as A1 or B.  Promoters specific to the 
T7 RNA polymerase (gp1) are labeled with a ‘ø’ in front of an italicized number 
representing the gene the promoter precedes (e.g., ø10).
 
Chapter 3.2.2.  Gene Regulation by DNA Entry:
 T7 development begins with adsorption of the phage particle to the E. coli lipo-
polysaccharide, creation of a channel for DNA entry (~1 min), and entry of DNA at a rate 
of ~75 base pairs per second (bp/s) [Garcia & Molineux, 1995; Molineux, 2001].  Wild-
type T7 DNA translocation effectively stops after 850bp has entered the cell, while the 
remainder of the genome is internalized by transcription, first by RNAP at 40 bp/sec and 
then by gp1 at ~200-300 bp/sec [Garcia & Molineux, 1995].  Complete internalization of 
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the T7 genome takes under 10 min at 30˚C, or about one third of the entire developmental 
cycle.  
 Genes cannot be transcribed before they enter the cell, thus, the slow entry of the 
T7 genome regulates the time of first expression (e.g., early genes are expressed first, 
etc.).  The organization of gene functions on the genome are mostly grouped by when 
they are expressed.  The early genes, whose functions involve evading host restriction, 
expression of gene 1, and blocking E. coli RNAP activity, are among the first to enter the 
cell and thus the first to get expressed.  Whereas genes that control particle 
morphogenesis, DNA packaging, and cell lysis, are all middle or late genes and 
consequently their expression is prohibited during early infection.

Chapter 3.2.3.  Gene Regulation by Promoter Specificities and 
Strengths:
 The amount of gene expression is dependent upon the type, strengths, and 
locations of the promoters on the genome.  Class I genes are expressed early by RNAP 
using the class I promoters, while class II and then class III promoters are utilized by gp1 
later during development.  Using one or more of three strong class I promoters (A1, A2, 
A3), RNAP transcribes about 7 kb containing the first 10 genes of T7, including gp1.  
Two weaker promoters (B and C) provide no detectable transcripts of T7 DNA in vivo but 
are known to be active in the absence of the A promoters.  Transcription by RNAP is 
thought to stop at the early terminator TE, which is ~ 80% efficient in vitro, or at least 
90% in vivo [Chamberlin, et. al., 1979; Dunn & Studier, 1980; Briat & Chamberlin, 
1984].  Gp1 transcribes both class II and III genes.  Ten T7 promoters lie within the class 
II region of the genome, fewer are present in close relatives of T7 but the significance for 
any given number of class II promoters is unclear.  Transcription from all 10 promoters 
terminate, both in vitro and in vivo, at ~ 80% efficiency at Tø, the major late 
transcriptional terminator.  Five 23-base conserved class III promoters direct primary 
expression of all late genes, three of these lie upstream of Tø and thus provide 
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overlapping transcripts with those from class II promoters.  Class III promoters are, 
however, stronger than their class II counterparts because they are less susceptible to 
abortive initiation [Ikeda, 1992; Lopez et al., 1997].  Two additional T7 promoters lie 
close to each genome end; øOL is thought to be very weak and does not yield detectable 
transcripts from T7 DNA in vivo but it is known to be active in certain mutant infections 
[Moffatt & Studier, 1988; García & Molineux, 1995].  øOR has a class III consensus 
sequence but transcribes only a single non-essential gene, and thus its possible role in 
DNA replication and DNA packaging is likely more important than its transcriptional 
activity.  
Chapter 3.2.4.  Gene Regulation by Protein-level Feedback 
Mechanisms:
 T7 gene expression is regulated by feedback controls enacted at the level of 
protein-protein interactions.  First gp0.7, through an unknown mechanism, and then gp2, 
by direct binding, act in concert to shut down transcription by RNAP and thus expression 
from host DNA [Nechaev & Severinov, 1999; Hesselbach & Nakada, 1977b; Brunovskis 
& Summers, 1972].   This feedback mechanism also allows for further differentiation 
between class I genes and those genes transcribed by gp1 (class II and class III genes).  
Later in the infection cycle, T7 lysozyme (gp3.5) inhibits the function of gp1 by the 
formation of a 1:1 complex.  At, low gp3.5 concentrations, class III promoters are 
preferentially expressed over class II promoters [Villemain & Sousa, 1998], whereas at 
high concentrations of gp3.5, most transcription is repressed and only short abortive 
transcripts, which are involved in the initiation of T7 DNA replication, are produced 
[Moffatt & Studier, 1987; Zhang & Studier, 1997, 2004].  Because gp3.5-mediated 
inhibition of gp1 is required to initiate DNA replication, most phage mRNA is produced 
from the original infecting copy, and not subsequent copies of the DNA.  Thus unlike 
most phage, T7 DNA replication and late transcription are not coupled (at least at high 
multiplicity of infection).  RNA synthesis, as measured by 3H-uridine incorporation, is 
43
mostly finished by the start of DNA replication, as measured by 3H-thymidine 
incorporation [Zhang & Studier, 2004].  This aspect of T7 biology is particularly useful 
because T7 gene expression be studied and modeled fairly independently of DNA 
replication, capsid assembly, packaging, and lysis. 
Chapter 3.2.5.  Other Factors:
 Little is known about regulation of T7 gene expression at the level of translation 
other than it is likely to occur.  For example, experiments in vivo and in vitro show that 
gene 0.3 mRNA is out-competed for translational machinery by late T7 mRNA [Strome 
& Young, 1978,1980a,b].  Due to the number of overlapping genes, translational coupling 
may play a role as well.  T7 mRNA seems to be stable in E. coli,  possibly by the 
modification of the major mRNA degradation enzyme in E. coli, RNase E [Summers 
1970; Marss & Yanofsky, 1971, Marchand et. al., 2001].  In addition, there are a number 
of RNase III recognition sites on the genome that may stabilize mRNA transcripts in vivo 
[for review, see Grungerg-Manago, 1999].  Also, RNase III activity is increased upon 
phosphorylation by gp0.7 [Mayer & Schweiger, 1983]. 
Chapter 3.3.  Results
Chapter 3.3.1.  Absolute Measurements of T7 mRNA Transcripts
For completeness, I describe Heather Keller’s measurements of T7 mRNA during 
infection [Keller et al., in preparation].  Keller used real-time RT-PCR to measure 21 T7 
genes over the course of infections.  To help constrain the model, this study measured 
absolute numbers of the average number of mRNA copies per cell.  To calculate absolute 
numbers of mRNA, known amounts of in vitro transcribed RNA were used to generate 
gene-specific standard curves that the experimental samples were compared against.  In 
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addition, exogenous B. subtilis mRNA was spiked into the crude RNA samples in order to 
account for differences in extraction efficiencies between samples.   
The real-time RT-PCR measurements agree with previously reported trends in the 
timing of T7 gene expression.  As shown in Figure 3-1, the timing of expression is 
directly correlated with genome position; class I genes are expressed first and show early 
peaks, followed by class II and then class III genes.  This pattern of expression is in 
accordance with the prevailing theory regarding T7 genome entry with expression 
proceeding from left to right across the genome [Zavriev & Shemyakin, 1982; Garcia & 
Molineux, 1995]. Additionally, the timing of the measurements closely matches previous 
gene expression studies which have shown that at 30˚C: class I RNA synthesis begins 0-4 
minutes and ceases 4-8 minutes post-infection; class II transcription begins 4-8 minutes 
and falls 8-12 minutes post-infection; class III genes are transcribed between 8 minutes 
post-infection and lysis, with the expression of genes 8, 9, and 10 initiating with class II 
genes, but persisting through late times of infection [McAllister & Wu, 1978].
In addition to the timing of expression, the relative amounts of mRNAs agree well 
with expectation.  Four of the class III genes measured encode key structural components 
of the T7 phage virion, including the head-tail connector (gene 8), the scaffolding protein 
(gene 9), the capsid protein (gene 10), and one of the tail proteins (gene 11).  Each T7 
virion requires 12, 139, 415, and ~12 copies of these proteins respectively [Endy et al., 
1997; Kemp et al., 2005].  Our mRNA measurements show that the peak expression 
levels of these genes correspond with the levels of protein required during infection, with 
gene 8 < gene 11 << gene 9 < gene 10 [Figure 3-1].  In addition to quantifying individual 
transcript levels, the real-time RT-PCR approach allows us to probe other characteristics 
of T7 gene expression, such as terminator efficiency.  T7 genes 11 and 12 are only 
transcribed when the T7 RNA polymerase reads through the Tø terminator downstream 
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Figure 3-1 (next page).  Real time measurements and simulation results showing 
absolute, gene-specific mRNA levels per cell during T7 infection.  Each plot shows the 
measured (green) and computed (red;blue;purple) number of T7 mRNA per cell 
throughout infection.  Measurements were made using real-time RT-PCR.  The solid lines 
show the average all of all replicates (2-4 extractions per gene, each extraction measured 
in triplicate).  Shaded regions represent the range of the measurements, with the standard 
deviation show by error bars.  Simulation data represents the Unfit model (blue), initial fit 
(red), and best fit model (purple; Traffic Jam model with increased promoter strength).  
The width of the computed curves shows the variation (± standard deviation) from the 
average of 25 simulations.  
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of gene 10.  The ratio of the gene 11 to gene 10 measurements (between 6 and 25 minutes 
post-infection) indicates an in vivo terminator efficiency for the phage specific terminator 
Tø. The measured average value of 78% ± 5% is consistent with previous in vitro 
measurements of ~80% [Lyakhov et al., 1997].  Previous in vivo measurements on 
plasmids give a range of termination efficiencies when transcribing T7 DNA (66-98%) 
depending on the promoter used to initiate transcription [Macdonald et al., 1993, 1994].  
 Unlike previous reports, many of the T7 genes measured show reduction in 
absolute transcript levels during middle and late infection, which is visually apparent in 
Figure 3-1.  19 of 21 genes show meaningful reduction from the peak expression levels 
(as measured by a Student T-test) [Keller et al., in preparation].  The rates of decline are 
transcript-specific with the class III genes displaying the greatest stability.  
 Measurement locations within genes were chosen to ensure specificity of the 
primers; consistent positioning within the gene was not a design criterion.  To test the 
possibility that different regions of a given transcript show non-uniform behavior, Keller 
designed a series of five primer pairs spaced throughout gene 1.  Each primer pair 
displayed different absolute levels of expression for gene 1.  For example, the peak 
expression at 10 minutes for gene 1 showed the most difference between measurements 
ranging from ~300 to ~1700 copies of RNA per cell [Keller et al., in preparation].  
However, the shape of the expression curves are consistent throughout infection.  Thus, 
while the absolute levels of mRNA may be affected by measurement location, the 
observed reduction in relative mRNA levels is still significant.  
Chapter 3.3.2.  Molecular Model for T7 Gene Expression
 I constructed a model for T7 gene expression using Tabasco.  Tabasco tracks 
individual molecules of phage DNA inside the cell and the polymerases transcribing the 
DNA at single-base resolution [§2].  The initial model was parameterized using empirical 
results combined with some prevailing assumptions of T7 biology [§3.6].  I did not adjust 
parameters a priori to account for system level data.
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 I compared mRNA levels of our measurements to output from the simulations 
based on our initial model [Figure 3-1].  Notably, given the available information prior to 
the mRNA measurements, the initial model did not encode mechanisms for RNA 
degradation.  The computed mRNA values are, for the most part, overestimates of the 
measured values and the average R2 (fraction of variance explained) is 0.2645 [§3.5.3].  
However, the timings for the initial rise in measured mRNA levels did match the 
simulation well [Figure 3], indicating the prevailing model for RNA polymerase mediated 
genome entry is consistent with the mRNA observations [Zavriev & Shemyakin, 1982; 
Garcia & Molineux, 1995].  In addition, the timing of transcription initiation and shutoff 
agree with published results [Figure 3-2; Zhang & Studier, 2004].
 Based on observed degradation of measured mRNA, I decided to incorporate 
mRNA degradation into the model.  I initially simulated a range of degradation rates 
constant for all genes (data not shown).  These simulations did not produce useful 
improvements in the comparisons.  At low degradation rates the simulations could not 
account for the fast decline of class I and II mRNA, and at high degradation rates the 
simulations could not produce high levels of class III mRNA.  I next attempted to 
estimate degradation rates by fitting a range of transcript-specific degradation rates to the 
measured data (called Initial fit).  Currently, an exhaustive search of degradation rates is 
computationally unfeasible.  Thus, I developed a fitting procedure that determines 
degradation rates of genes from left to right across the genome [§3.5.3].  While not 
exhaustive, comparisons between measured and fit mRNA levels were visually better and 
the average R2 was 88% better (0.4641 versus 0.2645) [Figure 3-1, red; Figure 7-2a; 
§3.5.3; §7.3.3].  The results for individual genes and estimated half-lives for transcripts 
are described in Table 3-1.  In general, class I genes were the quickest to be degraded, 
followed by class II genes, and most class III genes showed very little degradation.  There 
are exceptions to this trend, the most apparent of which are genes 1.1, 8, and 18.5.  
Finally, previous models and simulations, which did not account for mRNA degradation, 
failed to recapitulate the experimentally observed drop in class I and II protein synthesis 
rates [§1.2.3; Figure 1-2; Endy & Brent, 2001; Endy et al., 2000].  The simulations fit to 
the mRNA measurements produced better correspondence to the observed protein 
synthesis rates [Figure 3-3]. 
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Figure 3-2.  Simulated transcriptional activity during T7 infection.  Transcription initiations 
over time (a) from strong (dark blue) and weak (light blue) E. coli promoters as well as the three 
classes of T7 promoters (strong -- dark red; weak processivity -- magenta; weak processivity 
and binding -- pink) show initial rise at expected timings followed by shutoff later in infection.  
The attenuation of promoter activity is reflected in the RNA bases polymerized during infection 
by each of the polymerases (b), and correspond with published results [Zhang & Studier, 2004].  
Note the simulations do not account for transcription from the host genome.
Figure 3-3.  Simulated and Measured Protein Synthesis Rates.  Simulations (blue) 
match previous experimental results [Endy & Brent, 2001]  showing shutdown of class I 
and II mRNA much better than previous models (Figure 1-1) when the simulations are fit 
to mRNA degradation rates.  The simulations shown are from the Initial fit.  
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Chapter 3.3.3.  Constraining Models of T7 Gene Expression
 I wanted to test the ability of the new RNA measurements to constrain areas of 
uncertainty in the models.  I tested different assumptions used in the model concerning 
promoter strengths, RNA degradation, and polymerase interactions.  Generally, I would 
alter a particular assumption, and then test the ability of the new simulations to fit the 
mRNA data shown.  I hoped that altering the assumptions and looking at how the 
comparisons were affected would eliminate some hypotheses.  
 I observed that simulated RNA polymerase initiation rates indicated that the 
encoded high abortive initiation percentage was limiting the transcription initiation rate 
(data not shown).  The host and phage promoters on the T7 genome are among the 
strongest known prokaryotic promoters [Lopez et al., 1994].  I suspected that the 
measured in vitro rates of abortive initiation used in the simulation are higher than the 
actual in vivo rates.  I tested the effect of increasing promoter initiation rates of all the 
promoters [§3.6.5].  I then refit individual degradation rates to the measured mRNA 
levels [Table 3-1; Figure 7-1a; Figure 7-2b].  Overall, the simulations with increased 
RNA polymerase initiation rates give an average R2 that is only 14% better than the 
originally encoded rates.  Most of this change was due to better fits for the class I genes, 
which showed an average R2 that was 30% better.  
 I next tested different RNA degradation mechanisms in the simulations.  The 
Initial fit assumed the degradation machinery competes with ribosomes for the ability to 
degrade mRNA [Yarchuk et al., 1991, 1992].  Thus, an mRNA with a bound ribosome 
binding site is immune to degradation [Table 3-1; Figure 7-1b; Figure 7-2c].  I also tested 
a scenario where mRNA degradation was independent of translation initiation.  I found 
that the simulations assuming competition for RNA showed moderately better fits for 
class I genes (14%), but the class II and class III mRNA fits showed little change (4% 
better each).  
 Finally, I simulated different outcomes resulting from RNA polymerase 
interactions.  Transcribing T7 RNA polymerases are expected to interact with E. coli 
RNA polymerase during infection, because T7 RNA polymerase is measured to have a 
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five-fold higher synthesis rate [Garcia & Molineux, 1995].  I simulated, fit, and compared 
four separate hypotheses of polymerase interactions.   First, upon collision, the 
downstream transcribing polymerase could terminate transcription, allowing the upstream 
polymerase to pass (termed DSF for DownStream Falloff) [Table 3-1; Figure 7-1c; Figure 
7-2d].  Incomplete mRNA being transcribed from the terminated polymerase are also 
degraded, and ribosomes translating the nascent mRNA are freed.  Second, the upstream 
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half life nodeg init prom AltDeg DSF traffic USF
0.3 0.11 4 3 4 3 2 2
0.7 0.18 2 2 4 2 1 1
1 0.19 4 4 5 6 1 2
1.1 0.17 15 9 15 15 5 Inf
1.2 0.05 7 6 7 7 2 8
1.3 0.04 3 3 3 4 1 2
1.4 0.06 3 3 3 4 2 2
1.7 0.48 8 6 9 8 3 15
2 0.50 Inf Inf Inf Inf Inf Inf
2.5 0.18 14 11 12 15 6 Inf
3.5 0.43 14 14 Inf Inf 15 Inf
5 0.15 5 5 6 6 4 12
6 0.17 7 6 6 8 4 Inf
8 0.01 3 2 3 4 2 14
9 0.47 Inf Inf Inf Inf 14 Inf
10A 0.54 Inf Inf Inf Inf Inf Inf
11 0.44 Inf Inf Inf Inf Inf Inf
15 0.48 Inf Inf Inf Inf Inf Inf
16 0.23 14 10 13 15 7 Inf
17.5 0.24 Inf Inf Inf Inf 15 Inf
18.5 0.07 4 5 5 5 2 13
class I avg 0.0 3.9 3.5 4.8 4.1 1.4 2.3
class II avg 0.0 7.4 6.8 8.1 9.5 4.5 10.8
class III avg 0.0 12.2 10.0 13.1 15.5 6.2 53.9
class I R2 0.12 0.44 0.57 0.48 0.43 0.60 0.39
class II R2 0.28 0.46 0.52 0.50 0.44 0.50 0.36
class III R2 0.31 0.48 0.51 0.49 0.42 0.53 0.32
total R2 0.2465 0.4641 0.5295 0.4905 0.4299 0.542 0.3541
Table 3-1.  Estimated half-lives for mRNA and R2 for each gene.  T7 genes are listed 
in the first column.  The second column lists the R2.  Columns 3-8 list the estimated half 
lives for the initial fit (init), increased promoter strengths (prom), the alternative 
degradation model (AltDeg), the downstream falloff model (DSF), the traffic jam 
model (traffic), and the upstream falloff model (USF).  Each half-life fit is shaded in 
one of 5 levels of grey corresponding to R2 in 0.2 increments (darker indicates better 
fit).  Inf refers to no degradation rate, or an infinite half life.  The bottom of the table 
lists geometric mean for half-life and arithmetic mean of the R2 for each of the classes 
of genes.
polymerase could also terminate transcription (USF), and incomplete mRNA are treated 
as in the DSF case [Table 3-1; Figure 7-1d; Figure 7-2f].  Third, the upstream polymerase 
could follow at the speed of the downstream polymerase (Traffic) [Table 3-1; Figure 3-1, 
purple; Figure 7-2e].  Fourth, only an upstream T7 RNA polymerase can cause 
termination of a downstream E. coli polymerase (same as increased promoter strength 
model) [Table 3-1; Figure 7-1a; Figure 7-2b].  All other interactions in the Hybrid 
simulations follow the Traffic simulation rules.  I fit each of the models separately to the 
measured mRNA data.  The USF simulation was the worst at fitting the data with an 
average R2 of 0.35, the DSF simulation was 21% better at fitting the data [Table 3-1].  
The Hybrid and Traffic simulations both fit the model well, showing 49% and 53% better 
fits than the USF model, respectively [Table 3-1].  I did not consider a model where 
polymerases do not interact, i.e., they pass through one another unimpeded.  The internal 
data model of Tabasco cannot represent two polymerase occupying the same space on the 
DNA.  
Chapter 3.4.  Discussion
 In this study, the mismatch between previous models and experimental data led us 
to quantitatively measure T7 mRNA as well as to construct more detailed models of gene 
expression.  Heather Keller measured absolute mRNA levels during T7 infection for 21 
representative T7 genes.   These measurements agreed with many known aspects 
regarding the timing and levels of T7 gene expression.  However, the observed systematic 
mRNA degradation is in contrast to many previous studies [Summers, 1970; Mars & 
Yanofsky, 1971; Yamada et al., 1974a; Yamada et al., 1974b; Yamada et al., 1975].  I 
constructed a best-faith effort to construct a detailed, unfit, and biophysically realistic 
model of T7 gene expression during infection.  Initial comparisons between the model 
and the measured mRNA levels showed significant discrepancies, primarily due to model 
assuming mRNA levels were stable.  I developed a procedure to fit degradation rates to 
individual transcripts to fit the mRNA measurements.  This procedure produced  
estimates of the mRNA half-lives, and a much better overall fit to the data.  The fit 
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simulations also corrected previous discrepancies between the simulated and measured 
class I and II protein synthesis rates. 
  Measurement of absolute levels of mRNA provided stricter comparisons to our 
simulations than relative levels could have provided.  I used the mRNA measurements to 
evaluate different hypotheses related to promoter strengths, RNA degradation, and 
polymerase interactions.  For example, when I tested four different possibilities on the 
nature of expected polymerase interactions, two could not be optimized to fit the 
measurements well.  However, the large error associated with the absolute RNA levels 
prevented confident discrimination of models concerning promoter strengths and 
mechanisms for RNA degradation.  
The measurements also question previous work indicating that transcription 
ceases before DNA replication begins [Zhang & Studier, 2004].  The measurements show 
transcription late in infection of a region upstream of the first rightward facing host 
promoter A1.  Transcription in this early region begins 10-12 minutes post-infection, at 
least two minutes after transcription begins from all other measured regions [Keller et al., 
in preparation].  During DNA replication, T7 DNA forms concatemers connecting the 
left end of the genome to the right end [Watson, 1972].  The late rise of mRNA levels 
from this early region suggests that transcription from the right end of the genome is 
continuing through the concatemer junction.  The presence of concatemer junctions 
during transcription indicates that DNA replication is initiated before RNA production is 
complete.  DNA replication during the course of transcription would augment the levels 
of late gene expression predicted by the model.   Further exploration of the timing and 
extent of DNA replication during infection is needed to verify if the observations are 
meaningful.  
We chose to use real-time RT-PCR to measure RNA levels because of the 
method’s proven sensitivity, specificity, and dynamic range [Wong & Medrano, 2005; 
Bustin, 2000].  However, we found that many aspects of real-time RT-PCR detract from 
its usefulness in making absolute measurements for constraining a model.  First, the 
measurements show that the exponential nature of PCR leads to large error in absolute 
measurements, making comparison to a model difficult.   Second, we found that the 
location of the measured region within a gene affects the observed RNA levels.  We are 
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unable to distinguish between partial and complete transcripts using the standard 
50-150bp regions.  Therefore, our measurements are likely overestimates of the 
functional mRNA levels.  Longer amplification regions would decrease the detection of 
partial transcripts, but also lead to problems with RT efficiency, increased PCR 
optimization, and reduced throughput.   Third, real-time RT-PCR is expensive and time-
consuming for large-scale studies.  Ultimately, real-time RT-PCR is still one of the best 
methods currently available for accurate and sensitive measurement of mRNA, but better 
techniques are still needed [Wu & Schwartz, 2007]. 
Although our T7 gene expression model is more complete, there are still 
mechanisms that need elucidation before we can confidently make model-based 
predictions of perturbations such as genome rearrangements. For example, the models 
often underestimate the RNA levels measured in some late genes such as 10 and 15.  
Could this be explained by the concurrence of DNA replication and transcription we have 
hypothesized?  In addition, the simulator cannot match the sharp rise and subsequent fall 
for some class II genes such as 1.7, 2, 2.5.  Might this indicate our lack of understanding 
of degradation mechanisms and/or promoter strengths?  Also, we need a better 
understanding of how the properties individual genetic elements change when placed in 
different contexts in order to predict the effects of gene rearrangements.  For example, 
how do mRNA degradation rates change when moving a gene from one position to 
another?  Finally, for gene pairs that are expected to be on the same transcript, such as 
1.1/1.2 and 15/16, the measurements often show that the downstream genes have 
significantly lower mRNA levels.  Are there processivity effects of the RNA polymerase 
that I am not taking into account?  Further understanding of such questions will bring us 
closer to making accurate model-based predictions.
We can continue the process of increasing our measurement capabilities and study 
T7 until we can make predictable changes to the genome.  I have also started to work on 
another approach.  Rather than making our computational models more realistic 
approximations of the natural organism, I am constructing new biological organisms that 
are closer approximations of our models [§4].  Thus, I am constructing organisms that are 
better optimized to be understood by insulating and standardizing the genetic elements, as 
well as removing complicating elements.   
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Chapter 3.5.  Methods
Chapter 3.5.1.  Model Parameterization
I used mostly empirical data along with some assumptions of T7 biology to 
constuct a first-pass model of T7 gene expression.  Briefly, I derived canonical rates for 
transcription and translation from previous empirical studies.  I classified and 
parameterized three classes of T7 promoters and two classes of E. coli promoters. 
Polymerase processivity rates, translation rates, and termination efficiencies were taken 
from literature values as well.  Without better information, all translation initiation sites 
were assumed to have the same strength.  Complete details on the parameterization can 
be found in §3.6.
Chapter 3.5.2.  Simulation
 Simulations were executed using the Tabasco simulator [§2.2].  All data shown 
are for average of 25 runs of each simulation.  Simulation of a single infection run takes 
2-4 hours on a single processor (AMD Athalon).  Input files and scripts are provided in 
the appendix [§7].  
Chapter 3.5.3.  Fraction of Variance Explained (R2)
 I used R2 as a metric for comparing our models and measurements.  For each gene 
and timepoint I summed the mean-squared distance (MSD) from the average normalized 
simulator value to each of the individual normalized measurement values for that 
timepoint.  Both the simulations and measurements were normalized to the highest 
measurement or simulation value recorded for each particular gene.  I summed the MSD 
for all the gene’s timepoints from 0-25 minutes.  I also found the minimal MSD 
achievable by using the average measured value at each time-point instead of the 
simulated value in the calculation.  Then I divided the minimal MSD by the simulation 
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MSD across all the timepoints to give an R2 for a particular gene.  The R2 will equal 1 if 
the simulations produce the average experimental value for each timepoint.  Many 
comparisons use the average R2, which refers to the average R2 for all genes in a 
particular simulation.  The average R2 is not equivalent to calculating R2 for all the 
timepoints in all the genes all at once. 
Chapter 3.5.4.  Fitting mRNA Degradation Rates
 I optimized mRNA degradation rates to the measured mRNA levels through an 
iterative process.  I first found an average mRNA degradation rate for all class I genes by 
fitting a range of degradation rates (from 0-15 minute half-lives in 1 minute increments) 
and finding local maxima for the R2.  I then set the class I average, and tested ranges for 
the average class II mRNA degradation rates and then class III rates.  After the averages 
were set for all the classes, I tested ranges and fixed degradation rates for each of the 
individual genes measured from left (gene 0.3) to right (gene 18.5).  Upon inspection, the 
R2 for almost all the genes and gene classes showed local maxima (or a maxima at one 
end of the range) at only one location.  Each fit was also inspected visually to make sure 
that the procedure did not produce obviously unrealistic fits.  Finally, I found that fitting 
the later genes did not affect the fits of the earlier genes substantially as evidenced by the 
lack of large R2 changes of the fits of upstream genes after fitting downstream genes.
Chapter 3.6.  Model Parameterization
Chapter 3.6.1. Constants for Transcription
Chapter 3.6.1.1.  RNA polymerase transcription rate and footprint
The rate of E. coli RNA polymerase transcription varies on the conditions and 
templates of the measurements.  For example, the transcription rate has been previously 
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measured in vitro to be 55 base pairs per second (bp/s) at 37˚C [Bremer & Yuan, 1968], 
but 43 or 25-28 bp/s at ~30˚C [Manor et al., 1969; Rose et al., 1970].  More recently, in 
vivo studies have measured the rate to be 45 bp/s at 30˚C and 24-62 bp/s at 37˚C [Garcia 
& Molineux, 1995; Epshtein & Nudler, 2003].  I use the 45 bp/s measurement in our 
simulations because the mRNA measurements are done at 30˚C. For the T7 RNA 
polymerase transcription rate, I used previous in vitro and in vivo measurements to obtain 
a value of 230 bp/s [Golumb & Chamberlin, 1974a; Garcia & Molineux, 1995].
In addition to the transcription rate, I parameterized the footprint of the 
polymerase in order to account for when they do or do not block other proteins from 
accessing the DNA.  The T7 polymerase elongation complex keeps a transcription bubble 
size of ~9 bp, and a potential footprint of ~13 bp [Liu & Martin, 2002].  I used the latter 
value in the size of the footprint during T7 transcription.  E. coli polymerase is protected 
from cleavage by free radicals by ~25 bp [Zaychikov et al., 1995; Nudler et al., 1996; 
Nudler et al., 1998; Korzheva et al., 2000; Greive & von Hippel, 2005].  I used 15 bp as 
an estimate for the amount of DNA blocked by all the polymerases.
Chapter 3.6.1.2.  Promoters Strengths
E. coli promoter parameterization
There are three major E. coli promoters, A1, A2, and A3 that are known to direct 
most E. coli polymerase transcription during infection [Dunn and Studier, 1983].  In vitro 
studies also identified several minor promoters named B, C, D (also known as A0), and E 
[Minkley & Pribnow, 1973; Delius et al., 1973; Stahl & Chamberlin, 1977].  Due to its 
leftward directionality, I did not include the D promoter in the simulation.  In addition, 
the E promoter was also ignored due to its location close to the right end of the T7 
genome.  Very little activity E. coli polymerase activity remains by the time the E 
promoter has entered [Hesselbach and Nakada, 1977].  
I used stopped-flow kinetic analysis data to parameterize the A1 promoter 
[Johnson & Chester, 1998].  Abortive initiation assays show that the minor promoters 
have approximately a ten fold reduction in binding, which is reflected in our 
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parameterization by a 10-fold increase in koff [Dayton et al., 1984].  Figure 2-6 and Table 
3-2 describe the exact parameters used in simulations. 
T7 promoter parameterization
Traditionally, the T7 promoters 
are classified into one of three groups: 
the class II non-consensus promoters, 
the class III consensus promoters, and 
the replication promoters [Dunn and 
Studier, 1983].  The class III promoters, 
along with one of the replication 
promoters, øOR, all share the same 23 
base pair sequence from –17 to +6 
relative to the transcription start site at 
+1.  The class II promoters and the 
other replication promoter, øOL, have 
mutations from this consensus sequence 
that are described in Table 3-4.  I could 
not find a biophysical justification to 
differentiate between the replication 
promoters from the class II and class III 
promoters, so I treated øOL as a class II, 
and øOR as a class III T7 promoter.  
Due to a lack of quantitative 
data to parameterize each promoter 
separately, I grouped the promoters into 
classes that could be parameterized.  All 
the consensus promoters have the same 
parameters.  I classified the non-
consensus promoters by their deviations 
from the consensus sequence into either 
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Name of 
constant
A1,A2,A3 B,C w/ gp0.7 w/ gp2
kon 1.5E7 1.5E7 as before 0
koff 0.28 2.8 as before N/A
kiniton 0.19 0.19 as before N/A
runoff % 100 100 70 N/A
kelong 6 6 as before N/A
krecyc N/A N/A 0.19 N/A
Table 3-3.  Constants for the E. coli RNA 
polymerase promoter initiation.  See Table 
3-2 for an explanation of the constants.
Name of 
Constant
Process Description
kon
Rate of RNA polymerase binding to 
DNA to form an initiation complex 
(M-1s-1). 
koff Initiation complex releasing to form RNA polymerase and free DNA (s-1).
kiniton
Rate of transition from an initiation 
complex to an elongation complex 
(creation of first two nucleotides and 
bubble formation) (s-1).
runoff %
Percent of elongation complexes that 
continue transcribing past the 
promoter region instead of recycling 
to an initiation complex
kelong
Rate of elongation complex clearing 
promoter and leaving initiation phase 
(s-1).
krecyc
Rate of recycling by promoter fall 
off and rebinding to initiation 
complex (s-1).  
Table 3-2.  Description of promoter constants 
used in model. See Figure 2-6 for the 
corresponding visual depictions of the constants.
weak processivity, or weak binding and processivity.  It is known that the region from –
17 to –5 mostly contributes to the free energy of polymerase binding, the –3 to –1 region 
is mostly important in initial double strand melting, and the +1 to +6 region is important 
in the formation of a stable elongation complex [Bandwar & Patel, 2002].  Differences in 
the -3 to +6 region affect the kinetic rate of polymerase initiation similarly by reducing 
the rate of polymerase initiation [Ikeda, 1992].  Thus, differences from consensus in the 
binding region (-17 to -5) places the promoter in the weak binding category, and 
differences in the -4 to +6 region lead to weak processivity.  The only exception is the 
øOL promoter, where the –11 G to A difference was previously characterized as having 
very little effect both in vivo and in vitro [Ikeda et al., 1992].  
After a preliminary analysis of available kinetic data, I created a framework for 
promoter initiation in Tabasco in order to reflect the mechanisms thought to control T7 
RNA polymerase promoter initiation [Figure 3-2].  I then parameterized each class of T7 
promoters above from interpretation of available data.  For consensus promoter binding I 
used a kon of 1.82E8 M-1s-1 and a koff of 0.2 seconds [Bandwar et al., 2002; Ujvari and 
Martin, 1996].  For weaker binding, I used constants of 6.0E7 M-1s-1 and 18 s-1 for the 
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Non-consensus 
Promoter
differences from 
23bp consensus
grouping
øOL -11,1 weak processivity 
ø1.1A -17,2,4 weak binding&processivity
ø1.1B 3,4,5 weak processivity
ø1.3 -5,5 weak binding&processivity
ø1.5 -2,3,4,5 weak processivity
ø1.6 -2,3,4,5,6 weak processivity
ø2.5 -1,1,4,5 weak processivity
ø3.8 -13,-12,-11,-2 weak binding&processivity
ø4c -17,-13,2 weak binding&processivity
ø4.3 -2,3,4,5,6 weak processivity
ø4.7 -17,-16,-13,3,4,5,6 weak binding&processivity
Table 3-4.  Non-consensus T7 promoters classification.  The T7 
weak promoters are split into two classes.  The first class has  
differences in the binding region (-17 to -5) and the processivity 
region (-3 to 6).  The second class has differences only in the 
processivity region (see text).
kon and koff respectively [Bandwar et al., 2002].  Finally, I estimated promoter clearance 
rates based on the work of Ikeda [Ikeda, 1992].
The constants for the initiation rate to form an elongation complex (kiniton), the 
rate to clear the promoter if it is does not fall off (kelong), and the rate at which 
terminated elongation complexes recycle to the promoter complex (krecyc) are all kept 
constant across the different types of promoters.  All these constants were derived from 
the promoter initiation studies of Jia and Patel [Jia & Patel, 1996].  Kiniton was measured 
directly at a rate of 1.82 M-1s-1.  I inferred from the study that the the rate of addition of 
bases +2 to +6 (kelong) is 30 s-1bp-1, plus the remaining 9 bases for the polymerase to 
clear the promoter at ~230 bp/s, which gave a total of 5.8 s-1.  Krecyc represents the 
addition of 4 bases and then a 1 second falloff step, to give a total rate of 0.88 s-1.
Chapter 3.6.1.3. Feedback inhibition on RNA polymerases
Interactions of the E. coli RNA polymerase with gp0.7 and gp2.
The phosphorylation of the ß’ subunit of the E. coli RNA polymerase by gp0.7 is 
thought to cause a reduction in host transcriptional activity [Zillig et al., 1975].  
Paradoxically, phosphorylation and host shutoff functions are distinct and separable by 
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T7 Polymerase T7 Polymerase :: Lysozyme
Name of 
constant
strong wbp wp strong wbp wp
kon (/M s) 1.82E8 6.0E7 1.82E8 1.82E8 6.0E7 1.82E8
koff (/s) 0.2 18 0.2 0.2 18 0.2
kiniton (/s) 3.5 3.5 3.5 0.875 0.875 0.875
runoff % 70 30 30 42 18 18
kelong (/s) 5.8 5.8 5.8 1.45 1.45 1.45
krecyc (/s) 0.88 0.88 0.88 0.22 0.22 0.22
Table 3-5.  Constants for T7 polymerase initiation for different 
promoter classes.  The parameterization of T7 promoters is split into 3 
classes respresenting the T7 concensus promoters (strong), and two classes 
of weak promoters; those with differences causing weak processivity (wp) 
and those with both weak processivity and weak binding (wbp) [Table 3-4].
mutation [Michalewicz & Nicholson, 1992; Simon & Studier, 1973].  For the purposes of 
this model, I assumed a generalized catalytic model for reducing host polymerase activity 
by gp0.7.  I encoded the measured 70% reduction in activity [Hesselbach & Nakada, 
1977a], by assuming gp0.7 modified host polymerase will abort initiation 30% of the 
time.  I assumed the rate at which phosphorylation occurs to be quick, with an kon 
equivalent to the fast association rate measured in the gp1-gp3.5 interaction (see below).  
More recent analysis, which was not accounted for in this study, shows that gp0.7 
phosphorylation increases rho-dependent transcription termination [Severinova & 
Severinov, 2006].
Gp2, the protein encoded by gene 2, strongly inhibits E. coli RNA polymerase 
transcription [Hesselbach et al., 1974; Hesselbach & Nakada, 1975].  From interpretation 
of data from Hesselbach and Nakada [1977b], the Kd of the gene 2, host holoenzyme 
interaction is between 2.8E-8 and 5.6E-8 M, which is ~2-3 times as strong that of the 
gp1-gp3.5 interaction (92 nM, see below).  I assumed that this difference is a reduction in 
koff, to 1.1 s -1, because traditionally koff is the determinant in the strength of binding 
interactions.  I chose the higher end of strength because of data showing that the 
disassociation rate of the complex is quite slow [Hesselbach & Nakada, 1977b].  The 
transcriptional activity of the gene 2-host RNA polymerase complexes are assumed to be 
zero.
Interactions of T7 polymerase with T7 lysozyme.
T7 lysozyme encoded by gene 3.5 inhibits transcription by the T7 RNA 
polymerase by the formation of a 1:1 complex [Moffatt & Studier, 1987; Zhang & 
Studier, 1997, 2004].  I use the association and dissociation rates for the T7 polymerase 
and lysozyme of 3.8E7 M-1s-1 and 3.5 s-1 respectively [Stano & Patel, 2004].  From 
Kumar & Patel’s study, I estimate that T7 lysozyme’s effect on transcription are 
approximately ~60%, thus reducing the runoff percentage for strong and weak promoters 
to 42% and 18% respectively [Kumar & Patel, 1997].  In addition, attenuation of the rates 
of initiation and initial elongation are also observed to be 25% of uninhibited polymerase 
[Kumar & Patel, 1997].  The effect seems to occur for both class II and class III 
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promoters equally [Ikeda & Bailey, 1992].  A summary of parameter changes upon 
lysozyme binding is presented in Table 3-5.
Chapter 3.6.1.4.  Transcription Termination
There are three known functional terminators on the T7 genome.  Starting from 
the left end of the genome, terminator TE causes termination of RNAP quite efficiently in 
vitro (>95%) with the addition of an unknown protein co-factor in E. coli called tau [Briat 
& Chamberlin, 1984].  In vivo termination rates are also increased by modification of the 
E. coli RNA polymerase by gp0.7 [Zillig et al., 1975; Nechaev & Severinov, 2003; 
Severinova & Severinov, 2006].  However, T7 RNA polymerase efficiently transcribes 
past TE [Dunn & Studier, 1980].   Currently, I set the termination rate of E. coli RNA 
polymerase at TE to 100% for reasons discussed in the polymerase interaction section 
(§3.2.1.5).  
There are two specific terminators of T7 RNA polymerase.  The first is called Tø 
located between gene 10 and gene 11 and is about 80% efficient in vitro [Lyakhov, et al., 
1997].  The T7 lysozyme activity was shown to have no effect on the termination at Tø.  I 
used the in vitro termination efficiency for the simulations.  The other is the CJ pause site 
located near the left end of the genome [Golomb & Chamberlin, 1974a].  As this 
terminator is located upstream of all known promoters, its role in gene expression is 
probably minimal.  Thus, the CJ terminator was ignored for the sake of these simulations.  
Chapter 3.6.1.5.  Inter-Polymerase Interactions
Several lines of circumstantial evidence points to interactions between host and 
phage polymerase.  First, upstream E. coli polymerases that collide with downstream 
polymerase tend to rescue polymerases from small pauses in a cooperative manner 
[Epshtein & Nudler, 2003].  In addition, expression of a gene from tandem E. coli   
promoters causes interference of RNAP and attenuates gene expression [Adhya & 
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Gottesman, 1982; Horowitz & Platt, 1982; Nomura et al., 1985].  I assumed for the sake 
of these simulations that an upstream polymerase, upon encountering a downstream 
polymerase, will follow behind and be limited by the speed of the downstream 
polymerase.  This can lead to problems with genome entry however, if there is any read-
through by the E. coli polymerase at TE, which is why I approximated the termination 
efficiency at 100%.  
Chapter 3.6.2.  mRNA Degradation
While there is some evidence of early class I T7 RNA being unstable [Yamada et 
al., 1974a,b, 1975], it is generally thought that T7 mRNA is quite stable during infection. 
To begin, I initially assumed for the sake of simplicity, that T7 mRNA does not degrade.
Chapter 3.6.3.  Constants for Translation
There is little data available on translational strengths of T7 genes.  Thus I 
assumed that all proteins are transcribed with equal efficiency.  I used a simple model for 
translation initiation.  I assumed diffusion limited binding of the ribosome to the RNA 
with a rate of 1E7 M-1s-1 [de Smit & van Duin, 2003], followed by a slow initiation step 
of 0.3 s-1 [Kennell & Riezman, 1977].  I assumed the rate of translation to be constant 
across all mRNA at an average rate of 15 amino acids per second, taken from the analysis 
of in vivo ribosomal elongation rate experiments [Dalbow & Young, 1975].  Estimates of 
the physical and chemical footprints of the ribosome range between 30 and 40 bases 
[Steitz, 1969; Hüttenhofer & Noller, 1994; Yusupova et al., 2001].  I used 40 bases to be 
prudent.
Chapter 3.6.4.  Host Parameters
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 I assumed the host cell to have an average volume of 8E-16 L [Donachie & 
Robinson, 1987].  I assumed a value of 1800 molecules of active host RNA polymerases 
in the cell at the time of infection [Bremer & Yuan, 1968].  I also overestimated the 
number of ribosomes available for T7 infection in two ways.  First, I assumed that no 
host mRNA translation is occurring at the time of infection.  Furthermore, I assumed that 
10,000 ribosomes are available to the cell, which is on the high end for a cell with 
doubling time of ~30 minutes [Bremer & Dennis, 1996].
Chapter 3.6.5.  Model Refinements
 I tested different models for phage gene expression based on their ability to fit the 
mRNA profiles by fitting the models to the measured mRNA profiles [§3.5.4].  I first 
increased promoter strengths of the encoded promoters in T7.  Both the E. coli strong 
promoters and T7 promoters are amongst the strongest known promoters known in vivo 
in E. coli [Lopez et al., 1994].  The initial parameterization of the promoter strengths 
were based on in vitro measurements, and the initiation rates were limited by the 
initiation timings.  I expected that these values were underestimates of the actual in vivo 
rates, and thus I increased the initiation rates of these promoters to test the effects on the 
overall fit.  The initiation rate (kiniton) of the strong E. coli promoters was increased from 
0.19 per second to 0.4 per second.  I increased the T7 promoter strengths by increasing 
the runoff percentage of uninhibited T7 polymerase to 50% and 100% (from 30% and 
70%) for the class II and III promoters respectively.    The refinements testing alternative 
degradation model and the polymerase interaction models are described earlier in the text 
[§3.3.3]. 
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Chapter 4.  Refactoring
 This chapter is based on a manuscript I co-wrote and published with Leon Chan 
and Drew Endy [Chan et al., 2005].  The planning, design, construction, and testing of 
work done on this chapter was done in conjunction with Leon Chan.
Chapter 4.1.  Introduction
 In nature, the success of an individual organism depends directly on its ability to 
continue to exist and replicate.  Not surprisingly, natural biological systems appear to 
have evolved, and continue to evolve, to meet these requirements [e.g., Block et al, 1982; 
Aho et al, 1988].  However, should we also expect that the ‘design’ of an evolved 
organism would be further optimized for the purposes of human understanding and 
interaction? Evidence drawn from fields outside biology suggests that the answer is no.
 For example, consider two different approaches to programming computers and 
electronics: ‘genetic programming’ and ‘structured design.’  In genetic programming, 
evolutionary algorithms are used to evolve computer software or electrical hardware for a 
particular task [Koza et al, 2003].  The absolute performance of evolved systems often 
meets, and sometimes exceeds, that produced by human-directed designs [Spector et al, 
1999].   However, so-evolved systems are difficult to understand, fix, and modify for new 
applications [Jacob, 1977].  By contrast, a structured design process produces systems 
that, in addition to functioning, are designed to be easy to understand and extend 
[Abelson et al, 1996].  Not surprisingly, an artifact produced via structured design may 
not be optimal when evaluated only in terms of absolute algorithmic or physical 
performance.  However, a structured design process can bypass two limitations, direct-
descent and replication-with-error, which constrain the designs of evolved systems.  
Thus, we might paradoxically expect that a structured design process will, when 
practical, produce artifacts whose designs can ‘evolve’ more quickly.
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 Here, I, with Leon Chan, converted the genome of a natural biological system, 
bacteriophage T7, to a more structured design.  Our work was initially motivated by past 
failures in modeling T7 development (below) and by a desire to better understand how 
the parts that comprise bacteriophage T7 work together to encode a functioning whole 
[Kirschner, 2005]. The design approach we used was inspired by the practice of 
‘refactoring,’ a process that is typically used to improve the design of legacy computer 
software [Fowler et al, 1999]. In general terms, the goal of refactoring is to improve the 
internal structure of an existing system for future use, while simultaneously maintaining 
external system function.
Bacteriophage T7 (T7) is an obligate lytic phage that infects Escherichia coli 
[Molineux, 1999,2005].  Scientists isolated T7 and other phage to begin to study the 
physical characteristics and components of biological systems [Demerec & Fano, 1945]. 
Genetics, and then biochemistry, enabled the discovery and characterization of some of 
the individual elements that participate in T7 development.  Sequencing of the T7 
genome revealed additional elements [Dunn & Studier, 1983], not all of which have 
obvious functions [§1.2.1; §4.4.1].
Synthesis of the knowledge of individual parts and mechanisms produced 
descriptive, system-level models for T7 development, from genome entry to phage 
particle formation [Studier & Dunn, 1983].  Two features specific to T7 biology made the 
construction of system-level models easier.  First, compared to other phage, T7 is 
relatively independent of complex host physiology [§1.2].  Second, RNA polymerase 
pulls most of the T7 genome into the newly infected cell [Zavriev & Shemyakin, 1982; 
Garcia & Molineux, 1995].  Polymerase mediated genome entry is a relatively slow 
process that results in the direct physical coupling of gene expression dynamics to gene 
position.  
More recently, others and I have used computational models of T7 infection to 
begin to explore questions related to the organization of genetic elements on the T7 
genome and the timing and control of gene expression across uncertain physical 
environments [Endy et al., 1997,2000; You & Yin, 2002a,b]. In using these computational 
models, some predictions did not agree with experiments [Endy & Brent, 2001].  For 
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example, a mutant phage expected to grow faster than the wild type grew slower [Endy et 
al., 2000].
Upon inspection, disagreements between model-based prediction and experiment 
could have arisen for at least three reasons.  First, our models could not meaningfully 
include unknown functions.  For example, disruption of an uncharacterized nonessential 
gene, 1.7, appeared to impact DNA replication [Endy et al, 2000]. While differences 
between expectation and observation can suggest follow-on science, a lack of complete 
component-level understanding debased our system-level analyses.  Second, the 
boundaries of genetic elements on the T7 genome are more complex than our models of 
the genome.  For example, genes 2.8 and 3 are most easily modeled as separable genetic 
elements even though the actual genes 2.8 and 3 overlap [Figure 4-1A; Figure 7-4].  
Element overlap may also encode uncharacterized function(s) having to do with the 
regulation of protein synthesis or the coupling of selective pressures during evolution.  
For example, bioinformatic analysis of microbial genomes suggests that gene overlaps 
are conserved across evolutionary distance [e.g., Johnson & Chisholm, 2004]. Element 
overlap also prohibits independent element manipulation.  For example, on the wild-type 
genome, we cannot change the gene 3 ribosome binding site without at least changing the 
codon usage of gene 2.8.  Third, a computer model built with separable parts that encode 
independent functions can be over-manipulated relative to the actual physical system.  
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A. Wild-type T7 2.8-3 elements
----------------2.8----------------->
acgcaaagggaggcgacatggcaggttacggcgctaaaggaatccgaaa
     <--3-RBS---><----------------3--------------
B. T7.1 parts 28 and 29
acgcaaGgggagAcgacaCggcaggttacggcgctaaggatccggccgcaaagggaggcgacatggcaggttacggcgctaaa
----------------2.8-----------------><D28R|D29L><--3RBS------><---------------3----
Figure 4-1.  Element decompression and part design. (A) The coding regions of genes 2.8 and 3
overlap in the wild-type T7 genome.  The ribosome binding site of gene 3 (underlined) is encoded
within gene 2.8. (B) Distinct genetic parts make up the T7.1 genome. The natural ribosome
binding site and start codon (green) for gene 3 are disrupted by point mutations (capitals);
mutations do not change the amino acid sequence of the 2.8 protein.  Parts 28 and 29 are separated
by bracketing restriction sites, BamHI (blue) and EagI (orange).  Figure S2 lists all changes in the
DNA sequence of T7.1 relative to wild-type T7.
For example, while we could simulate the expected behavior of large sets of permuted 
genomes, we could not easily move a single open reading frame to another arbitrary 
position on the actual T7 genome [Endy et al, 2000].
Wild-type T7 is a superb organism for discovering the primary components of a 
natural biological system [Studier, 1972].  However, is the original T7 isolate also best 
suited for understanding how all parts of the phage are organized to encode a functioning 
whole?  Given our experiences, we decided to attempt to engineer a surrogate genome, 
which we designated T7.1.
Chapter 4.2.Results
Chapter 4.2.1.  Design Goals
 Six goals drove our design of the T7.1 genome. First, we wanted to define a set of 
components that function during T7 development and, for each element, choose an exact 
DNA sequence that we could use to encode element function.  Second, we wanted the 
DNA sequence encoding the function of any one element to not overlap with the DNA 
sequence encoding any other element.  Third, we wanted the DNA sequence of each 
element to encode only the function assigned to that element and not any other functions.  
Fourth, we wanted to enable the precise and independent manipulation of each element.  
Fifth, we needed to be able to construct the T7.1 genome. Sixth, we needed the T7.1 
genome to encode viable bacteriophage; at the start of this work, we were uncertain how 
many simultaneous changes the wild-type genome could tolerate.
Chapter 4.2.2.  Design Process
 Briefly, we began design of the T7.1 genome by re-annotating the genome of 
wild-type T7. The wild-type T7 genome is a 39,937 base pair linear double-stranded 
DNA molecule [Dunn & Studier, 1983].  We annotated the genome by specifying the 
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boundaries of the following functional genetic elements: 57 open reading frames with 57 
putative ribosome binding sites encoding 60 proteins, and 51 regulatory elements 
controlling phage gene expression, DNA replication, and genome packaging.  Our own 
re-annotation can be found online at http://openwetware.org/wiki/T7.1/Reannotation.
 To specify the architecture of T7.1, we organized the functional genetic elements 
into 73  ‘parts.’  Each part contains one or more elements. While the DNA sequence of 
elements within parts may overlap, there is no overlap across part boundaries [Figure 
4-1B]. Next, we organized contiguous parts into ‘sections’ with section boundaries 
defined by restriction endonuclease sites found only once in the sequence of the wild-type 
genome.  Six sections, alpha through zêta, make up the T7.1 genome [Figure 4-2A; 
Figure 7-4].  Sections were used to compartmentalize changes across the genome.  In 
addition, sections can be built, tested, and manipulated independently.
 To specify the DNA sequence of T7.1, we eliminated sequence overlap across part 
boundaries. Overlaps were eliminated by exact duplication of the wild-type DNA 
sequence; subsequent sequence editing produced a single instance of any duplicated 
element [Figure 4-1B; Figure 7-4].  All sequence edits within open reading frames were 
silent and maintained the wild-type tRNA specification or, when necessary, specified a 
higher abundance tRNA [Ikemura, 1981]. We also added bracketing restriction 
endonuclease sites to insulate and enable the independent manipulation of each part 
[Figure 4-2C, E; Figure 7-3].  Bracketing sites are not used elsewhere in the sequence of 
any one section but are reused across sections. The DNA sequence of T7.1 changes or 
adds 1,424 base pairs to the wild-type genome [Figure 7-4].
Chapter 4.2.3.  Construction & Testing
 The sections that comprise the T7.1 genome can be built and tested independently.  
We constructed the first two sections, alpha and beta [§4.4.3]. Alpha and beta contain the 
first 32 of 73 parts of the T7.1 genome, replacing the left 11,515 base pairs of the wild-
type genome with 12,179 base pairs of redesigned DNA, and encoding the entire T7 early 
region, the primary origins of DNA replication, most of the T7 middle genes, and the 
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control architecture that regulates T7 gene expression.  Alpha and beta also contain the 
highest density of elements across the genome.  We combined alpha and beta with the 
remainder of the wild-type (WT) genome to produce three chimeric phage: alpha-WT, 
WT-beta-WT, and alpha-beta-WT.  
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Figure 4-2.  Genome design. (A) We split the wild-type T7 genome into six sections, alpha through 
zêta, using five restriction sites unique across the natural sequence. (B) Wild-type section alpha genetic 
elements: protein coding regions (blue), ribosome binding sites (purple), promoters (green), RNase III 
recognition sites (pink), a transcription terminator (yellow), and others (gray). Elements are labeled by 
convention [7]. Images are not to scale, but overlapping boundaries indicate elements with shared 
sequence. The five useful natural restriction sites across section alpha are shown (black lines). (C) T7.1 
section alpha parts.  Parts are given integer numbers, 1 through 73, starting at the left end of the genome. 
Unique restriction site pairs bracket each part (red/blue lines, labeled D[part #]L/R). Added unique 
restriction sites (purple lines, U[part #]) and part length (# base pairs, open boxes) are shown. We do not 
know if sequence changes in and around parts 6 and 7 destroy the minor E. coli promoter, B.  (D) Wild-
type section beta genetic elements.  (E) T7.1 section beta parts.  Figure S2 depicts the six sections, alpha 
through zêta, which make up the T7.1 genome.
 We tested and recovered viable chimeric phage by transfection and plating.  All 
three chimeric phage are viable. We isolated DNA and performed restriction digests 
across alpha and beta to confirm that individual parts could be independently 
manipulated.  30 of 32 parts in sections alpha and beta can be cut out as designed [Figure 
4-3]. We also sequenced alpha and beta.  Sequencing revealed differences between the 
design of T7.1 and the actual ‘as-built’ sections.  Relevant sequence differences in section 
alpha include a single base deletion in gene 0.4 and in the E. coli terminator TE. 
Differences in section beta include a single amino acid substitution in both genes 1.8 and 
2, a single base deletion in gene 2.5, and an 82-base truncation in gene 2.8. All 
differences were due to errors or limitations in construction [Table 7-1; Table 7-2].
 Finally, we characterized some growth properties of the chimeric phage by liquid 
culture lysis and plating. Phage-induced lysis of log-phase 30°C liquid cultures indicated 
a 20,    -1.4, and 22% increase in the half-lysis times of the alpha, beta, and alpha-beta 
chimeras, respectively, relative to the wild type [Figure 4-4A]. Plaques were 
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Figure 4-3.  Cutting parts from T7.1 (A) Restriction enzymes specific to the sites that 
bracket parts (P#.Enzyme) and added unique restriction sites (U#.Enzyme) were used to 
cut section alpha (24).  A subset of the digests is shown.  As built, part 1 cannot be 
removed. (B) Restriction digests cutting out all parts in section beta.  As built, part 28 
cannot be removed.
indistinguishable early during plaque growth and at 30°C (not shown). At 37°C the 
chimeric phage plaques appeared to stop growing as the bacterial lawns developed; after 
24h at 37°C, plaque sizes relative to the wild type were smaller for each of the chimeric 
phage, with the alpha-beta chimera being smallest [Figure 4-4B].
Chapter 4.3.  Discussion
A system that is partially understood can continue to be studied in hope of exact 
characterization [Davis, 1946]. Or, if enough is known about the system, a surrogate can 
be specified to help study or extend the original.  Here, we decided to redesign the 
genome of a natural biological system, bacteriophage T7, in order to specify an 
engineered biological system that is easier to study and manipulate.  The new genome, 
T7.1, is based on our incomplete understanding of the information encoded in the wild-
type genome and our desire to insulate and independently manipulate known primary 
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Figure 4-4.  Characterization of T7.1 (a) Lysis of log-phase liquid cultures of E. coli BL21 (30˚C) by 
wild-type T7 (black), alpha-WT chimera (red), WT-beta-WT chimera (blue), alpha-beta-WT chimera 
(orange); absorbance of 0.275 is ~2E8 cells/ml.  Vertical bars show standard deviation at each time point 
(based on four replicates) [Materials & Methods].  (b) T7 plaques on E. coli BL21 (24 hrs, 37˚C, 10cm 
Petri dish).  Clockwise from top left: wild-type (WT) T7, alpha-WT chimera, WT-beta-WT chimera, 
alpha-beta-WT chimera [Materials & Methods].
(a) (b)
genetic elements. We constructed the first two sections of T7.1 and observed that the 
resulting chimeric phage are viable. 
Phage viability demonstrates the following for sections alpha and beta. First, our 
parts as chosen can be separated by exogenous DNA sequence.  Second, any functions 
encoded by part overlap are non-essential. Third, our current understanding of T7 is not 
insufficient to specify a viable bacteriophage.  Viability does not demonstrate sufficiency 
because (i) if the chimeric phage had not been viable then our current understanding 
would have been demonstrably insufficient, and (ii) while T7.1 is based on our current 
understanding, we do not have an exact understanding of all functions encoded in the 
T7.1 genome (e.g., genes of unknown function).  Finally, viability, combined with the 
observed similarities in lysis times, suggest that T7.1 preserves polymerase-mediated 
genome entry and remains relatively independent of host cell physiology.  
The T7.1 genome is easier to model and study. For example, by removing genetic 
element overlap, the T7.1 genome better matches the understanding of T7 biology 
encoded in our models, relative to the wild-type phage. However, more work is needed to 
demonstrate that the dynamic behavior of the system encoded by the T7.1 genome is 
easier to predict. Such work will benefit from the fact that the parts of T7.1 can be 
independently manipulated.
We constructed sections alpha and beta manually. Concurrent advances in de 
novo DNA synthesis technology have recently enabled the rapid automatic synthesis of 
DNA fragments the size of the T7.1 genome sections [Stemmer et al, 1995; Yount et al, 
2000; Smith et al, 2003; Kodumal et al, 2003; Tian et al, 2004].  As genome synthesis and 
engineering technologies continue to improve [Carlson, 2003], the use of bracketing 
restriction sites for manipulating each part should become less important, but the physical 
separation of parts by the elimination of sequence overlap will remain useful. In general, 
we expect that the ability to ‘write’ long fragments of synthetic DNA will directly 
accelerate the engineering of biology, and impact the science of biology at least as much 
as large-scale automated DNA sequencing technology.
The viability of T7.1 presents a choice.  T7.1 is a ‘physical model’ that can be 
used to continue to study the wild-type phage. Observed differences in the behavior of 
T7.1 relative to wild-type highlight relevant gaps in our understanding of the natural 
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system.  Or, as T7.1 is simpler and easier to manipulate and appears to retain features that 
make wild-type T7 an attractive system to study, we can define T7.1 as our new model 
system; successor phage based on T7.1 can be constructed in order to answer questions of 
genome organization, regulation, and evolution.  More generally, other natural biological 
systems could be redesigned and built anew in support of scientific discovery and human 
intention.
Chapter 4.4.Methods
Chapter 4.4.1.  Re-Annotation of the Wild-Type T7 Genome
Chapter 4.4.1.1.  Summary:
We used past experiments and observations to define specific boundaries of 
functional genetic elements on the bacteriophage T7 genome.  We followed the standard 
naming conventions developed by Studier and Dunn [Dunn & Studier, 1983; Studier & 
Dunn, 1983].  The discovery of coding domains in T7 is discussed earlier [§1.2.1].
Chapter 4.4.1.2.  Control Elements
4.4.1.2.A  Ribosome Binding Sites
The definition of a ribosome binding site (RBS) that we used here is a contiguous 
stretch of DNA that, when transcribed, produces a region of RNA that interacts with the 
ribosome and allows for the initiation of protein synthesis.  The T7 ribosome binding 
sites were first postulated by analysis of the sequence data upstream of protein coding 
domain start codons; DNA sequence complementary to the E. coli 16S rRNA suggested a 
functioning RBS.  Direct observation of proteins during T7 infection provides additional 
support for the function of a subset of RBSs [Studier & Maizel, 1969].
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4.4.1.2.B  RNA Polymerase Promoters
The definition of a promoter that we used here is a contiguous stretch of DNA that 
interacts with an RNA polymerase molecule and allows for the initiation of mRNA 
synthesis.  At least 22 RNA polymerase promoters help to coordinate transcription 
dynamics during T7 infection. The discovery and mapping of the RNA polymerase 
promoters is given earlier [§1.2.1].  The T7 RNA polymerase promoter was determined 
by sequencing the 23 base pair region common to the late T7 promoters [Boothroyd & 
Hayward, 1979].  Here, we used a 35 base pair region to define T7 promoters; our 
broader definition of T7 promoter elements hoped to include conserved regions beyond 
the initial 23 base pairs [Dunn & Studier, 1983].  The E. coli RNA polymerase promoter 
is less well defined.  Here, we used regions of at least 60 base pairs, ranging from the –50 
to +10 positions, to define the major and minor E. coli promoters (A0, A1, A2, A3, B, C, 
and E).  Also, a boxA recognition site located between A3 and gene 0.3 is thought to be 
involved with anti-termination of polymerases that initiate from the three strong early 
promoters, A1, A2, and A3 [Olson et al, 1982].  Finally, The cloning of random sections 
of the T7 genome into a plasmid that selected for transcription activity from the cloned 
fragment identified other possible promoters [Studier & Rosenberg, 1981].  Sequence 
analysis in regions containing these sections identified regions of homology to other 
known promoters [Dunn & Studier, 1983].  Any contribution of these additional 
promoters to wild-type T7 infection is not now defined. While we annotated these 
additional promoters, we did not incorporate them as functional genetic elements of T7.1.
4.4.1.2.C  RNA Polymerase Terminators 
 The definition of a terminator that we used here is a contiguous stretch of DNA 
that, during transcription, produces a region of mRNA that stops the process of 
transcription (at some efficiency).  The first T7 transcription termination site was 
identified by mapping the endpoints of mRNA starting from E. coli promoters [Studier, 
1972].  Later it was shown that termination occurred at the same place in vivo and in vitro 
[Dunn & Studier, 1973].  The termination site was later mapped precisely, sequenced, and 
subsequently named ‘TE’ [Studier et al, 1979; Dunn & Studier, 1980].  A second 
terminator specific to T7 RNA polymerase was suggested by in vitro transcription studies 
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on digested T7 DNA [Golomb & Chamberlin, 1974; Niles & Condit, 1975].  The 
terminator, named ‘Tø,’ was shown to function in situ [Dunn & Studier, 1980] and on 
plasmids [McAllister et al, 1981].  Both TE and Tø have stem loop structures that are 
thought to set termination efficiency [Dunn & Studier, 1973].  The stem loop and flanking 
sequence, which includes a poly-uridine tract, were taken together to define the element 
we used here.  While other terminators have been postulated, their precise location and 
function, if any, during wild-type infection are tenuous [Dunn & Studier, 1983], and thus 
we did not include them in our annotation.
4.4.1.2.D  RNaseIII Recognition Sites
The definition of an RNaseIII recognition site that we used here is a contiguous 
stretch of DNA that, when transcribed, produces a region of mRNA that is recognized and 
cleaved (at some efficiency) by RNaseIII.  Sites for specific cleavage of T7 RNA by 
RNaseIII were first shown in vitro and then correlated to in vivo data [Dunn & Studier, 
1973].  In time, ten RNaseIII sites were mapped and their sites of cleavage identified 
[Dunn & Studier, 1983].  The sites are thought to stabilize the 3’ end of T7 transcripts by 
providing a stem loop that prevents the binding of scanning single stranded RNA 
degradation enzymes. A downstream gene often immediately follows an RNaseIII site. 
Thus, we kept the RNaseIII recognition site elements as short as possible – with a 
minimum boundary set by the probable stem loop structures [Dunn & Studier, 1983].
4.4.1.2.E  DNA Replication Origins
The definition of a DNA replication origin that we used here is a stretch of DNA 
that is used to initiate the copying of phage DNA during T7 infection. The primary 
replication origin was mapped to the dual promoter region downstream of ø1.1A and 
ø1.1B by analysis of replication bubbles in electron micrographs [Dressler et al, 1972; 
Wolfson et al, 1972] and subsequently sequenced [Saito et al, 1980].  The secondary 
origin at øOL was identified using mutants that lacked the primary origin [Studier & 
Rosenberg, 1981; Tamanoi et al, 1980].  Finally, plasmids containing cloned fragments of 
T7 DNA were used to screen for regions that act as replication origins during T7 
infection; these experiments revealed that øOR and ø13 have origin activity [Dunn & 
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Studier, 1983].  While the precise boundaries of the replication origins are unknown, each 
appears to be linked to a functioning RNA polymerase promoter [Zhang & Studier, 
2004].  Here, we only annotate and define an element for the primary origin.  While we 
do not include other replication origins as elements, we do preserve the RNA polymerase 
promoters that are associated with these secondary origins as elements, and thus possibly 
the secondary origins as well. 
4.4.1.2.F  Terminal Repeats & Short-Repeats
The definition of a terminal repeat that we used here is a contiguous stretch of 
DNA present at both ends of the T7 genome, and a short repeat is a series of direct 
repeats of DNA near the end of the genome.  Both the left and right ends of the T7 
genome contain exact 160 base-pair direct repeats [Ritchie et al, 1967].  Also, adjacent to 
the direct repeats on both ends of the genome are regions of DNA that contain 12 
regularly arranged and highly conserved seven base pair sequences termed the short-
repeats left, SRL, and right, SRR [Dunn & Studier, 1981]. The terminal repeats and SRL/
R are thought to be involved in concatemer formation, DNA packaging, and particle 
maturation [Kelly & Thomas, 1969].  However, the mechanisms by which the direct 
repeats and the SRL/R act are unclear.  Thus, we treated each end’s direct repeat and 
SRL/R as a monolithic element (the design of T7.1 does not make any changes to the 
DNA sequence of these elements).
Chapter 4.4.2.  Design of T7.1 Genome
Chapter 4.4.2.1.  Design Goals & Overview
Three goals drove our design of T7.1.  First, we wanted to insulate and enable 
independent manipulation of all identified genetic elements [§4.2.2].  Second, we wanted 
the T7.1 genome to encode a viable bacteriophage.  Third, we wanted the behavior of 
T7.1 to be as close to wild-type T7 as possible.  The second and third goals acted as 
constrains on the changes that we attempted in pursuit of the first. 
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The design of T7.1 genome uses six sections, alpha through zêta.  Each section is 
made up of parts that contain one or more functional genetic elements [Figure 7-3].  In 
our design, the modification of parts on the full T7.1 genome is a two-stage process.  
First, parts are manipulated within a section. Second, sections are combined to assemble a 
full genome.  The design of sections beta through zêta were improved based on our 
experience building section alpha.
Chapter 4.4.2.2.  Definitions
#-Cutter: A restriction enzyme that cuts a particular DNA sequence # times
Functional Genetic Element: A promoter, protein coding domain, ribosome 
binding site, etc., defined in the re-annotation of the T7 genome [§4.2.2].
Part: A piece of DNA that encodes one or more functional genetic elements and is 
bracketed by a pair of identical restriction sites.
Construct: Any amalgamation of functional genetic elements or parts.  
Section: A segment of the T7.1 genome who boundaries are 1-cutters on the wild-
type T7 genome. 
Chapter 4.4.2.1.  Sections
We used sections to limit the number of simultaneous changes to the wild-type T7 
sequence and to make the construction process more manageable. Two practical 
considerations drove our choice of section boundaries.  First and foremost, the boundaries 
of the sections had to be compatible with the sparse distribution of 1-cutter sites across 
the wild-type genome. [The use of 1-cutter sites for section boundaries allows refactored 
sections to be easily combined with other sections or with wild-type DNA.]  Second, the 
number of parts per section was limited by the number of “useful” 0-cutters across the 
DNA sequence of each wild-type section.  Useful 0-cutters are specific, free or smaller 
recognition sites, dam/dcm insensitive, and leave sticky-end overhangs.  
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Chapter 4.4.2.2.  From Functional Genetic Elements to Parts
Parts are made up of one or more functional genetic elements.  Parts containing 
more than one element were sometimes used to maintain the natural proximity of 
elements known or likely to by physically or functionally coupled.  For example, we 
grouped most ribosome binding sites and downstream protein coding domains into two-
element parts. Also, some functional genetic elements overlap so severely as to prevent 
efficient separation (e.g., the genes 4A, 4B, 4.1, and 4.2).  Finally, some functional genetic 
elements were very short (<150bp) such that variants containing deletions or separations 
of the individual elements could be easily constructed (e.g., the E. coli promoter C and 
RNase III site R1).  In total, we combined the elements that make up T7.1 into 73 parts.  
We numbered parts, one to seventy-three, starting from the genetic left end. 
The arrangements of parts on the wild-type T7 DNA sequence sometimes resulted 
in the overlapping of the DNA sequence specifying parts.  To remove part-part overlap, 
we duplicated the DNA sequence of the overlap, providing both parts with an 
independent copy of the previously overlapping sequence.  If, as a result of sequence 
duplication, either of the parts encoded a function specific to an element in the other part, 
we mutated the sequence to eliminate the duplicate function.  All mutations to protein 
coding domains were silent and result in either no change in the tRNA or, when 
necessary, specify a higher abundance tRNA [Ikemura, 1981].  Parts separation is 
detailed in Figure 7-4.   
We surrounded each part with a restriction site pair that is not contained elsewhere 
in that section.  Typically, we added bracketing restriction sites to the DNA sequence of 
each part but, when appropriate, we integrated the sites into the natural DNA sequence.  
Also, to help reduce the length of T7.1 and were possible, we chose adjacent restriction 
sites to have overlapping sequence with one another.
 One of the most significant differences between the design of section alpha and 
the other sections was in our choice of bracketing restriction sites.  In section alpha, we 
picked restriction enzymes that did not cut within section alpha only.  However, as the 
construction of alpha proceeded, and cloning directly into the phage became useful, it 
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was clearly advantageous to use restriction enzymes that did not cut within the entire 
genome where possible.  
Chapter 4.4.2.3.  Design Features
4.4.2.3.A  Deletion and Insertion
The design of the T7.1 genome allows for the simple deletions of parts.  
Generally, the section containing the part is isolated and digested by the bracketing 
restriction enzyme.  The fragments can then be ligated to reform the section minus the 
deleted part, and then joined to the rest of the genome.  
Insertion of a new part can be more involved.  Most simply, if there is a pre-
existing restriction site due to a deletion operation, then a new part can be inserted in its 
place.  If no such site exists, another method involves using two restriction enzymes, 
NgoMIV and BspEI, that are 0-cutters across both the wild-type T7 and all refactored 
sections.  NgoMIV and BspEI have different recognition sequences but produce the same 
overhang upon digestion.  This allows for ligation of a product into these sites, while 
simultaneously preventing the restriction sites from being reformed.  Thus, a part 
adjacent to the desired insertion site must be replaced with the same part that has an 
NgoMIV site appended to it.  Then the part to be inserted is amplified with bracketing 
BspEI sites and inserted into the NgoMIV site.  Since neither restriction site is reformed 
upon insertion, this method can be reused to serially insert parts throughout the genome.  
4.4.2.3.B  Unstuffing Hooks
Since we didn’t know how a phage made of separated parts would behave (e.g., 
would it form plaques?), we thought that it would be prudent to be able to easily revert to 
the wild-type T7 sequence for purposes of comparison and debugging.  Thus, we used 
silent mutations to add additional 1-cutter restriction sites to section alpha. These new 
restriction sites, labeled U1-4, can be used to replace refactored regions with wild-type 
sequence. In sections beta through zêta, such extra sites were superfluous because we 
used 0-cutters to bracket parts. 
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4.4.2.3.C  Scaffolds
We used scaffolds to build sections alpha and beta. A scaffold is essentially the 
sequence that remains when all parts are removed from the section.  As such, the scaffold 
contains all the restriction sites required to assemble the parts to form the section.  In 
addition, if a fully refactored phage was not viable, we could use the scaffold to 
incrementally revert the sequence back to wild type in an attempt to restore function. 
Chapter 4.4.2.4.  T7.1 Annotation and Sequence
GenBank files for the annotation of T7.1 and the as-built section alpha and beta 
are available upon request and are being deposited with NCBI.  These three files plus a 
GenBank file of our re-annotation of wild-type T7 are now available online:
http://web.mit.edu/endy/www/ncbi/
Chapter 4.4.3.  Construction
Chapter 4.4.3.1.  Alpha
The design of the scaffold for section alpha included all functional genetic 
elements from the left end of T7 through R0.3, R0.5, parts 17,19, 21, plus the restriction 
sites required to add all remaining parts (1334 bp total).  The section alpha scaffold does 
not contain any known protein coding domains.  We sent the scaffold sequence to Blue 
Heron Biotechnology for synthesis (http://www.blueheronbio.com/).  The scaffold could 
not be assembled onto the standard cloning plasmids then in use by Blue Heron and us. 
Blue Heron agreed to instead ship the section alpha scaffold as four fragments with point 
mutations in each fragment.  The point mutations were:
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Fragment 1:  Single base changes at 89(G-T), 168(A-T), 169(C-A), 245(G-A) and 
249(C-A) as well as single base deletions at 138 and 159
Fragment 2:  A single base deletion in the -35 box of the A1 promoter
Fragment 3:  A four base deletion between the -35 and -10 boxes of the A3 promoter
Fragment 4:  A single base deletion in the loop of TE
We decided to discard Fragment 1 but to correct and make use of Fragments 2, 3 
and 4.  We built a new vector, pREB, to facilitate the assembly of section alpha.  pREB 
(for rebuild) started as a chimera of the inducible copy control system of pSCANS-5 and 
the insulated multi-cloning site (MCS) of pSB2K3-1 [§4.3.4]. We completed pREB by 
adding a smaller MCS containing PstI, BstBI and BclI restriction endonuclease sites and 
by removing nineteen other restriction sites from the plasmid backbone. 
To build section alpha we first cloned parts 5, 6, 7, 8, 12, 13, 14, 15, 16, 18, 20, 
22, and 24 into pSB104.  We cloned part 11 into pSB2K3.  Each part was cloned with its 
bracketing restriction sites surrounded by standard BioBricks restriction sites [Knight, 
2002].  We used site directed mutagenesis on parts 6, 7, 14 and 20 to introduce the sites 
U1, U2, U3 and U4 respectively.  Site directed mutagenesis on part 20 failed.
A single Eco0109I restriction site was removed by site directed mutagenesis from 
the vector pUB119BHB carrying scaffold Fragment 4.  Part 15 was subsequently cloned 
into this modified vector.  Scaffold Fragment 4 was then transferred by cloning into 
pREB.  The following parts were serially cloned into this vector: 7, 8, 12, 13, 14, 16, 18, 
20, 22 and 23.  The now-populated scaffold Fragment 4 was digested with NheI and BclI 
and purified.  
Parts 5 and 6 were cloned into pUB119BHB carrying scaffold Fragment 3.  This 
populated Fragment 3 was subsequently used for in vitro assembly of a construct 
spanning from the left end of T7 to part 7.  In vitro assembly of this construct began with 
digestion of wild-type T7 genomic DNA with AseI and isolating the 388bp left end 
fragment and ligating this to scaffold Fragment 2.  The correct ligation product was 
selected by PCR.  The mutation in part 3 (A1) was then fixed by PCR ligation by a two-
step process.  First primers with the corrected sequence for part 3 were used to amplify 
the two halves of the construct to the left and right of part 3.  A subsequent PCR ligation 
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was carried out to join these two constructs.  Scaffold Fragment 3 was then added to the 
above left-end construct once again by PCR ligation as described above. The mutation in 
part 4 (A2, A3 and R0.3) was repaired similarly to the mutation in part 3.  The right most 
primer used to amplify the entire construct contained an MluI site on the tail that was 
then used to ligate on a copy of part 7.  The ligation product was again selected by PCR.  
This populated left-end construct was then digested by NheI and purified.
  The right arm of a BclI digestion of wild-type T7 genomic DNA was then isolated 
and ligated to the populated left end construct and the populated Scaffold Fragment 4.  
The three-way ligation product was then transfected into IJ1127 [Materials and 
Methods].  Plaques were used to create lysates and DNA was purified and digested to 
screen for desired clones [Materials and Methods]. 
Part 11 was then cloned into the rebuilt section using the same method of three-
way ligation followed by transfection.  Cloning of part 9 required the in vitro assembly of 
a construct that spanned part 6 through part 9 because RsrII(D9L/R) cuts wild-type T7 
elsewhere.  The construct was created by amplifying the region spanning part 5 through 
part 12 of the refactored genome by PCR.  The PCR product was then digested with RsrII 
and ligated to part 9.  The correct ligation product was selected by PCR with a primer on 
the right end that contained a SacII site in the tail.  This PCR product was then digested 
with SacI and SacII and cloned into the phage as described above.  Lastly, the part 10 was 
cloned into the SacII site of the phage.
Chapter 4.4.3.2.  Beta
We constructed section beta using a process similar to that used with alpha.  A 
scaffold with all restriction sites as well as part 26 was made by Klenow extension of 
overlapping primers.  The product was digested with BstBI and cloned into pREB.  The 
following parts were then cloned into this vector: 23, 24, 27, 28, 30, 31 and 32.  Part 32 
(gene 3.8) had to be cloned as a truncation since we were unable to clone the full-length 
part, probably due to the previously reported toxicity of gene 3.8 product [Molineux IJ, 
personal communication].  The truncated version of part 32 still included the BglII site to 
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allow for assembly of section beta into a phage.  Parts 25 and 29, which were also 
previously reported to be toxic, were assembled in vitro.  To insert part 25, we amplified a 
region spanning part 23 through part 27 by PCR.  This fragment was then digested with 
BsiWI and part 25 was ligated to each of these fragments separately and selected for by 
PCR.  These two PCR products were then digested with DraIII, a restriction site internal 
to part 25, ligated and then selected by PCR.  The overall fragment was then digested 
with BclI and MluI, purified, and ligated to wild-type fragments on the left and right.  
The same method was used to insert part 29 by using the part 29 internal restriction site 
EcoO109I and then digesting this overall fragment with MluI and BglII for cloning into a 
phage.  Lastly, these two phage genomes were digested with MluI and the left fragment 
of the genome containing the refactored region spanning part 23 to 27 was ligated to the 
right fragment of the genome containing the refactored region spanning from part 27 to 
32. 
Chapter 4.4.3.3.  Synthesis & Construction Errors
Differences between the designed and constructed sections alpha and beta are 
detailed in Tables 7-1 and 7-2.  
 
Chapter 4.4.4.  Materials and Methods
Chapter 4.4.4.1.  Strains
E. coli
BL21: B hsdS Gal-
BR3: B rpoC-E2258K
D1210: HB101 lacIq
DH5alpha: φ80lacZΔM15 Δ(lacZYA-argF) U169 endA1 recA1 hsdR17 (rk-, mk+) thi-1 
gyrA96 relA1 phoA
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DH10B: mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 deoR recA1 araD139 Δ
(ara leu)7697 galU galK rpsL endA1 nupG
IJ1126: E. coli K-12 recB21 recC22 sbcA5 endA gal thi Su+ Δ(mcrC-mrr)102::Tn10
IJ1127: IJ1126 lacUV5 lacZ::T7 gene1-Knr
Phage
T7+, wild-type bacteriophage T7, was a gift of Dr. Ian Molineux (UT Austin)  
Chapter 4.4.4.2.  Media Recipes
L-broth or LB Medium (Luria-Bertani Medium) [Sambrook & Russell, 2001]
 10 g Bacto-tryptone
 5 g yeast extract
 10 g NaCl
 distilled water up to 1 L
1.5% T-agar [Garcia, 1996]
 10 g Bacto-Tryptone
 5 g NaCl
 15 g Bacto-agar
 distilled water up to 1 L
0.7% T-agar [Garcia, 1996]
 10 g Bacto-Tryptone
 5 g NaCl
 7 g Bacto-agar
 distilled water up to 1 L
50X TAE Electrophoresis Buffer [Sambrook & Russell, 2001]
 242 g Tris base
 57.1 ml glacial acetic acid
 100 ml 0.5 EDTA pH 8.0
 distilled water up to 1 L
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T7 Buffer [Garcia, 1996]
 0.1 M Tris-HCl pH 7.5
 1 M NaCl
 1 mM EDTA pH 7.5
TES Buffer [Garcia, 1996]
 50 mM NaCl
 50 mM Tris-HCl pH 7.5
 5mM EDTA pH 7.5
ρ=1.43 cesium chloride [Garcia, 1996]
 33 g cesium chloride
 50 ml 10 mM Tris-HCL pH 7.5, 10mM MgCl2
ρ=1.53 cesium chloride [Garcia, 1996]
 41 g cesium chloride
 50 ml 10 mM Tris-HCL pH 7.5, 10mM MgCl2
ρ=1.62 cesium chloride [Garcia, 1996]
 50 g cesium chloride
 50 ml 10 mM Tris-HCL pH 7.5, 10mM MgCl2
TE [Sambrook & Russell, 2001]
 10mM Tris-Cl pH 8.0
 1mM EDTA pH 8.0
Chapter 4.4.4.3.  General Protocols
4.4.4.3.A  Plating of T7
T7 was plated by adding various dilutions of a phage stock to 200uL of saturated BL21 
culture and 3mL of molten (46°C) 0.7% T-agar and pouring the mixed contents onto 
1.5% T-agar plates.  Plaques appeared after 3-5 hours of incubation at 37°C.
4.4.4.3.B  Isolation of T7 Genomic DNA From Crude Cell Lysates
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T7 genomic DNA was isolated according to the protocol described in Rene Garcia’s 
dissertation [Garcia, 1996], reproduced here:
1.   Grow 40 ml of permissive cells to a density of 108-109 cells/ml at 37°C in 
a rotary shaking water bath.  Inoculate the cells with a drop from a master 
phage stock.  Continue to shake cells in the water bath at 37°C until the 
culture clarifies.
2.   Add NaCl to a final concentration of 1 molar.  Centrifuge the lysate at 
10,000 rpm for 10 min.  Discard the cellular debris, and centrifuge the 
lysate at 24,000 rpm for 90 min in a SW28 rotor (Beckman).
3.   Discard the supernatant, and add 1 ml of T7 buffer or TES buffer to the 
phage pellet.
4.   Let the pellet site at 4°C for at least 5 hours.  Resuspend the pellet, and 
quickly spin down the cellular debris.  Discard the pellet.
5.   To the supernatant, add 0.5 ml of 50 mM Tris-HCl, pH 8 saturated phenol 
and gently mix the sample until an emulsion forms.  Quickly microfuge 
the sample to separate the layers.  Carefully remove the aqueous layer 
without disturbing the organic layer.  Phenol extract with 0.5 ml 50 mM 
Tris-HCl, pH 8 saturated phenol one more time.
6.   To the aqueous layer, add 0.5 ml of 50mM Tris-HCl, pH 8 saturated 
phenol: chloroform: isoamyl alcohol (25:34:1 by volume) mixture, and 
gently mix the sample until an emulsion forms.  Quickly microfuge the 
sample to separate layers.  Carefully remove the aqueous layer without 
disturbing the organic layer.  Phenol: chloroform: isoamyl alcohol and 
extract the aqueous layer one more time.
7.   Add 3 times volume of 95% ethanol alcohol to the sample.  A fibrous 
precipitate should form.  Spin down the precipitate, remove the 
supernatant, and wash the pellet with ethanol.  Dry the pellet.  Dissolve the 
pellet in 500 uL of water or TES buffer.  There should be about 109 
molecules of phage DNA/uL.  Store the DNA at -20°C.
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4.4.4.3.C  Purification of T7 Particles via CsCl-gradient Centrifugation
T7 particles were purified by cesium chloride gradient centrifugation according to 
Garcia’s protocol [Garcia, 1996].  The protocol is reproduced here:
1. Grow 100ml of permissive cells to a density of 108 to 109 cells/ml at 37°C 
in a rotary shaking water bath.  Inoculate the cells with a drop from a 
master phage stock.  Continue to shake cells in the water bath at 37°C 
until culture clarifies.  [NOTE – As a standard laboratory protocol, T7 
stocks have always been propagated at 30°C; however, at this temperature 
cultures infected with (A1, A2, A3)- T7 mutants take longer to clarify that 
those infected with (A1, A2, A3)+ phages or with mutants that eject their 
DNA faster.  At 37°C the differences in lysis periods are not as 
pronounced.  Stocks of (A1, A2, A3)- T7 mutants are propagated at 37°C 
to decrease the growth disadvantage of spontaneous arising mutants that 
eject their DNA faster.  For constancy (A1, A2, A3)+ phages are also 
grown at this higher temperature.]
2. Add NaCl to the lysate to make the final concentration 1 molar.  
Centrifuge the lysate at 10,000 rpm for 10 min, Discard the cellular debris, 
and add 10 grams polyethylene glycol (PEG) m.w. 8000 (10% w/v) to the 
supernatant.  Gently stir the mixture until the PEG has totally dissolved.  
Keep lysate on ice for 1 hour.
3.   Pellet the phage at 5,000 rpm for 15 min.  Decant the supernatant, and 
very gently resuspend the pellet in 3.5 ml of T7 buffer.  Centrifuge the 
lysate at 5,000 rpm for 10 min, and keep the supernatant.
4.   Pour a cesium chloride step gradient: ass .5 ml of cesium chloride with a 
density of 1.6 to the bottom of a centrifuge tube that fits in a SW 40.1 
rotor.  Gently layer 0.5 ml of cesium chloride ρ=1.5 onto the ρ=1.6 layer.  
Finally ass 0.5 ml of cesium chloride ρ=1.4 onto the ρ=1.5 layer.
5.   Gently layer the phage supernatant onto the cesium chloride step gradient.  
Centrifuge the phage in a SW 50.1 rotor at 30,000 rpm for 2 to 3 hours.  
The phage will band at the ρ=1.5 layer.
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6.   Remove the phage band from the side of the tube with a syringe.
7. Remove the cesium chloride by dialysis against 0.5 to 1 liter of T7 buffer 
at 4°C.
4.4.4.3.D  Purification of T7 Genomic DNA From CsCl-gradient Purified Phage Particles
 T7 particles were purified by cesium chloride gradient centrifugation (above).  
The DNA was then purified by subsequent rounds of phenol and phenol:chloroform 
extraction as follows:  pH7.8 phenol [Sambrook & Russell, 2001] was added in a 1:1 
volume ratio to the sample and the tube was inverted to mix the aqueous and organic 
phases.  The mixture was centrifuged for 10 minutes at 13,000g.  The aqueous layer was 
removed and subjected to an additional round of phenol extraction.  This resulting 
aqueous layer was added in a 1:1 volume ratio to pH7.8 phenol:chloroform:isoamyl 
alcohol (25:24:1) [Sambrook & Russell. 2001], mixed and centrifuged for 5 minutes.  
This extraction step was repeated again.  The DNA was precipitated by adding a 10% 
sample volume of 3M sodium acetate and 2-5 sample volumes of cold (4°C) absolute 
ethanol.  The samples were mixed and incubated at -80°C for 1 hour.  The DNA was then 
pelleted by centrifugation for 30 minutes at 13,000g and at 4°C.  The DNA pellet was 
washed once with 80% ethanol, dried and resuspended in TE buffer.
4.4.4.3.E  Purification of Restriction Enzyme Digested Fragments
 All restriction enzyme digestions were carried out according to the manufacturer’s 
directions.  All fragments smaller than 10kb were purified using Qiaquick gel extraction 
kit (Qiagen).  All fragments larger than 10kb were purified by electro-elution as follows:  
20ug of digested product was preincubated with 1uL of a 1000X solution of SYBR Gold 
(Molecular probes) for 15 minutes.  200ng of DNA was loaded into each well of a 0.5% 
TAE agarose gel and electrophoreised at 1-1.5V/cm and at 4°C for 16-20 hours.  Agarose 
blocks containing desired restriction fragments were excised under UV transillumination 
and loaded into a dialysis bag (3500 MWCO Snakeskin dialysis tubing, Pierce) 
containing 1X TAE.  Fragments were electro-eluted from the agarose blocks for 1-5 
hours at 5V/cm.  After the completion of electro-elution was confirmed by UV 
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visualization, the electric field was reversed for 1 minute to aid in elution.  The liquid 
contents of the bag were then subjected to one round of phenol extraction to remove trace 
amounts of agarose and the DNA was ethanol precipitated and resuspended in TE buffer.
4.4.4.3.F  Plating of Phage for Comparative Plaque Analysis
 Stocks of cesium chloride purified phage were serially diluted to an appropriate 
titer.  50, 100 or 200uL of that dilution was mixed with 200uL of saturated BL21 culture, 
added to 12mL of molten (50°C) 0.7% T-agar and plated directly on Petri dishes.  Plaques 
were allowed to grow for 5-48 hours at 30°C or 37°C.
4.4.4.3.G  Measuring Phage Lysis Curves 
 1mL containing 2x108 cells of BL21 was infected at a MOI of 5 and 200uL of the 
resulting mixture was loaded per well into a 96 well ViewPlate (Packard) at 30°C.  
Mineral oil was layered into each well and the OD was monitored at 30°C with agitation 
by a Wallac Victor3 plate reader (Perkin-Elmer).
4.4.4.3.H  Sequencing of DNA
 All sequencing of phage DNA was performed using the dideoxy terminator 
method.  All sequencing was performed by the MIT Biopolymers Laboratory using a 
Perkin Elmer Applied Biosystems Division model 377 DNA sequencer.  When long 
regions of DNA were sequenced, primers were designed at 500-800bp intervals to both 
sense and antisense strands.  All reported sequence represents at least two separate 
sequence runs with no intervening ambiguities.
4.4.4.3.I  Template preparation of phage genomic DNA for sequencing
 For phage sequencing, only full length packaged genomic DNA (described above) 
was used as template.
4.4.4.3.J  Template preparation of cloned parts for sequencing
 The preparation of sequencing template for cloned parts was done using Qiaprep 
spin Miniprep Kit (Qiagen).  When the quantity of purified plasmid was insufficient for 
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sequencing,  a subsequent Templiphi (Amersham) reaction was used to amplify the 
sequencing template. 
4.4.4.3.K  Template preparation of in-vitro constructs for sequencing
 In-vitro constructs were amplified using PCR, gel purified and used as template in 
a sequencing reaction. 
Chapter 4.4.4.4.  Genome Design and Sequence Analysis Tools
Restriction Site Distribution
 All design and annotation of DNA constructs was done using Vector NTI 
(InforMax).  All restriction analyses were performed with Vector NTI (InforMax), 
NEBcutter [Vincze et al, 2003], and REBASE [Roberts et al, 2005].  A perl script was 
written to search for sites within coding regions where restriction sites could be 
introduced by silent mutation [http://web.mit.edu/endy/www/software/cuts/].
Sequencing Analysis and Contig Assembly
 Sequence analysis and contig assembly was done with AlignX and Contig 
Express (InforMax).
Chapter 4.4.4.5.  Genome Construction Protocols
4.4.4.5.A  Oligonucleotide Synthesis
 All oligonucleotides were synthesized by MWG, Invitrogen or using an ABI 
Model 394 DNA synthesizer (Tom Knight).
4.4.4.5.B  Part Amplification
 All parts were amplified by PCR using the following reaction mixture: 5uL 10X 
Thermo Pol Buffer (NEB), 20pM primer1, 20pM primer2, 3-30ng T7 genomic DNA, 
1unit Vent polymerase (NEB), 10uM each dNTP and water to 50uL.  The mixture was 
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thermocycled (MJ Research PTC-200) as follows: 95°C for 2 minutes, 25-35 cycles of 
95°C for 30 seconds, 50°C-60°C for 30 seconds, 72°C for 1-5 minutes, 72°C for 10 
minutes.
4.4.4.5.C  Part Cloning
 All parts and vectors (0.1 - 50pmoles) were restriction enzyme digested according 
to the manufacturers’ directions (NEB, Fermentas).  Parts and vectors were then purified 
by gel electrophoresis (0.5 - 2% TAE agarose gel, 3 - 8 V/cm) and extracted with 
Qiaquick gel extraction kit (Qiagen).  Ligation reactions using T4 DNA ligase (NEB) 
were carried out in a 3:1 part:vector molar ratio according to the manufacturer’s 
directions.  Ligation products were dialyzed on nitrocellulose membranes (Millipore) 
against 1000X volume of water for 30 minutes.  Ligation products were transformed by 
electroporation using 1800V across a 1mm gap (Bio-Rad Gene Pulser Xcell) and plated 
on the appropriate medium.  Screening for clones was performed by colony PCR with the 
following protocol: Colonies were picked and diluted in 100uL of water.  1uL of that cell 
suspension was added to 1uL 10X Thermo Pol Buffer (NEB), 4pM primer1, 4pM 
primer2, 0.5U Taq Polymerase (NEB), 2uM each dNTP and water to 10uL.  This mixture 
was thermocycled as follows: 95°C for 6 minutes, 25-35 cycles of 95°C for 30 seconds, 
54°C for 30 seconds, 72°C for 1-5 minutes, 72°C for 10 minutes.
4.4.4.5.D  Site Directed Mutagenesis of Parts
 Site specific changes were performed on the cloned parts using QuickChange 
Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer’s directions.  
Primers were 5’ phosphorylated using Polynucleotide Kinase (NEB) according to the 
manufacturer’s directions.
4.4.4.5.E  Construction of pREB Plasmid
 pREB was constructed from pSB2K3-1 [http://parts.mit.edu], a chimera of 
pSCANS-5 (gift of John Dunn, Brookhaven National Laboratory) and pSB1A3-1 [http://
parts.mit.edu].  The multiple cloning site of pSB2K3-1 was replaced by a PstI-BstBI-BclI 
multiple cloning site by primer annealing and cloning.  Primer duplexes were prepared 
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using the following steps: the reaction mixture, 100pM each primer, 2uL restriction 
buffer (NEB) and distilled water to 20uL was incubated as follows: 95°C for 4 minutes, 
0.1°C/s ramp to 80°C, 80°C for 4 minutes, 0.1°C/s ramp to 70°C, 70°C for 4 minutes, 
0.1°C/s ramp to 60°C, 60°C for 4 minutes, 0.1°C/s ramp to 50°C, 50°C for 4 minutes, 
0.1°C/s ramp to 22°C, 22°C for 10 minutes.  The annealed duplexes were 5’ 
phosphorylated using Polynucleotide Kinase (NEB).  pREB was then cleaned of 
restriction sites using QuickChange Multi Site-Directed Mutagenesis Kit (Stratagene) and 
screened by digestion.
4.4.4.5.F  Construction and Cloning of the Beta Scaffold
 The beta scaffold was constructed by annealing two partially overlapping primers 
as described above.  The overhangs were then filled in using Klenow fragment (NEB) 
extension according to the manufacturer’s directions.  The extension product was 
digested with BstBI and cloned into pREB.
4.4.4.5.G  Assembly of Section Fragments in E. coli:
 Parts were cloned into the scaffold using the same cloning method as above with 
the addition of treating the purified cut vector with Antarctic Phosphatase (NEB) 
according to the manufacturer’s directions and using a molar ratio of 6-10:1 insert:vector 
in the ligation reaction.  Screening was again performed by colony PCR but included a 
second PCR to verify directionality via an internal primer.
4.4.4.5.H  Assembly of Section Fragments in vitro
 Fragments were assembled in vitro using both PCR ligation and traditional T4 
DNA ligation.  T4 DNA ligation products were subsequently selected by PCR.  All 
amplification was carried out as described above using either Taq polymerase, Vent 
Polymerase or a 99:1 Taq:PfuTurbo (Stratagene)  enzyme mixture.  Selection of ligation 
products was carried out using various serial dilutions of the ligation products as 
template.
4.4.4.5.I  Ligation of 2 or 3 DNA Fragments for Phage Transfection
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 4x109 molecules of each DNA fragment was ligated using T4 DNA ligase (NEB) 
and incubated at 16°C overnight.  In certain cases, up to 4x1010 molecules of a particular 
DNA fragment was added to drive the reaction towards the desired outcome.  
4.4.4.5.J  Preparation of Competent Cells for Phage Transfection
 Competent cells were prepared according to Garcia’s protocol [Garcia, 1996] and 
allowed to rest at 4°C for 20-24 hours prior to transfection.  Garcia’s protocol is 
reproduced here:
1. Grow 20 ml of cells to a density of 5 x 108 cells/ml in L broth at the 
desired temperature.
2.  Pellet the cells in a centrifuge at 5,000 rpm for 5 min. Remove the 
supernatant.
3.  Resuspend the cell pellet in 10 ml of ice-cold 50mM CaCl2 (half volume 
of starting culture).
4.  Incubate the cells on ice for 30 min.
5.   Pellet the cells in a centrifuge at 5,000 rpm for 5 min. Remove the 
supernatant.
6.  Resuspend the cell pellet in 2 ml of ice-cold 50 mM CaCl2 (one-tenth 
volume of the starting culture).  The cells are ready to take up DNA.
4.4.4.5.K  Transfection of the Ligation Products
 All pipette tips were pre-chilled at -20°C, molten 0.7% T-agar was kept at 46°C 
and 1.5% T-agar plates were equilibrated to room temperature.  The ligation mixture was 
added to 200uL of cold (4°C) competent cells and incubated in an ice bath for 30 
minutes.  The mixture was then added to 2.5mL of molten (46°C) 0.7% T-agar, gently 
mixed for 10 seconds by manual agitation and poured onto a 1.5% T-agar plate.  The 
plates were then incubated at 37°C for 3-5 hours.
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Chapter 5.  Future & Conclusions 
Chapter 5.1.  Simulation
 I have built a new simulator called Tabasco that allows simulation of gene 
expression at a single-molecule, single base-pair resolution by encoding logical rules of 
gene expression directly into the simulator.  Using these rules, Tabasco does not have to 
track or encode every possible state, just those states that are accessed during the course 
of a simulation.  Efforts for building simulators similar to Tabasco will continue to be 
useful for systems where the number of possible states is much larger than the number of 
molecules that transition between those states.  For example, the biosynthesis of the large 
polysaccharide chains (glycosaminoglycans) on proteoglycans is a multi-step pathway 
leading to proteins with large structural diversity [Esko, 1999].  The production of 
glycosaminoglycans (GAGs) is difficult to explore using traditional simulation methods 
because the number of possible species that may arise during sugar production are large.  
Using logical rules of how enzymes recognize, modify, and extend GAGs in vivo, we can 
simulate the evolution of individual GAGs in order to explore the mechanisms of 
proteoglycan formation.  In collaboration with Jonathan Behr and Tarak Upadhyaya, we 
are constructing a simulator based on Tabasco to simulate GAG formation. 
 
Chapter 5.2.  Modeling
 I constructed a best-faith model for gene expression during the infection of 
bacteriophage T7 using the Tabasco simulator.  Together with Heather Keller, we found 
that the previous discrepancies between simulations and measurements of class I and II 
protein synthesis rates are accounted for by the previously uncharacterized degradation of 
mRNA.  The new models of T7 gene expression are better and more detailed, but we still 
need to address several points of uncertainty before we can expect accurate model-based 
predictions.  
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 First, we need to understand mechanisms that lead to the newly characterized 
mRNA degradation.  While we have characterized degradation rates on the natural 
genome, the question remains as to what factors determine the stability of a particular 
message.  If we move a gene from one position to the next, can we reasonably predict the 
stability of the gene’s mRNA?  Second, our understanding of RNA polymerase 
processivity and interactions on the genome is limited.  Recent studies have explored 
such processes in greater detail, and may help to improve future models [Zhou & Martin, 
2006; Epshtein & Nudler, 2003].  Third, more work on the functioning of individual 
components in the context of a larger genome is needed in order for new genome 
architectures to reliably work according to expectation.  Fourth, we must reevaluate our 
assumptions that gene expression and DNA replication are independent processes.  In the 
process of measurements of mRNA levels during infection, we observed transcription late 
in infection of a region of DNA that most likely was due to genome concatemer 
formation during DNA replication.  If transcription and replication are concurrent, the 
expected increase of transcription rates of class III mRNA could lead to better 
correspondence between the measurements and simulations [§4].  Finally, the model 
would benefit from system-wide absolute measurements of protein levels and relative 
measurements of the strengths of the ribosome binding sites, the latter of which are 
currently being made by Heather Keller.  
 Construction of a better model will allow exploration of how genome designs are 
(or are not) optimized to solve challenges T7 is faced with.  For example, an individual 
T7 particle, suspended in solution, lacks information detailing the size, growth state, and 
genotype of its future host cell.  At the time of infection, the number of other T7 particles 
that are simultaneously infecting the host is uncertain.  However, we know that wild-type 
T7 can produce near-identical growth curves at multiplicities of infection (MOI) from 1 
to ~20 [Endy, personal communication].  We also know that wild-type T7 plaques 
continue to grow as host cells begin to enter stationary phase and that T7 can infect 
~1/10th volume minicells [Ponta et al., 1977; Libby et al., 1984; Shepherd et al., 2001].  
While other phage (e.g., lambda) use variation in host cell state and multiplicity of 
infection to trigger developmental decisions (e.g., lysis or lysogeny) [Ptashne, 2004], T7 
appears able to maintain its consistent lifestyle in spite of environmental uncertainty.  
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 One mechanism for controlling 
system response to uncertainty in MOI 
and cell volume would be to use negative 
feedback [Becskei & Serrano, 2000; 
Rosenfeld et al., 2002] to regulate the 
activity of the E. coli and T7 RNA 
polymerases, wherein the rates of 
polymerase inhibition would depend on 
the rates of synthesis for the early and 
middle T7 proteins.  A cell infected at a 
high MOI would inactivate the host RNA 
polymerase faster, producing less phage 
protein on a per-phage-infecting basis.  
Similarly, a phage that infected a large cell 
would be able to synthesize more of the 
early proteins needed to take advantage of 
increased host resources.
 Both early and middle T7 proteins 
are known to inhibit the E. coli and T7 RNA polymerases [§3.2.3].  The standard model 
for T7 infection is that gp0.7, gp2 and gp3.5 are used to control transitions in T7 gene 
expression, from early to middle to late classes, and to help initiate DNA replication 
[Figure 5-1; Studier & Dunn, 1983].  The relative positioning of these genes on the 
genome play an important role in determining the extent of the feedback inhibition 
because  the timing and level of gene expression is in essence controlled by the gene 
location.  An accurate model for T7 gene expression would allow us to explore the extent 
that the natural T7 genome is optimized to handle such uncertainty.
Chapter 5.3.  Refactoring and T7.2
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Figure 5-1.  Simulated effects of the loss of 
negative feedback regulation on phage 
resource allocation during infection.  The 
amino acid incorporation rate for the class I 
(blue), class II (red), and class III (green) 
proteins are plotted as a function of infection 
time with (dark) and without (light)
transcriptional feedback mechanisms encoded in 
the simulation.  Class I and class II proteins 
show sustained expression at the expense of 
class III protein production when the 
transcriptional feedback mechanisms are not 
present.  
 The design and synthesis of T7.1 afforded us a first experience at design and 
construction of an engineered T7 genome.  For example, the design of section alpha took 
six person-months to complete.  We were not entirely confident that section alpha, with 
~400 base pairs changed or added, would be viable.  So, during the design phase, we 
were careful to try to exclude every possible change that might impact phage 
development.  We did this by minimizing changes of variables that we were aware of, 
from genetic element secondary structure to untranslated mRNA regions.  When we 
discovered that section alpha was viable, we began design of section beta, which took 
two-person weeks.  We then subsequently designed the rest of the T7.1 genome in three-
person days.  Some of the reduction in design times arose via simple optimization of 
techniques, but another change was due to our knowledge of the types and extent of 
changes that could be made.
 However, the resulting T7.1 genome is more constrained by our initial uncertainty 
than driven by our primary design goal – to construct a genetic system that is a physical 
instance of our understanding of a biological system that we believe, to first 
approximation, to understand.  I have designed and planned construction of a second-
generation synthetic T7 genome, which I designate T7.2, in order to improve our 
understanding of the functional genetic elements that contribute to phage gene 
expression. The design of T7.2 makes good use of our initial experience with designing 
and building T7.1 [§2].  For example, we now know that the wild-type T7 genome can 
tolerate many simultaneous engineered changes without gross impact to phage viability.
 Five goals drove the design of T7.2; the first four goals revisited or extended 
those used in the design of T7.1.  First, the T7.2 genome only includes elements that are 
thought to contribute to phage gene expression.  Moving beyond our design of T7.1, I  
actively erased or deleted elements of unknown function.  Second, the T7.2 genome 
design does not include any functions that might be encoded via the physical coupling of 
multiple genetic elements. Third, the design of T7.2 enables unique and selection-
independent manipulation of each genetic element via restriction enzymes. Fourth, for 
practical reasons, the design of T7.2 is designed to encode a viable bacteriophage.  Fifth, 
to attempt to make our modeling of gene expression easier, I used standard synthetic 
elements in place of the natural elements that regulate transcription and translation.  
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Taken together, the design of T7.2 should specify a genome that is simpler to model and 
manipulate, in which we have a putative function for each base pair of DNA involved in 
phage gene expression. Thus, I hypothesize that T7.2 will also encode a dynamic system 
that is easier to model and interact with, relative to the wild type.
Chapter 5.3.1.  T7.2 Design Specification
 The design of the T7.2 genome is a component-based design.  I defined and 
specified each component, added them to the Registry of Standard Biology Parts (http://
parts.mit.edu), and compiled the individual components to construct a design draft of the 
genome.  Part numbers indexed in the Registry take the form BBaZ0XXX.  After the 
initial draft, I did global optimizations such as restriction site additions, RBS-CDS 
secondary structure removal, and addition of elements to aid in measurement of system 
function to construct a draft sequence of the T7.2 genome (BBaZ0506).  The following 
sections describe the considerations made for each step of the process.  
Chapter 5.3.1.1.  Coding Domains
 There are 57 annotated genes on the T7 genome encoding 60 proteins.  Many of 
the natural T7 genes are not known to contribute to phage development in the set of 
conditions in which I wish to assay them, and they confound systems-level analysis.  The 
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Figure 5-2.  T7.2 Design (next page).  In the T7.2 design, I defined and concatenated 
individual parts to arrive at the design.  The labeled genetic elements include protein coding 
regions (light blue & green lozenges), strong and medium strength ribosome binding sites 
(orange & red arcs before coding domains), the three major E. coli promoters (blue arrows), 
two standardized classes of T7 weak promoters (orange & pink arrows), standardized T7 
strong promoters (red arrows), standardized RNase III recognition sites (pink diamonds), 
transcription terminators (red circles), a fluorescent reporter construct (purple stars), and other 
regions of importance (gray). Sites where I removed RNA secondary structure across the 
RBS-gene interface are labeled by verticle blue lozenges.  The genome will be constructed in 
sections to make hybrid phage at labeled natural T7 single cut sites (red lines).  Additional 
single-cut restriction sites were used throughout the design to aid in further manipulations 
(black lines). 
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following genes are not conserved across other T7 relatives and encode no known 
function during T7 development: 0.4, 0.5, 0.6A/B, 1.4, 1.5, 1.6, 1.8, 2.8, 3.8, 4.1, 4.2, 4.7, 
5.3, 6.3, 7, 7.7.  I did not include these genes in the design of T7.2.   I also included many 
genes that will eventually be removed, but am including to be cautious.  These genes 
mostly show evolutionary conservation or anecdotal evidence for important functions.  I 
included the genes in the design, but have made them easier to remove in the future.  
These genes are 0.3, 1.1, 4.3, 4.5, 5.5-5.7, 5.7, 5.9, 6.5, 18.5, 18.7, 19.2, 19.3, 19.5. 
Chapter 5.3.1.2. Ribosome Binding Sites
 Each gene has a corresponding putative ribosome binding sites (RBS) that 
controls translation initiation.  I standardized the RBS of these genes to reduce the 
parameters necessary to represent the system, and possibly to reduce any unknown 
functions of translation coupling.   I chose three RBS to standardize from that were 
measured by Heather Keller to have a varied range of expression rates.  I assigned one of 
these RBS to each coding domain based on both knowledge of the amounts of total 
protein production necessary for phage function, as well as computational analysis of the 
strength of existing ribosome binding sites.  The computational analysis assigned 
predicted strengths [Table 6-3] of the RBS based on their sequence through a published 
algorithm [Barrick et al., 1994]. I standardized the natural sites to three ribosome binding 
sites (strong, medium, and weak) that were characterized experimentally by Heather 
Keller.  After the design was completed, I found the weak RBS only mapped to genes that 
were not included in the T7.2 design.  Thus I use only two standardized RBS - the strong 
RBS based on the gene 5 (BBaZ0261), and an exogenous RBS (BBaZ0262; Weiss, 
2001).  The assignments of the RBS are shown in Figure 5-2.
Chapter 5.3.1.3. Host Promoters
 I encoded only the three strong host promoters (A1, A2, A3).  I removed the other 
annotated promoters by virtue of not including genes they were contained in, or by point 
102
mutations intended to obliterate function.   The edits are annotated at http://parts.mit.edu. 
The following is the listing of promoters that were removed:
B: Located mostly in gene 0.5, which is not encoded
C: Only -35 region is included within coding domain of gene 0.7; -10 region and 
start are not included in T7.2 design.
E: Strong -10 region mutated, -35 region not included
S1: -35 and -10 regions edited to remove promoter
S2: -35 region edited, -10 region already not optimal
S3: -35 and -10 regions edited to remove promoter
S4: -35 and -10 regions edited to remove promoter
S5: Located within gene 5.3 which is not included
S6: -35 and -10 regions edited to remove promoter
F1: Only -35 region is included within coding domain of gene 6.5; n 10 region 
and start are not included in T7.2 design.
F2: -35 region mutated, -10 region already not optimal
Chapter 5.3.1.4. Phage Promoters
 I standardized the phage promoters that I encoded into the genome. In our models, 
I split the promoters into three class; weak binding and processivity, weak processivity, or 
strong promoters [§3.6.1.2]. The natural T7 promoters on the T7 genome are listed in 
Table 3-4, along with their classification.  I used the ø2.5, ø3.8, and ø10 promoters as the 
standard for the weak processivity (BBaZ0253), weak processivity and binding 
(BBaZ0252), and the strong promoters (BBaZ0251), respectively.  I chose these three 
promoters they were used in past detailed kinetic studies.  Applying a conservative 
approach, each promoter occupies 35 bp, more than the necessary and sufficient 23 bp.   
Finally, as a consequence of removing genes, sometimes two T7 promoters would 
become directly adjacent.  In those cases, I removed one of the two T7 promoters.  The 
final distribution of T7 promoters is shown in the final design diagram [Figure 5-2].
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Chapter 5.3.1.5.  Miscellaneous elements
 I treated the primary origin of replication, and the promoters that are contained 
within it (ø1.1A and ø1.1B), as a separate part in order to prevent disturbances 
(BBaZ0291).  In addition, I treated the left end (BBaZ0292; 377 bp) and right end 
(BBaZ0293; 399 bp) of the genome as individual parts due to their large repeats and 
importance in DNA replication and packaging.  Also, I kept the definitions for the 
transcriptional terminators as they were in T7.1. TE (BBaZ0271) and Tø  (BBaZ0272), 
while the CJ terminator remained unaltered in the right end part.  Finally, I specified 
addition of a fluorescent reporter, Venus YFP, into the genome [Nagai et al., 2002].  
Chapter 5.3.1.6. RBS - CDS Interface
 To avoid possible effects of introduced secondary structure at the interface 
between the standardized RBS and the coding domains that could interfere with 
expression, Alex Mallet and I analyzed and minimized secondary structure for many 
genes.  Alex designed software to evaluate secondary structure effects, and developed a 
minimization procedure to reduce the secondary structure across the part interface 
[Mallet, 2006].    Briefly, we used the RNAfold algorithm [Hofacker et al., 1994] to 
evaluate free energy of the possible secondary structures of the 20 RBS with the first 13 
codons of the CDS.  Structures that had significant secondary structure across the 
interface (>-9 kCal/mol) were marked to be modified.  Those structures that were 
changed are labeled on Figure 5-2.  For each of the genes to be altered, we chose three 
alternative codons for each amino acid residue, and calculated secondary structures of all 
possible combinations of the codons.  The search reduced secondary structure pairing 
significantly.  I used the minimum free energy structure for the coding domains in the 
T7.2 design.
Chapter 5.3.1.7.  Restriction Enzyme Cut Sites.  
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 In the T7.1 design, I flanked each part with restriction enzyme recognition sites to 
allow easy part manipulation.  However, I was limited by the number of independent 
recognition sites, and thus many of the restriction sites cut more than once in different 
sections of the T7.1 genome.  We had expected to be able to clone substantial portions of 
each genome, but the sections proved to be fairly toxic.  I found that having single cut 
sites spaced farther apart would be better for future manipulations.  After the draft initial 
T7.2 design was complete, I added restriction cut sites that cut only once on the genome 
approximately every 1000 bp [Figure 5-2].  
Chapter 5.3.2. T7.2 Construction Plans
 The manual construction of T7.1 proved to be very tedious.  Thus, I explored 
automated ways to construct T7 sections.  Commercial synthesis companies have become 
somewhat adept at building DNA the size of T7 sections.  However, most companies rely 
on cloning in E. coli in order to produce their DNA.  I worked with Codon Devices on in 
vitro methods to construct the genomes.  Codon Devices constructed the first 8000 bp of 
the T7.2 genome in 9 ~1000 bp fragments.  Efforts on combining these fragments 
together is still ongoing, and is now beyond the scope of this thesis.  
Chapter 5.4.  Conclusions
 In this thesis, I worked to construct accurate and biophysically realistic models of 
gene expression for a natural biological system, bacteriophage T7.  I constructed more 
detailed simulation tools [§2], and used them to make new, more detailed models of 
bacteriophage T7 gene expression [§3].  Heather Keller then made system-wide 
measurements of T7 mRNA levels, and I showed that the inability of the previous models 
to account for class I and II protein synthesis attenuation late in infection can be 
accounted for by mRNA degradation.  However, the models still lack sufficient 
information to provide predictable gene expression in T7 variants containing arbitrary 
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genetic rearrangements.  For example, if we move a gene from one position to another, 
we would not have a mechanistic model for how the rate of mRNA degradation would 
change. 
 We can continue to improve computational models by better characterizing 
individual components, and compare them to system-wide measurements to analyze the 
validity of models.  Differences between the models and measurements can lead to 
further understanding, and point towards future work.  We can hope that in the future, our 
models will progress to a point where they are realistic representations of the natural 
phage, and that model-based predictions of arbitrary perturbations can be trusted.  
 I also embarked on a complementary approach to the process of trying to 
understand natural systems.  Rather than making models of T7 evermore detailed, I 
decided to construct synthetic phage that are closer physical representations of our 
models.  Leon Chan and I began, by designing and constructing a portion of a new phage, 
T7.1, where we define and insulate genetic elements eliminating genetic overlaps that we 
assigned no function to in our models [§4].  The resulting phage had similar gross 
characteristics to T7 and the genome of T7.1 is now easier to model.  
 I have also designed a new phage, T7.2, that goes beyond simply specifying a 
genome that is easier to model, to a phage where infection is easier to model [§5.3].  For 
example, in our models, I assume the measured kinetics of one T7 strong promoter are 
the same for all the strong T7 promoters.  We could further study the phage promoters in 
their individual contexts to test the validity of the assumption.  Alternatively, we can 
standardize the relevant sequences to match the model more accurately.  Thus, we don’t 
necessarily care about the natural T7 genome per se, we care about how individual 
elements in a genome can interact to produce the dynamic system that leads to 
development of a replicating and productive phage. 
 Construction of synthetic biological systems in support of understanding and 
analyzing natural biological systems can serve a number of purposes.  First, 
recapitulation of observable functions provides a powerful test of our understanding of 
how system components interact to form a functioning whole [Sprinzak & Elowitz, 
2005].  Differences between models used to design synthetic systems and the synthetic 
systems themselves point to gaps in our understanding of the governing components and 
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interactions [Chan et al., 2005].  Likewise, differences between synthetic and natural 
systems can lead to insight into what other functions the natural biological systems might 
serve.  Second, evolving surrogate synthetic systems can act as a tool to understand how 
the individual parts of the natural system contribute to system fitness, as well as provide a 
platform to understand how evolutionary processes can optimize system performance.  
Third, constructing more defined, measurable, and manipulable developmental systems 
provides a foundation for the rational engineering of novel self-replicating, self-
assembling systems [Knight, 2005].  
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Chapter 7.  Appendices
Chapter 7.1.  T7 Modeling Appendix
Chapter 7.1.1.    Simulation and Measurements Comparisons
Figure 7-1 (following 4 pages).  Real time measurements and simulation results 
showing absolute, gene-specific mRNA levels per cell during T7 infection.  Each plot 
shows the measured (green) and computed (red;blue;purple) number of T7 mRNA per 
cell throughout infection.  Measurements were made using real-time RT-PCR.  For all 
graphs, the solid lines show the average all of all replicates (2-4 extractions per gene, 
each extraction measured in triplicate).  Shaded regions represent the range of the 
measurements, with the standard deviation show by error bars.  Simulation data plotted 
are the unfit (blue) and the best fit model (purple; traffic jam model with increased 
promoter strength).  The red plots represent the final fitting of the other models tested: 
(a)  Increased promoter strength; (b) Alternative degradation model; (c) DownStream 
Falloff model; (d) Upstream Falloff model.  The width of the computed curves shows 
the variation (± standard deviation) from the average of 25 simulations.
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Chapter 7.1.2.  Fitting Procedure Charts.  
Figure 7-2.  Fitting simulations of T7 mRNA levels to measured data (next 3 
pages).  Each table shows the optimization procedure to fit the RT-PCR mRNA 
measurements  for the initial fit (a), the altered promoter model (b), the alternative 
degradation model (c), the DownStream Falloff polymerase interaction model (d), 
the Traffic Jam polymerase interaction model (e), and the UpStream Falloff model 
(f).  Each row shows the simulations run to fix the mRNA levels for one particular 
gene, or class average.  The columns represent mRNA half-lives tested in 
minutes.  The values shown in each entry are R2 for the particular gene and half-
life being tested.  A shaded box means the half-life was not tested.  To begin, in 
row 1, an average mRNA half-life was tested for all the class I genes.  The highest 
R2 found (highlighted) was fixed, and I then tested and fixed the class II average 
half-life (row 2).  After the average class III values were set, each gene was then 
optimized against the mRNA measurement profiles for different half-lives.  After 
this process was complete, I show the final the final R2 found after the last 
simulation in the last column.  As can be seen, the R2 were not significantly 
changed from the original value, meaning optimization of downstream genes did 
not significantly affect the fit of the upstream genes.  Finally, the last row shows 
the average R2 for all the individual fits.    
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 None Final
class I  0.3643 0.4078 0.4179 0.4047 0.3814 0.3579 0.3397 0.3196 0.3033          0.1229 0.4437
class II    0.4168 0.4271 0.426 0.4185 0.4107                  0.4586
class III 0.2572 0.3403 0.3673 0.3612 0.354 0.3474 0.3417 0.3366 0.3359 0.335        0.327 0.3055 0.4842
0.3  0.3825 0.4142 0.417 0.4042 0.384                    0.4216
0.7 0.4973 0.5323 0.5242 0.4994 0.4727                      0.5297
1 0.4496 0.561 0.6364 0.6665 0.6663                      0.6724
1.1      0.1414  0.154  0.1652 0.1679 0.1713 0.1723 0.1743 0.176 0.1775 0.1804 0.17 0.1755
1.2      0.2339 0.264 0.2713 0.2858 0.2758 0.259 0.2437            0.2828
1.3 0.2968 0.4712 0.5656 0.5553 0.4519 0.365 0.3026                  0.5804
1.4 0.4517 0.6355 0.7417 0.6985 0.6042                      0.7418
1.7      0.5338 0.5445 0.5501 0.5522 0.5558 0.5546 0.5552 0.5541 0.552      0.483 0.555
2      0.4697            0.4853 0.4867 0.4872 0.4873 0.4887 0.4951 0.4946
2.5      0.1801            0.2077 0.2064 0.2064 0.2086 0.2085 0.1792 0.2073
3.5      0.3281            0.3916 0.3972 0.4016 0.406 0.4059  0.4083
5 0.2307 0.257 0.2751 0.2831 0.2882 0.2838 0.2813 0.2756                0.287
6      0.4639 0.492 0.5042 0.5091 0.5059 0.4956              0.5159
8 0.1717 0.4609 0.5093 0.2437 0.1324                      0.5355
9    0.2783                  0.3932 0.3978 0.4046 0.4502 0.4529
10A    0.3359                  0.4241 0.4287 0.4327 0.5148 0.5161
11    0.2899                  0.3558 0.3621 0.3653 0.4189 0.4216
15    0.4305                  0.4579 0.4599 0.4603 0.4773 0.4765
16    0.2579                  0.4799 0.4855 0.4723 0.2677 0.4786
17.5    0.1662        0.2058 0.2093 0.2129 0.2136 0.2192 0.2183 0.2208 0.2222 0.2323 0.232
18.5  0.458 0.6367 0.7605 0.7434 0.6616 0.5722                  0.7605
Total Avg 0.4641
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 None Final
class I 0.3272 0.4329 0.5077 0.4895 0.4448                    0.0799 0.5699
class II 0.3641 0.4307 0.4572 0.4603 0.4508 0.4383 0.429 0.4174              0.2795 0.5195
class III    0.3549 0.3684 0.3606 0.3551 0.3532 0.3515 0.3505  0.3473  0.3442  0.3431 0.3231 0.5079
0.3  0.5296 0.5809 0.531 0.4549                      0.5838
0.7 0.6053 0.6667 0.6413 0.5772 0.5146                      0.6703
1 0.4493 0.6069 0.7148 0.7455 0.7336                      0.7649
1.1    0.1433 0.1605 0.1731 0.1833 0.1909 0.1962 0.2056 0.205            0.1982
1.2    0.2371 0.3108 0.3993 0.4132 0.385 0.331 0.2771 0.2288            0.4370
1.3 0.346 0.6196 0.7132 0.4991 0.344                      0.7652
1.4  0.7514 0.7986 0.6305 0.4506 0.3368 0.2468                  0.8426
1.7  0.5144 0.5483 0.5741 0.5877 0.5974 0.5973 0.5946 0.5918 0.5922            0.5912
2  0.4628 0.4736 0.4822 0.4878 0.4924 0.4975 0.4991 0.5013 0.5044 0.5064 0.5057 0.5082 0.5091 0.5096 0.5182 0.5161
2.5 0.1406  0.186 0.2062 0.2214  0.2376  0.2466 0.246 0.2476 0.2466 0.2455  0.2391 0.1621 0.2456
3.5      0.3608 0.3842 0.4024 0.4184 0.434 0.4382 0.453 0.4575 0.4625 0.4683 0.4731 0.4715  0.4751
5      0.331 0.3356 0.3279 0.3196 0.3078 0.2958 0.2846 0.2748 0.2632 0.2565 0.2495    0.3324
6  0.3925 0.4975 0.5855 0.627 0.6387 0.6137 0.5827 0.5398              0.6336
8 0.191 0.3965 0.2699 0.1175 0.0654 0.044 0.0323                  0.4022
9            0.3839 0.4006 0.4132 0.4263 0.4363 0.4452 0.4537 0.4613 0.4689 0.5123 0.5098
10A            0.4034      0.4452 0.4505 0.4588 0.4647  0.5871 0.5897
11            0.3444      0.3773 0.3809 0.3857 0.3923 0.3974 0.48 0.4791
15            0.4555      0.4644 0.4682 0.4697 0.471 0.4714 0.4902 0.4905
16        0.3924 0.4396 0.4769 0.5086 0.5209 0.5267 0.5224 0.5168 0.5099 0.4992    0.5230
17.5            0.2132      0.2314 0.2347 0.2384 0.2393 0.2435 0.2499 0.2481
18.5    0.7255 0.8322 0.7616 0.6294 0.5201                  0.8212
Total Avg 0.5295
(b)
(a)
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 None Final
class I 0.2453 0.3279 0.4061 0.4505 0.4472                    0.0801 0.4831
class II 0.3526 0.4022 0.4412 0.4603 0.452 0.4404 0.4362 0.4174 0.2873              0.4972
class III      0.3612 0.3634 0.3593 0.3525 0.3501 0.3473 0.346  0.3433  0.3411  0.3206 0.4903
0.3 0.261 0.3476 0.4155 0.4484 0.4409                      0.4578
0.7  0.4742 0.5297 0.5405 0.5131 0.4912                    0.5502
1    0.5968 0.6582 0.6977 0.6884 0.6609                  0.7050
1.1              0.1836 0.1869 0.195 0.1976 0.199 0.2043 0.2035 0.2071 0.1784 0.1989
1.2      0.2512 0.3259 0.3619 0.3777 0.3503 0.3101 0.28            0.3658
1.3 0.3045 0.5153 0.6744 0.591 0.4049 0.3093 0.2183                  0.6210
1.4  0.6905 0.802 0.7141 0.5077 0.3921                    0.7609
1.7      0.5551 0.5708 0.5786  0.5866 0.5903 0.5872 0.5847 0.5823        0.5874
2      0.477              0.5024 0.5047 0.5038 0.5058 0.5137 0.5112
2.5      0.1903          0.2375 0.2393 0.2422 0.24 0.2366 0.2386 0.1644 0.2324
3.5      0.3453                0.4432 0.4483 0.4514 0.4618 0.4611
5      0.3078 0.3185 0.3215 0.3168 0.3111 0.3081              0.3240
6      0.4976 0.5888 0.6033 0.5896 0.5792                0.6033
8 0.1603 0.3526 0.4084 0.2206 0.1166    0.0413                0.4176
9              0.3618        0.4149 0.4215 0.4256 0.4944 0.4908
10A              0.3949        0.4315 0.4379 0.4427 0.5495 0.5534
11              0.3359        0.3657 0.3706 0.3751 0.4542 0.4520
15              0.4515        0.4614 0.4624 0.4637 0.4828 0.4831
16              0.4461 0.4756 0.4783 0.4947 0.5012 0.5045 0.4988 0.4904 0.2374 0.4995
17.5              0.2043          0.2237 0.2249 0.2423 0.2400
18.5      0.7497 0.7977 0.7343 0.6381 0.5236                0.7858
Total Avg 0.4905
(c)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 None Final
class I 0.2883 0.3549 0.3948 0.4036 0.3928 0.3738                    0.4296
class II    0.3959 0.4079 0.4079 0.4036 0.3957                  0.4385
class III 0.2485 0.3002 0.3401 0.3459 0.3367 0.3305 0.3263 0.3222 0.3199 0.3167 0.315 0.314 0.3117 0.3112 0.3097 0.2921 0.4227
0.3  0.4643 0.4985 0.4755 0.4397 0.391                    0.4997
0.7 0.4714 0.5008 0.4995 0.4818 0.457                      0.5025
1 0.4065 0.4819 0.5282 0.5531 0.5628 0.5664 0.5539 0.5438 0.5349 0.523 0.4624          0.5645
1.1      0.1387      0.16 0.1643 0.1687 0.1699 0.1718 0.173 0.1739 0.1757 0.1740 0.1740
1.2      0.216 0.2513 0.2713 0.2804 0.275                0.2799
1.3  0.4186 0.5283 0.5478 0.4803 0.4071                    0.5569
1.4  0.577 0.6844 0.6923 0.6164 0.5435                    0.7050
1.7      0.5342 0.5443 0.5498 0.5561 0.5573 0.5559              0.5547
2      0.4689              0.4859 0.4864 0.4864 0.4881 0.4949 0.4939
2.5      0.1772      0.2 0.2022 0.2041 0.2051 0.2068 0.2056 0.2059 0.207 0.1781 0.2058
3.5      0.3184            0.3794 0.3833 0.3871 0.3896 0.3913 0.4121 0.4130
5      0.2643 0.2678 0.2679 0.267 0.2641                0.2693
6      0.3855 0.4053 0.4187 0.4234 0.4264 0.4247              0.4277
8 0.1458 0.3046 0.467 0.3768 0.2387 0.159 0.1167                  0.4753
9      0.2789            0.3338 0.3388 0.3407 0.3454 0.3478 0.3875 0.3882
10A      0.3394                0.3932 0.3959 0.3984 0.4527 0.4536
11      0.29                0.3281 0.329 0.3336 0.369 0.3693
15      0.4308                0.4468 0.4487 0.4487 0.4601 0.4607
16      0.2615          0.3788 0.3759 0.3843 0.3897 0.3931 0.3962 0.3249 0.4035
17.5      0.1675              0.1945 0.1945 0.1964 0.1976 0.2079 0.2084
18.5    0.5252 0.5936 0.6135 0.5996 0.5548 0.5049                0.6224
Total Avg 0.4299
(d)
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 None Final
class I 0.4744 0.5207 0.3139 0.2033 0.1527 0.1238                    0.6007
class II  0.4178 0.4294 0.4122 0.3965 0.377                    0.504
class III 0.3186 0.3674 0.3616 0.3577 0.353 0.3509 0.3466 0.3455 0.3431 0.3418 0.3428 0.3404 0.3395 0.3376 0.3394 0.3087 0.5314
0.3 0.5158 0.6247 0.4561 0.302 0.2138                      0.6501
0.7 0.6824 0.4816 0.3238 0.2235 0.1669                      0.6983
1 0.684 0.6413 0.3624 0.2166 0.1435                      0.6915
1.1  0.2044 0.2687 0.3088 0.318 0.2969 0.2693 0.2325 0.2055 0.1851            0.3287
1.2 0.2187 0.7568 0.3078 0.109 0.0593 0.0419                    0.6573
1.3 0.6279 0.4296 0.157 0.0806 0.0524                      0.5781
1.4 0.5258 0.7024 0.5844 0.4281 0.3137                      0.705
1.7 0.5558 0.5701 0.5778 0.5744 0.5749        0.5507        0.519 0.3705 0.5798
2    0.4773              0.5017 0.5052 0.5055 0.5061 0.5061 0.5074 0.5104
2.5    0.1978 0.2192 0.2295 0.2375 0.237 0.2368 0.2357 0.237 0.2309 0.2235 0.2213    0.127 0.2332
3.5      0.3587            0.4875 0.4901 0.4974 0.4939 0.4997 0.4535 0.5
5  0.3096 0.3348 0.3379 0.3244 0.3073                    0.3032
6 0.3278 0.4696 0.6226 0.6935 0.6651 0.6108 0.5367                  0.6961
8 0.2634 0.3311 0.1075 0.0483                        0.344
9  0.2801                  0.5483 0.5495 0.5616 0.5675 0.5115 0.5755
10A  0.3351                  0.5104 0.5223 0.531 0.5379 0.7012 0.7099
11  0.2901                    0.4388 0.4477 0.4508 0.5693 0.5724
15  0.4328                    0.4934 0.4938 0.496 0.5207 0.5206
16  0.2565 0.3346 0.4394 0.5207 0.5615 0.5755 0.5598 0.5257 0.4852 0.4565 0.4243 0.383 0.3644 0.3358 0.1039 0.5725
17.5  0.1694              0.2785  0.2891 0.2942 0.2974 0.2979 0.2631 0.2979
18.5 0.3637 0.6581 0.2353 0.2506 0.2655                      0.6581
Total Avg 0.542
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 None Final
class I 0.3237 0.363 0.351 0.3248 0.2984 0.2745                    0.3927
class II  0.3433 0.3442 0.3383 0.3308 0.327                    0.3646
class III        0.287 0.2958 0.3006 0.3038 0.3082 0.3063 0.3085 0.3099 0.309 0.3071 0.3089 0.2881 0.3159
0.3 0.3767 0.4121 0.4056 0.374 0.3468                      0.4112
0.7 0.472 0.4513 0.414 0.3785 0.3464                      0.4737
1 0.5441 0.5955 0.5644 0.5145 0.4575                      0.5972
1.1  0.1222  0.1348  0.1446 0.1484 0.1515 0.1518 0.154 0.155 0.1556 0.1575 0.1585 0.1587 0.1655 0.1663
1.2  0.1364  0.199  0.231 0.2363 0.2402 0.2348 0.2278  0.22  0.217    0.2361
1.3 0.3578 0.4701 0.4477 0.3782 0.3048 0.2492                    0.4719
1.4 0.4977 0.6292 0.6129 0.503 0.4397                      0.6387
1.7    0.4634 0.4676 0.4714 0.4737 0.4751 0.4766 0.4777 0.478 0.4782 0.4792 0.4796 0.4801 0.4802 0.4794 0.4772
2    0.4468              0.4524 0.4524 0.4528 0.453 0.4534 0.4553 0.4542
2.5    0.1361          0.1428 0.1435 0.1439 0.1442 0.1443 0.1445 0.1449 0.1477 0.1465
3.5    0.2575              0.2728 0.2747 0.2747 0.2756 0.2755 0.2849 0.283
5    0.2215  0.2246 0.2258 0.2259 0.2271 0.2271 0.2275 0.2272 0.2276 0.2275 0.2274 0.2272 0.2234 0.2274
6    0.2781            0.3104 0.3125 0.316 0.3162 0.3165 0.3174 0.3263 0.3255
8        0.1972 0.219 0.2279 0.2356 0.2579 0.2431 0.2431 0.262 0.26 0.265 0.2609 0.1967 0.2601
9                      0.2485 0.2484 0.2499 0.2511 0.2603 0.2611
10A                      0.3138 0.3145 0.3147 0.3152 0.3238 0.325
11                      0.2679 0.2683 0.269 0.269 0.2756 0.276
15                  0.4329 0.4326 0.4332 0.4345 0.4347 0.435 0.442 0.4413
16                      0.2882 0.2823 0.2879 0.2897 0.327 0.3363
17.5                      0.1575 0.1583 0.1571 0.158 0.1648 0.1666
18.5  0.2819 0.3181 0.3489 0.3812 0.3972 0.4049 0.415 0.4357 0.4373 0.4405 0.4474 0.461 0.4533 0.4511 0.4238 0.461
Total Avg 0.3541
(f)
(e)
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Section Alpha
Section Beta
Figure 7-3.  Genome design. We split the wild-type T7 genome into six sections, alpha through 
zêta, using five restriction sites unique across the natural sequence. Each section shown here has a 
wild-type section with representations of the genetic elements: protein coding regions (blue), 
ribosome binding sites (purple), promoters (green), RNase III recognition sites (pink), transcription 
terminators (yellow), and others (gray). Elements are labeled by convention [7].  Images are not to 
scale, but overlapping boundaries indicate elements with shared sequence. The useful natural 
restriction sites across each section are shown (black lines).  T7.1 sections are shown below the wild-
type sections. Parts are given integer numbers, 1 through 73, starting at the left end of the genome.  
Unique restriction site pairs bracket each part (red/blue lines, labeled D[part #]L/R). Added unique 
restriction sites (purple lines, U[part #]) and part length (# base pairs, open boxes) are shown. 
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Section Gamma
Section Delta
Section Epsilon
Section Zêta
Figure 7-4.  Differences between wild-type T7 and T7.1.  A listing from left to right on 
the T7 genome of the changes made during design of T7.1.  Changes are shown by 
comparison of the annotated wild-type T7 (above) and T7.1 (below) sequences.  Point 
mutations are capitalized.  The natural ribosome binding sites are underlined.  The 
bracketing restriction sites surrounding parts are orange (left cutter) and blue (right 
cutter), with overlaps of neighboring bracketing restriction sites in light green.  Other 
features include start codons (green), stop codons (red), and overlaps of start and stop 
codons (purple).  
Changes in Section Alpha
LeftEnd-Part1: TR-SRL/A0 
T7:	
 gagtgtctctctgtgtccctatctgttacagtctcctaaagtatcctcct
	
 ------TR---------->               <-------SRL-----
T7.1:	
 gagtgtctctctgtgtccctatcGgttacCgtctcctaaagtatcctcct
	
 ------TR---------->    <-D1L->    <-------SRL-----
Part1-Part2: SRL/A0-øOL 
T7:	
 acctaaagacgccttgttgttagccataaagtgataacctttaatcattgtctttattaa
	
 --SRL-->                                       <-----øOL----
T7.1:	
 acctaaagGTTaccgcatgcttgttgttagccataaagtgataacctttaatcattgtctttattaa
	
 --SRL-->      <D2L->                                  <-----øOL----
	
        <-D1R->
Part2-Part3: øOL-A1 
T7:	
 aaggagagacaacttaaagagacttaaaagattaatttaaaatttatcaaaaag
	
 ---ø0L-->                                    <---A1---
T7.1:	
 aaggagagacaacttaaagagCAtgcttaaaagattaatcgattaaaatttatcaaaaag
	
 ---øOL-->           <D2R->           <D3L->        <---A1---
Part3-Part4: A1-A2/A3/BoxA/R0.3 
T7:	
 gagagggacacggcgaatagccatcccaatcgacaccggggtcaaccggataagtagacagcctgataagtcgcacgaaaaacagg
	
 ----A1---->                                                                <----A2----
T7.1:	
 gagagggacacggcgaatagccatcccaatcgaTaccggggtcaaccggataagtagaAagcTtgataagtcgcacgaaaaacagg
	
 ----A1---->                 <D3R->                        <D4L->           <----A2----
Part4-Part5: A2/A3/BoxA/R0.3-0.3 
T7:	
 gatattcactaataactgcacgaggtaacacaagatggctatgtctaaca
	
 ---R0.3--->        <-0.3RBS->     <------0.3------
T7.1:	
 gatattcactaagcttgcgcgctgcacgaggtaacacaagatggctatgtctaaca
	
 ---R0.3--->     <D5L->   <-0.3RBS->     <------0.3------
	
           <D4R->
Part5-Part6: 0.3-0.4 
T7:	
 cgaggagtacgaggaggatgaagagtaatgtctactacc
	
 -------------0.3----------->
	
          <-0.4RBS->        <----0.4----
T7.1:	
 cgaggagtacgaggaggaCgaagagtaagcgcgcaccaggtcgaggagtacgaggaggatgaagagtaatgtctactacc
	
 -------------0.3-----------><D5R-><-D6L->         <-0.4RBS->        <----0.4----
U1-R0.5: U1/0.4-R0.5 
T7:	
 caaagaactgtacgaaaacaacaaggcaatagctttagaatctgctgagtgatagactcaaggtc
	
 --------------------------------------------0.4---->
                                                        <-------R0.5-------
T7.1:	
 caaagaGctCtacgaaaacaacaaggcaatagctttagaatctgctgagtgaaccaggtgagtgatagactcaaggtc
	
 --------------------------------------------0.4----><-D6R-><-------R0.5-------
              <-U1->
 
R0.5-Part7: R0.5-0.5 
T7:	
 gcctttatgattatcactttacttatgagggagtaatgtatatgctt
	
 -------R0.5------->      <-0.5RBS-><----0.5----
T7.1:	
 gcctttatgattatcacttacgcgtcttatgagggagtaatgtatatgctt
	
 -------R0.5-------><D7L->    <-0.5RBS-><----0.5----
U2
T7:	
 gctctaggtctagctgtaggtgcatcc
	
 ---------------0.5---------
T7.1:	
 gctctaggGctagctgtaggtgcatcc
	
 ---------------0.5---------
	
           <-U2->
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Part7-Part8: 0.5-0.6A/B 
T7:	
 catcaaaggggcactacgcaaatgatgaagcac
	
 ---------0.5------------>
	
    <-0.6RBS->        <----0.6----
T7.1:	
 catcaaaggCgcactacgcaaatAaacgcgtacgcaaaggggcactacgcaaatgatgaagcac
	
 ---------0.5------------><D7R->   <-0.6RBS->        <----0.6----
	
                             <D8L->
Part8-Part9: 0.6A/B-0.7 
T7:
	
 aacaggcactagccaacacactgaacgctatctcataacgaacataaaggacacaatgcaatgaacattacc
	
 ----0.6---->                                <-0.7RBS->      <----0.7----
T7.1:
	
 aacaggcactagcgtacggtccgcgaacataaaggacacaatgcaatgaacattacc
	
 ----0.6----><D8R->           <-0.7RBS->      <----0.7----
	
                 <-D9L->
Part9-Part10: 0.7-C/R1 
T7:	
 caacattgataagcaacttgacgcaatgttaatgggctgatagtcttatct
	
 -------------------0.7-----------------> <----R1---
	
     <------------------------C---------------------
T7.1:	
 caacattgataagcaacttgacgcaatgttaatgggctgacggtccgccgcggattgataagcaacttgacgcaatgttaatgggctgatagtcttatct
	
 -------------------0.7-----------------><-D9R-><D10L><------------------------C---------------------
	
                                                                                           <----R1---
Part10-Part11: C/R1-1 
T7:	
 ataggtacgatttactaactggaagaggcactaaatgaacacgatt
	
 ----R1----->          <-1RBS->    <-----1-----
T7.1:	
 ataggtacgatttactaacccgcggccgctggaagaggcactaaatgaacacgatt
	
 ----R1----->       <D10R>       <-1RBS->    <-----1-----
	
                       <D11L>
Part11-Part12: 1-ø1.1A/R1.1/ø1.1B 
T7:	
 gcgttcgcgtaacgccaaatcaatacgactcactatagagggacaaac
	
 -----1----->                        <---R1.1----
	
           <---------------ø1.1A---------------->
T7.1:	
 gcgttcgcgtaacggccgttaattaaaacgccaaatcaatacgactcactatagagggacaaac
	
 -----1-----><DllR><-D12L-><---------------ø1.1A---------------->
	
                                                     <---R1.1----
Part12-Part13:  ø1.1A/R1.1/ø1.1B-1.1 
T7:	
 tataggagaaccttaaggtttaactttaagacccttaagtgttaattagagatttaaattaaagaattactaagagaggactttaagtatgcgtaacttc
	
 ---ø1.1B--->                                                            <-1.1RBS->      <----1.1----
T7.1:	
 tataggagaaccttaaggtttaactttaagacccttaagtgttaattaAagatttaaattaaagaattCctaagagaggactttaagtatgcgtaacttc
	
 ---ø1.1B--->                             <-D12R->              <D13L>   <-1.1RBS->      <----1.1----
Part13-Part14: 1.1-1.2 
T7:	
 ctgggagggtcagtaagatgggacgttta
	
 ------1.1------> <----1.2----
	
 <-1.2RBS->
T7.1:	
 ctgggagggtcagtaagaattccaggactgggagggtcagtaagatgggacgttta
	
 ------1.1------><D13R>     <-1.2RBS->       <----1.2----
	
                     <D14L->
U3
T7:	
 gacgaggacgttctgttcaatatgtgtactgattggttgaaccat
	
 ----------1.2--------------------------------
T7.1:	
 gacgaggacgttctgttcaatatgtgCactgattggttgaaccat
	
 ----------1.2--------------------------------
	
                        <-U3->
	

Part14-Part15: 1.2-ø1.3/R1.3 
T7:	
 gttgaaggactggaagtaatacgactcagtatagggacaa
	
 --------1.2------->          <---R1.3---
	
       <--------------ø1.3---------------
T7.1:	
 gttgaaggactggaagtaatccaggacccggactggaagtaatacgactcagtatagggacaa
	
 --------1.2-------><D14R->   <--------------ø1.3---------------
	
                       <D15L->                       <---R1.3---
Part15-Part16: ø1.3/R1.3-1.3 
T7:	
 atttaaccaataggagataaacattatgatgaacatt
	
 ----R1.3--->             <----1.3----
	
          <-1.3RBS->
T7.1:	
 atttaaccaataggaggacccgggccaataggagataaacattatgatgaacatt
	
 ----R1.3--->      <D16L>   <-1.3RBS->      <----1.3----
	
               <D15L->
Part16-Part17: 1.3-TE 
T7:	
 agagaaaatgtaatcacactggctcaccttcgggtgggcctt
	
 -----1.3---->    <----------TE------------
T7.1:	
 agagaaaatgtaacccgggcccaaaatgtaatcacactggctcaccttcgggtgggcctt
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 -----1.3----><D16R>                <----------TE------------
	
                 <D17L>
Part17-Part18: TE-1.4 
T7:	
 gcctttctgcgtttataaggagacactttatgtttaagaag
	
 -TE-->        <1.4RBS >      <----1.4----
T7.1:	
 gcctttcagggaaaacgggcccatggttataaggagacactttatgtttaagaag
	
 -TE-->          <D17R>      <1.4RBS >      <----1.4----
	
                     <D18L>
Part18-Part19: 1.4-ø1.5 
T7:	
 cgtgtggagtatagttaactggtaatacgactcactaaagg
	
 -----------1.4---------->
	
              <---------ø1.5--------------
T7.1:	
 cgtgtggagtatagttaactggtaatccatggcgccgttaactggtaatacgactcactaaagg
	
 -----------1.4----------> <D18R>    <---------ø1.5--------------
	
                               <D19L>
Part19-Part20: ø1.5-1.5 
T7:	
 taaaggaggtacacaccatgatgtactta
	
 ----ø1.5--->     <----1.5----
	
  <-1.5RBS->
T7.1:	
 taaaggaggtacggcgcctaggcactaaaggaggtacacaccatgatgtactta
	
 ----ø1.5---><D19R>       <-1.5RBS->      <----1.5----
	
                 <D20L>
U4 
T7:	
 gtcattgtaggatgccttgcgctccactgtagcgatgat
	
 -------1.5-----------------------------
T7.1	
 gtcattgtaggatgccttgcTctTcactgtagcgatgat
	
 -------1.5-----------------------------
	
                   <-U4-->
Part20-Part21: 1.5-ø1.6 
T7:	
 tgccagatggtcacgcttaatacgactcact
	
 --------1.5-------->
	
        <--------ø1.6-----------
T7.1:	
 tgccagatggtcacgcttaacctaggacgtctggtcacgcttaatacgactcact
	
 --------1.5--------><D20L>     <--------ø1.6-----------
	
                          <D21L>
Part21-Part22: ø1.6-1.6 
T7:	
 taaaggagacactatatgtttcgactt
	
 ----ø1.6--->   <----1.6----
	
 <-1.6RBS->
T7.1:	
 taaaggagacacgacgtctagacactaaaggagacactatatgtttcgactt
	
 ----ø1.6---><D21R>       <-1.6RBS->     <----1.6----
	
                 <D22L>
Par22-Part23: 1.6-1.7 
T7:	
 tcaaggaggtgttctgatgggactgtta
	
 -------1.6------>
	
  <--1.7RBS-->   <----1.7----
T7.1:	
 tcaaAgaAgtgttctgatctagaaccggttcaaggaggtgttctgatgggactgtta
	
 -------1.6------><D22R><D23L> <--1.7RBS-->   <----1.7----
Changes in Section Beta
Part23-Part24: 1.7-1.8 
T7:	
 gaactctttgagaaacataaggataaatgttatgcataacttcaagtca
	
 -----------------1.7------------------>
	
                <-1.8RBS->      <------1.8--------
T7.1:	
 gaactctttgagaaacataaAgataaatgttaCgcataaccggtgacctctttgagaaacataaggataaatgttatgcataacttcaagtca
	
 -----------------1.7------------------>  <D24L->           <-1.8RBS->      <-----1.8---------
	
                                       <D23R>
Part24-Part25: 1.8-2 
T7:	
 gaactttggaaatcgagaggtcaatgactatgtcaaacgta
	
 ------------1.8----------->  <-----2-----
	
               <--RBS-->
T7.1:	
 gaactttggaaatcgagaggtcaatgaggtcaccgtacgttggaaatcgagaggtcaatgactatgtcaaacgta
	
 ------------1.8-----------><D24R>               <--2RBS-->     <-----2-----
	
                                  <D25L>
Part25-Part26: 2-ø2.5 
T7:	
 ttgtgtagcaccgaagtaatacgactcactat
	
 ---------2-------->
	
       <-----------ø2.5----------
T7.1:	
 ttgtgtagcaccgaagtaacgtacgaattcagcaccgaagtaatacgactcactat
	
 ---------2--------><D25R>     <------------ø2.5---------
	
                         <D26L>
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Part26-Part27: ø2.5-2.5 
T7:	
 cactattagggaagactccctctgagaaaccaaacgaaacctaaaggagattaacattatggctaagaag
	
 -----ø2.5----->                          <-2.5RBS->       <----2.5----
T7.1:	
 cactattagggaagagaattcccgggcgaaacctaaaggagattaacattatggctaagaag
	
 -----ø2.5-----><D26R>            <-2.5RBS->       <----2.5----
	
                     <D27L>
Part27-Part28: 2.5-2.8 
T7:	
 gcagacgaagacggagacttctaagtggaactgcgg
	
 ---------2.5-----------><----2.8----
	
          <-2.8RBS->
T7.1:	
 gcagacgaagacggGgacttctaacccgggatccgaagacggagacttctaagtggaactgcgg
	
 ---------2.5-----------><D27R>       <-2.8RBS->     <----2.8----
	
                             <D28L>
Part28-Part29: 2.8-3 
T7:	
 acgcaaagggaggcgacatggcaggttacggcgctaaaggaatccgaaa
	
 ----------------2.8----------------->
	
     <--3RBS-->   <----------------3--------------
T7.1:	
 acgcaaGgggagAcgacaCggcaggttacggcgctaaggatccggccgcaaagggaggcgacatggcaggttacggcgctaaaggaatccgaaa
	
 ----------------2.8-----------------><D28R>      <--3RBS-->   <---------------3---------------
	
                                           <D29L>
Part29-Part30: 3-3.5 
T7:	
 gattaaaaaggaaaggaggaaagaaataatggctcgtgta
	
 ------------3--------------->
	
           <-3.5RBS->        <----3.5----
T7.1:	
 gattaaaaCgCaaGggGggGaagaaataacggccgccgcggaaaggaaaggaggaaagaaataatggctcgtgta
	
 ------------3---------------><D29R><D30L>    <-3.5RBS->        <----3.5----
Part30-Part31: 3.5-ø3.8/R3.8 
T7:	
 tctgaccgtggataattaattgaactcactaaag
	
 ------3.5----->
	
       <------------ø3.8-----------
T7.1:	
 tctgaccgtggataaccgcggacatgtcgtggataattaattgaactcactaaag
	
 ------3.5-----><D30R><D31R><------------ø3.8-----------
Part31-Part32: ø3.8/R3.8-3.8 
T7:	
 tttccctttgttcgcattggaggtcaaataatgcgcaagtct
	
 -------R3.8------>            <----3.8----
	
                 <-3.8RBS->
T7.1:	
 tttccctttgttcgcattggaggtcaaataatacatgtcgacgaggtcaaataatgcgcaagtct
	
 -------R3.8------>              <D31R>  <-3.8RBS->   <----3.8----
	
                                     <D32L>
Changes in Section Gamma
Part32-Part33: 3.8-4A/4B/4.1/4.2 
T7:	
 tagaactaggagggaattgcatggacaattcgcacgattccgatagtgt
	
 --------------------3.8---------------------->
	
       <-4ARBS->     <-------------4A-------------
T7.1:	
 tagaactagAagAgaattgcaCggacaattcgcacgattccgataggtcgacgtacgctaggagggaattgcatggacaattcgcacgattccgatagtgt
	
 --------------------3.8----------------------><D32R>      <-4ARBS->     <------------4A--------------
	
                                                    <D33L>
Part33-Part34: 4A/4B/4.1/4.2-ø4.3 
T7:	
 ggagagtcccattctaatacgactcactaaa
	
 -------4.2------>
	
     <------------ø4.3----------
T7.1:	
 ggagagtcccattctaacgtacggccgagtcccattctaatacgactcactaaa
	
 -------4.2------><D33R>    <------------ø4.3----------
	
                      <D34L>
Part34-Part35: ø4.3-4.3 
T7:	
 ctaaaggagacacaccatgttcaaactg
	
 ----ø4.3---->   <----4.3----
	
  <-4.3RBS->
T7.1:	
 ctaaaggagacacaccggccggtggcgcgcctaaaggagacacaccatgttcaaactg
	
 ----ø4.3---->  <D34R>   <D35L> <-4.3RBS->     <----4.3----
Part35-Part36: 4.3-4.5 
T7:	
 ttctttgagtaatcaaacaggagaaaccattatgtctaacgta
	
 ----4.3---->    <-4.5RBS->     <----4.5----
T7.1:	
 ttctttgagtaatggcgcgccaccggcgaaacaggagaaaccattatgtctaacgta
	
 ----4.3---->  <D35R><-D36L->  <-4.5RBS->     <----4.5----
Part36-Part37: 4.5-R4.7/ø4.7 
T7:	
 attgataactaagagtggtatcct
	
 ----4.5----><----R4.7---
T7.1:	
 attgataactaacaccggcgaagcttaagagtggtatcct
	
 ----4.5----><-D36R-><D37L> <----R4.7---
Part37-Part38: R4.7/ø4.7-4.7 
T7:	
 ctataggagatattaccatgcgtgaccct
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 ----ø4.7---->    <----4.7----
	
   <-4.7RBS->
T7.1:	
 ctataggagatattaccaagcttcctggactataggagatattaccatgcgtgaccct
	
 ----ø4.7---->    <D37R>        <-4.7RBS->     <----4.7----
	
                       <D38L->
Part38-Part39: 4.7-5 
T7:	
 aagtcacgataatcaataggagaaatcaatatgatcgtttct
	
 ----4.7---->   <-5RBS->       <-----5-----
T7.1:	
 aagtcacgataatcctggagctagcatcaataggagaaatcaatatgatcgtttct
	
 ----4.7----><D38R-><D39L>    <-5RBS->       <-----5-----
Part39-Part40: 5-5.3 
T7:	
 atttgccactgatacaggaggctactcatgaacgaaaga
	
 -----5-----> <-5.3RBS->    <----5.3----
T7.1:	
 atttgccactgagctagcatgctacaggaggctactcatgaacgaaaga
	
 -----5-----><D39R>     <-5.3RBS->    <----5.3----
	
                 <D40L>
Part40-Part41: 5.3-5.5 
T7:	
 ataaaactataggagaaattattatggctatgaca
	
 ----5.3---->           <----5.5----
	
         <-5.5RBS->
T7.1:	
 ataaaactatagcatgccatggtataggagaaattattatggctatgaca
	
 ----5.3---->    <D41L> <-5.5RBS->     <----5.5----
	
            <D40R>
Part41-Part42: 5.5-5.7 
T7:	
 acgggaggtgttctgatgtctgactac
	
 ------5.5------>
	
  <-5.7RBS->    <----5.7----
T7.1:	
 acgCgaggtgttctgaccatggatccgggaggtgttctgatgtctgactac
	
 ------5.5------><41R>    <-5.7RBS->    <----5.7----
	
                     <42L>
Part42-Part43: 5.7-5.9 
T7:	
 tgggaggatgtgtctaatgtctcgtgac
	
 -------5.7------>
	
 <-5.9RBS->      <----5.9----
T7.1:	
 tgggCggGtgtgtctaaggatccgcggcgaatgggaggatgtgtctatgtctcgtgac
	
 -------5.7------><D42R>        <-5.9RBS->     <----5.9----
	
                      <D43L>
Part43-Part44: 5.9-6 
T7:	
 ctagaggagaaacttaatggcacttcttgacc
	
 ---------------5.9----------->
	
 <-6RBS->        <--------6------
T7.1:	
 ctagaAgaAaaacttaaCggcacttcttgaccgcgggcccggaactagaggagaaacttaatggcacttcttgacc
	
 ---------------5.9-----------><D43R>        <-6RBS->        <--------6------
	
                                   <D44L>
Part44-Part45: 6-6.3 
T7:	
 gacaaggagatttacctgtggagaccgtagcgt
	
 --------------6-------------->
	
   <-6.3RBS->     <------6.3------
T7.1:	
 gacaaggaAatttacctCtggagaccgtagggcccgggcaaggagatttacctgtggagaccgtagcgt
	
 --------------6-------------->  <D45L><-6.3-RBS->    <------6.3------
	
                              <D44R>
Part45-Part46: 6.3-R6.5/ø6.5 
T7:	
 gacactaagtgataaact
	
 ----6.3---->
	
       <---R6.5----
T7.1:	
 gacactaaAtAacccgggagctcactaagtgataaact
	
 ----6.3----><D45R>        <---R6.5----
	
                  <D46L>
Part46-Part47: R6.5/ø6.5-6.5 
T7:	
 cgattattactttaagatttaactctaagaggaatctttattatgttaacacct
	
 ----R6.5---->            <-6.5RBS->       <----6.5----
T7.1:	
 cgattattactttaagatttaagagctcgagtaagaggaatctttattatgttaacacct
	
 ----R6.5---->         <D46R>   <-6.5RBS->       <----6.5----
	
                          <D47L>
Part47-Part48: 6.5-6.7 
T7:	
 tgatggggaggattgacactatgtgtttctca
	
 ------6.5------>    <----6.7----
	
   <-6.7RBS->
T7.1:	
 tgatggCgaAgattgactcgagaattctgatggggaggattgacactatgtgtttctca
	
 ------6.5------><D47R>       <-6.7RBS->        <----6.7----
	
                      <D48L>
Part48-Part49: 6.7-7 
T7:	
 tttggaggtaagaagtgatgtctgagttc
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 ------6.7-------->
	
   <-7RBS->       <-----7-----
T7.1:	
 tttggaggtaagaagtgagaattcgatcgcatttggaggtaagaagtgatgtctgagttc
	
 ------6.7--------><D48R>         <-7RBS->       <-----7-----
	
                        <D49L>
Part49-Part50: 7-7.3 
T7:	
 tttaaggaggtataagttatgggtaagaaa
	
 -------7------>   <----7.3----
	
  <-7.3RBS->
T7.1:	
 tttaaggaggtataacgatcggtccgctttaaggaggtataagttatgggtaagaaa
	
 -------7------><D49L>       <-7.3RBS->       <----7.3----
	
                    <D50R->
Part50-Part51: 7.3-7.7 
T7:	
 atcaacatttaatcaggaggttatcgtggaagactgc
	
 ----7.3----> <-7.7RBS->  <----7.7----
T7.1:	
 atcaacatttaacggtccgctgcagtcaggaggttatcgtggaagactgc
	
 ----7.3----><D50R-><D51L> <-7.7RBS->  <----7.7----
	

Changes in Section Delta
Part51-Part52: 7.7-8 
T7:	
 gacatggagacacatttaatggctgagaaa
	
 -------7.7-------->
	
    <-8RBS->       <-----8-----
T7.1:	
 gacatggagacacatttaactgcagcgtacgagacatggagacacatttaatggctgagaaa
	
 -------7.7--------><D51R><D52L>    <-8RBS->       <-----8-----
Part52-Part53: 8-ø9 
T7:	
 cagccgggaatttaatacgactcactatag
	
 -------8------>
	
   <------------ø9-------------
T7.1:	
 cagccgggaatttaacgtacgatcgccgggaatttaatacgactcactatag
	
 -------8------><D52L>   <------------ø9-------------
	
                    <D53L>
Part53-Part54: ø9-9 
T7:	
 tagggagacctcatctttgaaatgagcgatgacaagaggttggagtcctcggtcttcctgtagttcaactttaaggagacaataataatggctgaat
	
 ----ø9--->                                                            <-9RBS->         <----9----
T7.1:	
 tagggagacctcatctttgaaatgagcgatcgacaagaggttggagtcctcggtcttcctgtagaattcaactttaaggagacaataataatggctgaat
	
 ----ø9--->                <D53R>                               <D54L>    <-9RBS->         <----9----
Part54-Part55: 9-ø10 
T7:	
 tcgaacttctgatagacttcgaaatta
	
 -----9----->   <----ø10----
T7.1:	
 tcgaacttctgatagaattccgcggacttcgaaatta
	
 -----9----->  <D54R>     <----ø10----
	
                    <D55L>
Part55-Part56: ø10-10A/B 
T7:	
 tatagggagaccacaacggtttccctctagaaataattttgtttaactttaagaaggagatatacatatggctagcatg
	
 ----ø10---->                                       <-10RBS->       <----10-----
T7.1:	
 tatagggagaccacaaccgcggatccctctagaaataattttgtttaactttaagaaggagatatacatatggctagcatg
	
 ----ø10---->    <D55R>                               <-10RBS->       <----10-----
	
                     <D56L>
Part56-Part57: 10A/B-Tø 
T7:	
 gctgagcaataactagcataaccccttggggcct
	
 ----10----->     <-------Tø-------
T7.1:	
 gctgagcaataaggatcccgggctagcataaccccttggggcct
	
 ----10-----><D56R>         <-------Tø-------
	
                 <D57L>
Part57-Part58: Tø-11 
T7:	
 gttttttgctgaaaggaggaactatatgcgctcata
	
 --Tø-->   <-11RBS->      <----11----
T7.1:	
 gttttttgctgacccgggccctgaaaggaggaactatatgcgctcata
	
 --Tø-->     <D57R>    <-11RBS->      <----11----
	
                <D58L>
Part58-Part59: 11-12 
T7:	
 tgactcgctaacattaataaataaggaggctctaatggcactcat
	
 ----11---->         <-12RBS->     <----12----
T7.1	
 tgactcgctaagggcccaagcttaataaataaggaggctctaatggcactcat
	
 ----11----><D58R><D59L>     <-12RBS->     <----12----
Changes in Section Epsilon
Part59-Part60: 12-R13/ø13 
T7:	
 ccggtatttaataaatattctccctgtgg
	
 ----12---->      <----R13----
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T7.1:	
 ccggtatttaattaaagcttcccggattctccctgtgg
	
 ----12---->   <D59L>      <----R13----
	
                    <D60R->
Part60-Part61: R13/ø13-13 
T7:	
 tatagggagaacaatacgactacgggagggttttcttatgatgactat
	
 ----ø13---->          <-13RBS->      <----13----
	
 ----R13--->
T7.1:	
 tatagggagaacaatactcccggaattctacgggagggttttcttatgatgactat
	
 ----ø13---->     <D60R->      <-13RBS->      <----13----
	
 ----R13--->           <D61L>
Part61-Part62: 13-14 
T7:	
 acgaaaggaggataaccatatgtgttgggc
	
 ------13------>    <----14----
	
    <-14RBS->
T7.1:	
 acgaaaggCggCtaagaattcgtacgcacgaaaggaggataaccatatgtgttgggc
	
 ------13------><D61R>         <-14RBS->       <----14----
	
                     <D62L>
Part62-Part63: 14-15 
T7:	
 gacggggaggtaatgagctatgagtaaaat
	
 -----14----->      <----15----
	
   <-15RBS->
T7.1:	
 gacCggCaggtaacgtacgatcgccaagacggggaggtaatgagctatgagtaaaat
	
 -----14-----><D62R>          <-15RBS->        <----15----
	
                  <D63L>
Part63-Part64: 15-16 
T7:	
 gtaaggagtaactaaaggctacataaggaggccctaaatggataagta
	
 ----15---->           <-16RBS->      <----16----
T7.1:	
 gtaaggagtaacgatcggccgtaaaggctacataaggaggccctaaatggataagta
	
 ----15----><D63R>              <-16RBS->      <----16----
	
                <D64L>
Changes in Section Zêta
Part64-Part65: 16-ø17 
T7:	
 gggagcgtaggaaataatacgactcactatag
	
 -------16------->
	
     <--------------ø17----------
T7.1:	
 gggagcgtaggaaataacggccgcggcgtaggaaataatacgactcactatag
	
 -------16-------><D64R>  <--------------ø17----------
	
                     <D65L>
Part65-Part66: ø17-17 
T7:	
 gggagaggcgaaataatcttctccctgtagtctcttagatttactttaaggaggtcaaatggctaacgt
	
 --ø17-->                                      <-17RBS->   <----17----
T7.1:	
 gggagaggcgaaataatcttctcccgcggtgtaagcttcttagatttactttaaggaggtcaaatggctaacgt
	
 --ø17-->               <D65R>   <D66L>             <-17RBS->   <----17----
Part66-Part67: 17-17.5 
T7:	
 aacgagtaattggtaaatcacaaggaaagacgtgtagtccacggatggactctcaaggaggtacaaggtgctatca
	
 ---17--->                                            <-17.5RBS->   <--17.5--
T7.1:	
 aacgagtaattggtaaatcacaagcttgaaagacgtgtagtccacggatccggactctcaaggaggtacaaggtgctatca
	
 ---17--->            <D66R>                  <D67L>       <-17.4RBS->   <--17.5--
Part67-Part68: 17.5-18 
T7:	
 caataaggagtgatatgtatggaaaagga
	
 ----17.5---->     <----18----
	
   <-18RBS->
T7.1:	
 caataaAgaAtgaggatcccgggaataaggagtgatatgtatggaaaagga
	
 ----17.5----><D67R>     <-18RBS->       <----18----
	
                  <D68L>
Part68-Part69: 18-R18.5 
T7:	
 cattacagtgatatactcaa
	
 ----18---->
	
     <-----R18.5-----
T7.1:	
 cattacaatagcccgggcccacattacagtgatatactcaa
	
 ----18----><D68R>        <-----R18.5-----
	
               <D69L>
Part69-Part70: R18.5-E/18.5/18.7 
T7:	
 gtcattgtctatacgagatgctcctacgtgaaatctgaaagttaacgggaggcattatgctagaatt
	
 -R18.5->                    <-------------------E------------------
	
                                             <-18.5RBS-> <---18.5---
T7.1:	
 gtcattgtctatacgagatgctgggccctacgtgaattctgaaagttaacgggaggcattatgctagaatt
	
 -R18.5->              <D69R>     <D70L>         <-18.5RBS-> <---18.5---
Part70-Part71: E/18.5/18.7-19/19.2/19.3 
T7:	
 aacgtaagtaggaaatcaagtaaggaggcaatgtgtctactca
	
 ---18.5--->        <-19RBS->    <----19----
T7.1:	
 aacgtaagtaggaattcgtacgaagtaaggaggcaatgtgtctactca
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 ---18.5---><D70R>       <-19RBS->    <----19----
	
                 <D71L>
Part71-Part72: 19/19.2/19.3-øOR 
T7:	
 ggtgatttatgcattaggactgcatagggatgcactatagaccacggatggtcagttctttaagttactgaaaagacacgat
	
 -19->                                                                       <-øOR-
T7.1:	
 ggtgatttatgcattaggactgcatagggatgcactatagaccacgtacgatggtcagttctttaagttactgcagaaaagacacgat
	
 -19->                                       <D71R>                    <D72L>      <-øOR-
Part72-Part73: øOR-19.5 
T7:	
 gagagga...94nt... gattatattgtattagtatcaccttaacttaaggaccaacataaagggaggagactcatgttcc
	
 -øOR->                                                      <-19.5RBS->    <-19.5-
T7.1:	
 gagagga...94nt... gattatattgtattagtatcaccttaactgcagtcgaccaacataaagggaggagactcatgttcc
	
 -øOR->                                       <D72R>           <-19.5RBS->    <-19.5-
	
                                                   <D73L>
Part73-SRR/TR: 19.5-SRR/TR 
T7:	
 cgattagggtcttcctgaccgactgatggctcaccgagggattcagcggtatgattgcatcacaccacttcatccctata
	
 -19.5->                                                                   <-SRR-
T7.1:	
 cgattagggtcgacttcctgaccgactgatggctcaccgagggattcagcggtatgattgcatcacaccacttcatccctata
	
 -19.5-> <D73R>                                                               <-SRR-
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Location on T7.1 
(Genome Position)
Nature of Difference Probable Reason 
for Difference
Expected Outcome
D1L (164-170), D1R  
& D2L (338-350)
Restriction sites were 
not added in 
construction
Difficulties in 
manipulating left end of 
genome resulted in using 
wild-type
Loss of manipulability in 
part 1 (containing A0)
gene 0.4  (1418) Single base deletion Unknown Frameshift after 27th 
amino acid followed by 
early termination of gene 
0.4
D6L (1304-1310)
D6R  (1494-1500)
Restriction sites appear 
twice.
Inefficiency of digestion 
of scaffold 
No expected change
gene 0.6B Single base addition Error is known to be in 
stock of wild-type 
genome
Dependent upon nature 
of putative translational 
slippage in formation of 
gene 0.6B
D11L (3302-3307) Restriction site appears 
twice
Inefficiency of digestion 
of scaffold
No expected change
gene 1  (4877) Single base mutation Error in PCR or within 
wild-type genome
Silent mutation, no 
expected change
gene 1  (5159) Single base mutation Error in PCR or within 
wild-type genome
Silent mutation, no 
expected change
gene 1  (5399) Single base mutation Error in PCR or within 
wild-type genome
Silent mutation, no 
expected change
D14R (6591-6597) Restriction site appears 
twice
Inefficiency of digestion 
of scaffold
No expected change
TE (7827) Single base deletion Primer synthesis error Possible loss of function 
of transcriptional 
terminator.
D20L (8082-8086) Restriction site appears 
twice
Inefficiency of digestion 
of scaffold
No expected change
U4 (8153-8159) Restriction site was not 
added in construction
Failure in site-directed 
mutagenesis
Loss of manipulability of 
overlap in parts 18 and 
19
D22L (8247-8253) Restriction site appears 
twice
Inefficiency of digestion 
of scaffold
No expected change
Table 7-1.  Errors in synthesis & construction of section alpha.
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Location on T7.1 
(Genome Position)
Nature of Difference Probable Reason 
for Difference
Expected Outcome
gene 1.7 (8794) Single base silent 
mutation
Error during PCR or 
within wild-type genome
No expected change
gene 1.8 (9245) Single base mutation Error during PCR or 
within wild-type genome
Amino acid change in 
gene 1.8 from Asp to 
Gly
gene 2.0  (9447) Single base mutation Error during PCR or 
within wild-type genome
Amino acid change in 
gene 2.0 from Glu to Val
gene 2.5 (10351) Singe base deletion Error during primer 
design
deletion in stop codon; 
read-through adding on 
8AA
gene 2.8 (10627) Single base mutation Error during PCR Amino acid change in 
gene 2.8 from Asp to 
Gly
gene 2.8 
(10717-10803)
82 base deletion Error in cloning of part Loss of function in gene 
2.8  in addition to 
unknown effect on 
translation of 3.0 due to 
read-through
gene 3.0 (10926) Single base silent 
mutation
Error during PCR or 
within wild-type genome
No expected change
Table 7-2.  Errors in synthesis & construction of section beta.
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gene calculated strength gene
calculated 
strength gene
calculated 
strength gene
calculated 
strength
0.3 7.28 2.8 4.3 6.7 7.64 18.5 6.9
0.4 5.64 3 5.89 7 6.61 18.7 7.64
0.5 5.28 3.5 8.32 7.3 6.88 19 4.89
0.7 4.94 3.8 6.79 7.7 5.51 19.2 5.33
1 5.59 4.1 6.35 8 4.99 19.3 5.24
1.1 6.48 4.2 7.91 9 6.65 19.5 7.01
1.2 7.84 4.3 7.31 11 7.8 0.6A 5.62
1.3 7.61 4.5 8.33 12 6.69 10A 7.37
1.4 6.85 4.7 7.34 13 6.21 4A 6.76
1.5 7 5 8.57 14 6.86 4B 6.8
1.6 7.13 5.3 6.61 15 6.37 B0030 6.13
1.7 6.18 5.5 8.47 16 6.55 B0031 3.84
1.8 7.56 5.7 6.18 17 5.87 B0032 6.31
2 7.94 5.9 6.69 17.5 5.92 B0033 5.87
2.5 6.86 6 7.34
Table 7-3.  Calculated ribosome binding site strength for T7 genes.  I used the computational 
algorithm from the Barrick et al., 1994 study to predict RBS strength of all the T7 genes and 4 
BioBrick RBS (B0030-B0033).  
Chapter 7.3.  Input Files
Chapter 7.3.1.  Input Files for Simple Gene Expression Models
Tabasco Input File for Single-molecule Simple Gene Expression model
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="500" random_seed="34143" simulation_name="test-1" time_step="50" time_end="25000" 
min_num_for_init_output="1">
<CELL volume="1E-15" growth_rate="0" polymerase_interaction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="40" id="2" organism_id="2" footprint="15" name="coli Pol" />
<SPECIES name="test" n="0" ID="3" organism="1" />
<REACTIONS>
<REACTION>
3>0;7E-4 
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="3800" copy_number="1" entry_rate_constant="50000" entry_offsite="3800">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
 <POLYMERASE polymeraseID="2" aon="4e7" aoff="4" ainiton="1.2" runoff_percent="0" aelong="0.23" arecyc="0" />
</PROMOTER>
<TERMINATOR start="3600" stop="3610" stopsite="3610" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
</TERMINATOR>
<RBS start="495" stop="500" startsite="500"  initstepsize="20" strength="1.15e4" stopsite="522" protid="3" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Species-level Simple Gene Expression model
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="1000" random_seed="34143" simulation_name="test-1" 
time_step="50" time_end="25000" min_num_for_init_output="1">
<CELL volume="1E-15" growth_rate="0" polymerase_interaction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="40" id="2" organism_id="2" footprint="15" name="coli Pol" />
<SPECIES name="rib" n="10000" ID="3" organism="1" />
<SPECIES name="pol" n="700" ID="4" organism="1" />
<SPECIES name="promoter" n="1" ID="5" organism="1" />
<SPECIES name="pol-promoter" n="0" ID="6" organism="1" />
<SPECIES name="pol-promoter-init" n="0" ID="7" organism="1" />
<SPECIES name="pol-dna-elong" n="0" ID="8" organism="1" />
<SPECIES name="rbs" n="0" ID="9" organism="1" />
<SPECIES name="rib-rbs" n="0" ID="10" organism="1" />
<SPECIES name="rib-elong" n="0" ID="11" organism="1" />
<SPECIES name="cust_prot" n="0" ID="12" organism="1" />
<REACTIONS>
<REACTION>
4+5>6;4e7 
</REACTION>
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<REACTION>
6>4+5;4 
</REACTION>
<REACTION>
6>7;1.2 
</REACTION>
<REACTION>
7>5+8;0.23 
</REACTION>
<REACTION>
8>4+9;0.645 
</REACTION>
<REACTION>
3+9>10;1.15e4 
</REACTION>
<REACTION>
10>9+11;0.1308 
</REACTION>
<REACTION>
11>3+12;20 
</REACTION>
<REACTION>
12>0;7e-4 
</REACTION>
<REACTION>
9>0;2.5e-3 
</REACTION>
<REACTION>
10>3;2.5e-3 
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="3800" copy_number="1" entry_rate_constant="50" 
entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
	
 <POLYMERASE polymeraseID="2" aon="0" aoff="4" ainiton="1.2" runoff_percent="35" 
aelong="5" arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3600" stop="3610" stopsite="3610" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
</TERMINATOR>
<RBS start="485" stop="500" startsite="500"  initstepsize="50" strength="0" 
stopsite="3500" protid="3" initRateConstant="0.14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Chapter 7.3.2.  Input Files for Polymerase Interaction Simulations
Tabasco Input File for Downstream Falloff
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="100" random_seed="34206" simulation_name="test-1" time_step="50" time_end="25000" 
min_num_for_init_output="1">
<CELL volume="1E-15" growth_rate="0" polymerase_interaction_model="DOWNSTREAM_FALL_OFF">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="300" id="2" organism_id="1" footprint="15" name="T7 pol" />
<POLYMERASE n="700" speed="40" id="3" organism_id="2" footprint="15" name="Coli pol" />
<SPECIES name="test-1" n="0" ID="4" organism="1" />
<SPECIES name="test-2" n="0" ID="5" organism="1" />
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<REACTIONS>
<REACTION>
4>0;7E-4 
</REACTION>
<REACTION>
5>0;7E-4 
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="4000" copy_number="1" entry_rate_constant="5000" entry_offsite="3950">
<PROMOTER start="405" stop="428" startsite="423" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent="100" aelong="6" 
arecyc="0" />
</PROMOTER>
<PROMOTER start="1505" stop="1528" startsite="1523" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="2" aon="1.26e8" aoff="0.2" ainiton="1.2" runoff_percent="70" aelong="5" 
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
</TERMINATOR>
<RBS start="485" stop="500" startsite="500"  initstepsize="50" strength="1.15e4" stopsite="1499" protid="4" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
<RBS start="1585" stop="1600" startsite="1600"  initstepsize="50" strength="1.15e4" stopsite="3600" protid="5" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Upstream Falloff
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="100" random_seed="34206" simulation_name="test-1" time_step="50" time_end="25000" 
min_num_for_init_output="1">
<CELL volume="1E-15" growth_rate="0" polymerase_interaction_model="UPSTREAM_FALL_OFF">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="300" id="2" organism_id="1" footprint="15" name="T7 pol" />
<POLYMERASE n="700" speed="40" id="3" organism_id="2" footprint="15" name="Coli pol" />
<SPECIES name="test-1" n="0" ID="4" organism="1" />
<SPECIES name="test-2" n="0" ID="5" organism="1" />
<REACTIONS>
<REACTION>
4>0;7E-4 
</REACTION>
<REACTION>
5>0;7E-4 
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="4000" copy_number="1" entry_rate_constant="5000" entry_offsite="3950">
<PROMOTER start="405" stop="428" startsite="423" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent="100" aelong="6" 
arecyc="0" />
</PROMOTER>
<PROMOTER start="1505" stop="1528" startsite="1523" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="2" aon="1.26e8" aoff="0.2" ainiton="1.2" runoff_percent="70" aelong="5" 
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
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</TERMINATOR>
<RBS start="485" stop="500" startsite="500"  initstepsize="50" strength="1.15e4" stopsite="1499" protid="4" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
<RBS start="1585" stop="1600" startsite="1600"  initstepsize="50" strength="1.15e4" stopsite="3600" protid="5" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Traffic Jam
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="100" random_seed="34206" simulation_name="test-1" time_step="50" time_end="25000" 
min_num_for_init_output="1">
<CELL volume="1E-15" growth_rate="0" polymerase_interaction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="300" id="2" organism_id="1" footprint="15" name="T7 pol" />
<POLYMERASE n="700" speed="40" id="3" organism_id="2" footprint="15" name="Coli pol" />
<SPECIES name="test-1" n="0" ID="4" organism="1" />
<SPECIES name="test-2" n="0" ID="5" organism="1" />
<REACTIONS>
<REACTION>
4>0;7E-4 
</REACTION>
<REACTION>
5>0;7E-4 
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="4000" copy_number="1" entry_rate_constant="5000" entry_offsite="3950">
<PROMOTER start="405" stop="428" startsite="423" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent="100" aelong="6" 
arecyc="0" />
</PROMOTER>
<PROMOTER start="1505" stop="1528" startsite="1523" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="2" aon="1.26e8" aoff="0.2" ainiton="1.2" runoff_percent="70" aelong="5" 
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
</TERMINATOR>
<RBS start="485" stop="500" startsite="500"  initstepsize="50" strength="1.15e4" stopsite="1499" protid="4" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
<RBS start="1585" stop="1600" startsite="1600"  initstepsize="50" strength="1.15e4" stopsite="3600" protid="5" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Traffic Jam with No T7 RNA Polymerase
_________________________________________________________________________________________
<REQUEST>
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<EXECUTE-SIMULATION runs="100" random_seed="34206" simulation_name="test-1" time_step="50" time_end="25000" 
min_num_for_init_output="1">
<CELL volume="1E-15" growth_rate="0" polymerase_interaction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="0" speed="300" id="2" organism_id="1" footprint="15" name="T7 pol" />
<POLYMERASE n="700" speed="40" id="3" organism_id="2" footprint="15" name="Coli pol" />
<SPECIES name="test-1" n="0" ID="4" organism="1" />
<SPECIES name="test-2" n="0" ID="5" organism="1" />
<REACTIONS>
<REACTION>
4>0;7E-4 
</REACTION>
<REACTION>
5>0;7E-4 
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="4000" copy_number="1" entry_rate_constant="5000" entry_offsite="3950">
<PROMOTER start="405" stop="428" startsite="423" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent="100" aelong="6" 
arecyc="0" />
</PROMOTER>
<PROMOTER start="1505" stop="1528" startsite="1523" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="2" aon="1.26e8" aoff="0.2" ainiton="1.2" runoff_percent="70" aelong="5" 
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
</TERMINATOR>
<RBS start="485" stop="500" startsite="500"  initstepsize="50" strength="1.15e4" stopsite="1499" protid="4" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
<RBS start="1585" stop="1600" startsite="1600"  initstepsize="50" strength="1.15e4" stopsite="3600" protid="5" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Traffic Jam with No E. coli RNA polymerase
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="100" random_seed="34206" simulation_name="test-1" time_step="50" time_end="25000" 
min_num_for_init_output="1">
<CELL volume="1E-15" growth_rate="0" polymerase_interaction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="40" footprint="35" />
<POLYMERASE n="700" speed="300" id="2" organism_id="1" footprint="15" name="T7 pol" />
<POLYMERASE n="0" speed="40" id="3" organism_id="2" footprint="15" name="Coli pol" />
<SPECIES name="test-1" n="0" ID="4" organism="1" />
<SPECIES name="test-2" n="0" ID="5" organism="1" />
<REACTIONS>
<REACTION>
4>0;7E-4 
</REACTION>
<REACTION>
5>0;7E-4 
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="4000" copy_number="1" entry_rate_constant="5000" entry_offsite="3950">
<PROMOTER start="405" stop="428" startsite="423" name="A1" organism_id="2">
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 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="0.28" ainiton="0.2" runoff_percent="100" aelong="6" 
arecyc="0" />
</PROMOTER>
<PROMOTER start="1505" stop="1528" startsite="1523" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="2" aon="1.26e8" aoff="0.2" ainiton="1.2" runoff_percent="70" aelong="5" 
arecyc="0.7" />
</PROMOTER>
<TERMINATOR start="3900" stop="3910" stopsite="3910" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="0.99" />
<POLYMERASE ID="3" efficiency="0.99" />
</TERMINATOR>
<RBS start="485" stop="500" startsite="500"  initstepsize="50" strength="1.15e4" stopsite="1499" protid="4" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
<RBS start="1585" stop="1600" startsite="1600"  initstepsize="50" strength="1.15e4" stopsite="3600" protid="5" 
initRateConstant="0.14" mrnadeg="2.5e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Chapter 7.3.3. Simulation Optimizations for Different Models
Tabasco Input File for Unfit Simulations
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500" 
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="no">
<CELL volume="8e-16" polymerase_interaction_model="CUSTOM">
<RIBOSOME initial_number="10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organism_id="2" footprint="15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organism_id="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="0" speed="45" id="4" organism_id="2" footprint="15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id="1" footprint="15" name="gp1" />
<POLYMERASE n="0" speed="230" id="7" organism_id="1" footprint="15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="0" ID="8" organism="1" />
<SPECIES name="gp0.4" n="0" ID="9" organism="1" />
<SPECIES name="gp0.5" n="0" ID="10" organism="1" />
<SPECIES name="gp0.6A" n="0" ID="11" organism="1" />
<SPECIES name="gp0.7" n="0" ID="12" organism="1" />
<SPECIES name="gp1.1" n="0" ID="13" organism="1" />
<SPECIES name="gp1.2" n="0" ID="14" organism="1" />
<SPECIES name="gp1.3" n="0" ID="15" organism="1" />
<SPECIES name="gp1.4" n="0" ID="16" organism="1" />
<SPECIES name="gp1.5" n="0" ID="17" organism="1" />
<SPECIES name="gp1.6" n="0" ID="18" organism="1" />
<SPECIES name="gp1.7" n="0" ID="19" organism="1" />
<SPECIES name="gp1.8" n="0" ID="20" organism="1" />
<SPECIES name="gp2.0" n="0" ID="21" organism="1" />
<SPECIES name="gp2.5" n="0" ID="22" organism="1" />
<SPECIES name="gp2.8" n="0" ID="23" organism="1" />
<SPECIES name="gp3.0" n="0" ID="24" organism="1" />
<SPECIES name="gp3.5" n="0" ID="25" organism="1" />
<SPECIES name="gp3.8" n="0" ID="26" organism="1" />
<SPECIES name="gp4A" n="0" ID="27" organism="1" />
<SPECIES name="gp4.2" n="0" ID="28" organism="1" />
<SPECIES name="gp4.3" n="0" ID="29" organism="1" />
<SPECIES name="gp4.5" n="0" ID="30" organism="1" />
<SPECIES name="gp4.7" n="0" ID="31" organism="1" />
<SPECIES name="gp5.0" n="0" ID="32" organism="1" />
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<SPECIES name="gp5.3" n="0" ID="33" organism="1" />
<SPECIES name="gp5.5" n="0" ID="34" organism="1" />
<SPECIES name="gp5.7" n="0" ID="35" organism="1" />
<SPECIES name="gp5.9" n="0" ID="36" organism="1" />
<SPECIES name="gp6.0" n="0" ID="37" organism="1" />
<SPECIES name="gp6.3" n="0" ID="38" organism="1" />
<SPECIES name="gp6.5" n="0" ID="39" organism="1" />
<SPECIES name="gp6.7" n="0" ID="40" organism="1" />
<SPECIES name="gp7" n="0" ID="41" organism="1" />
<SPECIES name="gp7.3" n="0" ID="42" organism="1" />
<SPECIES name="gp7.7" n="0" ID="43" organism="1" />
<SPECIES name="gp8" n="0" ID="44" organism="1" />
<SPECIES name="gp9" n="0" ID="45" organism="1" />
<SPECIES name="gp10A" n="0" ID="46" organism="1" />
<SPECIES name="gp11" n="0" ID="47" organism="1" />
<SPECIES name="gp12" n="0" ID="48" organism="1" />
<SPECIES name="gp13" n="0" ID="49" organism="1" />
<SPECIES name="gp14" n="0" ID="50" organism="1" />
<SPECIES name="gp15" n="0" ID="51" organism="1" />
<SPECIES name="gp16" n="0" ID="52" organism="1" />
<SPECIES name="gp17" n="0" ID="53" organism="1" />
<SPECIES name="gp17.5" n="0" ID="54" organism="1" />
<SPECIES name="gp18" n="0" ID="55" organism="1" />
<SPECIES name="gp18.5" n="0" ID="56" organism="1" />
<SPECIES name="gp19" n="0" ID="57" organism="1" />
<SPECIES name="gp19.5" n="0" ID="58" organism="1" />
<REACTIONS>
<REACTION>
12+2>3+11;3.8E7
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7 
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1 
</REACTION>
<REACTION>
5>21+3;1.1 
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
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 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="1514" stop="1564" startsite="1558" name="B" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi1.1A" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phi1.1B" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phi1.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="11180" stop="11203" startsite="11198" name="phi3.8" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop="13364" startsite="13359" name="phi4.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phi17" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
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 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="1" />
<POLYMERASE ID="3" efficiency="1" />
<POLYMERASE ID="4" efficiency="1" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi"  organism="1">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925"  initstepsize="50" elongstepsize="" strength="1e7" stopsite="1278" protid="8" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1433" protid="9" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid="10" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1797" protid="11" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="1e7" stopsite="3100" protid="12" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6394" protid="14" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7880" protid="17" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9092" protid="21" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9856" protid="22" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10276" protid="23" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10706" protid="24" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11161" protid="25" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13265" protid="27" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13326" protid="28" 
initRateConstant="0.3" mrnadeg="0" />
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<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13564" protid="29" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16467" protid="32" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17159" protid="34" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17359" protid="35" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17517" protid="36" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18507" protid="38" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18859" protid="39" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19131" protid="40" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19531" protid="41" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24818" protid="47" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27226" protid="48" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27723" protid="49" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36285" protid="53" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36547" protid="54" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58" 
initRateConstant="0.3" mrnadeg="0" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
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_________________________________________________________________________________________
Tabasco Input File for Initial Fit
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500" 
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="yes">
<CELL volume="8e-16" polymerase_interaction_model="CUSTOM">
<RIBOSOME initial_number="10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organism_id="2" footprint="15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organism_id="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="0" speed="45" id="4" organism_id="2" footprint="15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id="1" footprint="15" name="gp1" />
<POLYMERASE n="0" speed="230" id="7" organism_id="1" footprint="15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="0" ID="8" organism="1" />
<SPECIES name="gp0.4" n="0" ID="9" organism="1" />
<SPECIES name="gp0.5" n="0" ID="10" organism="1" />
<SPECIES name="gp0.6A" n="0" ID="11" organism="1" />
<SPECIES name="gp0.7" n="0" ID="12" organism="1" />
<SPECIES name="gp1.1" n="0" ID="13" organism="1" />
<SPECIES name="gp1.2" n="0" ID="14" organism="1" />
<SPECIES name="gp1.3" n="0" ID="15" organism="1" />
<SPECIES name="gp1.4" n="0" ID="16" organism="1" />
<SPECIES name="gp1.5" n="0" ID="17" organism="1" />
<SPECIES name="gp1.6" n="0" ID="18" organism="1" />
<SPECIES name="gp1.7" n="0" ID="19" organism="1" />
<SPECIES name="gp1.8" n="0" ID="20" organism="1" />
<SPECIES name="gp2.0" n="0" ID="21" organism="1" />
<SPECIES name="gp2.5" n="0" ID="22" organism="1" />
<SPECIES name="gp2.8" n="0" ID="23" organism="1" />
<SPECIES name="gp3.0" n="0" ID="24" organism="1" />
<SPECIES name="gp3.5" n="0" ID="25" organism="1" />
<SPECIES name="gp3.8" n="0" ID="26" organism="1" />
<SPECIES name="gp4A" n="0" ID="27" organism="1" />
<SPECIES name="gp4.2" n="0" ID="28" organism="1" />
<SPECIES name="gp4.3" n="0" ID="29" organism="1" />
<SPECIES name="gp4.5" n="0" ID="30" organism="1" />
<SPECIES name="gp4.7" n="0" ID="31" organism="1" />
<SPECIES name="gp5.0" n="0" ID="32" organism="1" />
<SPECIES name="gp5.3" n="0" ID="33" organism="1" />
<SPECIES name="gp5.5" n="0" ID="34" organism="1" />
<SPECIES name="gp5.7" n="0" ID="35" organism="1" />
<SPECIES name="gp5.9" n="0" ID="36" organism="1" />
<SPECIES name="gp6.0" n="0" ID="37" organism="1" />
<SPECIES name="gp6.3" n="0" ID="38" organism="1" />
<SPECIES name="gp6.5" n="0" ID="39" organism="1" />
<SPECIES name="gp6.7" n="0" ID="40" organism="1" />
<SPECIES name="gp7" n="0" ID="41" organism="1" />
<SPECIES name="gp7.3" n="0" ID="42" organism="1" />
<SPECIES name="gp7.7" n="0" ID="43" organism="1" />
<SPECIES name="gp8" n="0" ID="44" organism="1" />
<SPECIES name="gp9" n="0" ID="45" organism="1" />
<SPECIES name="gp10A" n="0" ID="46" organism="1" />
<SPECIES name="gp11" n="0" ID="47" organism="1" />
<SPECIES name="gp12" n="0" ID="48" organism="1" />
<SPECIES name="gp13" n="0" ID="49" organism="1" />
<SPECIES name="gp14" n="0" ID="50" organism="1" />
<SPECIES name="gp15" n="0" ID="51" organism="1" />
<SPECIES name="gp16" n="0" ID="52" organism="1" />
<SPECIES name="gp17" n="0" ID="53" organism="1" />
<SPECIES name="gp17.5" n="0" ID="54" organism="1" />
<SPECIES name="gp18" n="0" ID="55" organism="1" />
<SPECIES name="gp18.5" n="0" ID="56" organism="1" />
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<SPECIES name="gp19" n="0" ID="57" organism="1" />
<SPECIES name="gp19.5" n="0" ID="58" organism="1" />
<REACTIONS>
<REACTION>
12+2>3+11;3.8E7
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7 
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1 
</REACTION>
<REACTION>
5>21+3;1.1 
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="1514" stop="1564" startsite="1558" name="B" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
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 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi1.1A" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phi1.1B" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phi1.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="11180" stop="11203" startsite="11198" name="phi3.8" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop="13364" startsite="13359" name="phi4.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="30" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phi17" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="70" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="1" />
<POLYMERASE ID="3" efficiency="1" />
<POLYMERASE ID="4" efficiency="1" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi"  organism="1">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925"  initstepsize="50" elongstepsize="" strength="1e7" stopsite="1278" protid="8" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1433" protid="9" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
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<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid="10" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1797" protid="11" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="1e7" stopsite="3100" protid="12" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13" 
initRateConstant="0.3" mrnadeg="1.11e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6394" protid="14" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7880" protid="17" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9092" protid="21" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9856" protid="22" 
initRateConstant="0.3" mrnadeg="1.19e-3" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10276" protid="23" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10706" protid="24" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11161" protid="25" 
initRateConstant="0.3" mrnadeg="1.19e-3" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13265" protid="27" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13326" protid="28" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13564" protid="29" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16467" protid="32" 
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17159" protid="34" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17359" protid="35" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17517" protid="36" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18507" protid="38" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18859" protid="39" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19131" protid="40" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
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<RBS start="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19531" protid="41" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24818" protid="47" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27226" protid="48" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27723" protid="49" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52" 
initRateConstant="0.3" mrnadeg="1.19e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36285" protid="53" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36547" protid="54" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Increased Promoter Strength Fits
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500" 
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="yes">
<CELL volume="8e-16" polymerase_interaction_model="CUSTOM">
<RIBOSOME initial_number="10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organism_id="2" footprint="15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organism_id="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="0" speed="45" id="4" organism_id="2" footprint="15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id="1" footprint="15" name="gp1" />
<POLYMERASE n="0" speed="230" id="7" organism_id="1" footprint="15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="0" ID="8" organism="1" />
<SPECIES name="gp0.4" n="0" ID="9" organism="1" />
<SPECIES name="gp0.5" n="0" ID="10" organism="1" />
<SPECIES name="gp0.6A" n="0" ID="11" organism="1" />
<SPECIES name="gp0.7" n="0" ID="12" organism="1" />
<SPECIES name="gp1.1" n="0" ID="13" organism="1" />
<SPECIES name="gp1.2" n="0" ID="14" organism="1" />
<SPECIES name="gp1.3" n="0" ID="15" organism="1" />
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<SPECIES name="gp1.4" n="0" ID="16" organism="1" />
<SPECIES name="gp1.5" n="0" ID="17" organism="1" />
<SPECIES name="gp1.6" n="0" ID="18" organism="1" />
<SPECIES name="gp1.7" n="0" ID="19" organism="1" />
<SPECIES name="gp1.8" n="0" ID="20" organism="1" />
<SPECIES name="gp2.0" n="0" ID="21" organism="1" />
<SPECIES name="gp2.5" n="0" ID="22" organism="1" />
<SPECIES name="gp2.8" n="0" ID="23" organism="1" />
<SPECIES name="gp3.0" n="0" ID="24" organism="1" />
<SPECIES name="gp3.5" n="0" ID="25" organism="1" />
<SPECIES name="gp3.8" n="0" ID="26" organism="1" />
<SPECIES name="gp4A" n="0" ID="27" organism="1" />
<SPECIES name="gp4.2" n="0" ID="28" organism="1" />
<SPECIES name="gp4.3" n="0" ID="29" organism="1" />
<SPECIES name="gp4.5" n="0" ID="30" organism="1" />
<SPECIES name="gp4.7" n="0" ID="31" organism="1" />
<SPECIES name="gp5.0" n="0" ID="32" organism="1" />
<SPECIES name="gp5.3" n="0" ID="33" organism="1" />
<SPECIES name="gp5.5" n="0" ID="34" organism="1" />
<SPECIES name="gp5.7" n="0" ID="35" organism="1" />
<SPECIES name="gp5.9" n="0" ID="36" organism="1" />
<SPECIES name="gp6.0" n="0" ID="37" organism="1" />
<SPECIES name="gp6.3" n="0" ID="38" organism="1" />
<SPECIES name="gp6.5" n="0" ID="39" organism="1" />
<SPECIES name="gp6.7" n="0" ID="40" organism="1" />
<SPECIES name="gp7" n="0" ID="41" organism="1" />
<SPECIES name="gp7.3" n="0" ID="42" organism="1" />
<SPECIES name="gp7.7" n="0" ID="43" organism="1" />
<SPECIES name="gp8" n="0" ID="44" organism="1" />
<SPECIES name="gp9" n="0" ID="45" organism="1" />
<SPECIES name="gp10A" n="0" ID="46" organism="1" />
<SPECIES name="gp11" n="0" ID="47" organism="1" />
<SPECIES name="gp12" n="0" ID="48" organism="1" />
<SPECIES name="gp13" n="0" ID="49" organism="1" />
<SPECIES name="gp14" n="0" ID="50" organism="1" />
<SPECIES name="gp15" n="0" ID="51" organism="1" />
<SPECIES name="gp16" n="0" ID="52" organism="1" />
<SPECIES name="gp17" n="0" ID="53" organism="1" />
<SPECIES name="gp17.5" n="0" ID="54" organism="1" />
<SPECIES name="gp18" n="0" ID="55" organism="1" />
<SPECIES name="gp18.5" n="0" ID="56" organism="1" />
<SPECIES name="gp19" n="0" ID="57" organism="1" />
<SPECIES name="gp19.5" n="0" ID="58" organism="1" />
<REACTIONS>
<REACTION>
12+2>3+11;3.8E7
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7 
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1 
</REACTION>
<REACTION>
5>21+3;1.1 
</REACTION>
<REACTION>
25+6>7;3.8E7
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</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="1514" stop="1564" startsite="1558" name="B" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi1.1A" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phi1.1B" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
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<PROMOTER start="6409" stop="6432" startsite="6427" name="phi1.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="11180" stop="11203" startsite="11198" name="phi3.8" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop="13364" startsite="13359" name="phi4.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
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 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phi17" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="1" />
<POLYMERASE ID="3" efficiency="1" />
<POLYMERASE ID="4" efficiency="1" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi"  organism="1">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925"  initstepsize="50" elongstepsize="" strength="1e7" stopsite="1278" protid="8" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1433" protid="9" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid="10" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1797" protid="11" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="1e7" stopsite="3100" protid="12" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13" 
initRateConstant="0.3" mrnadeg="1.85e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6394" protid="14" 
initRateConstant="0.3" mrnadeg="2.78e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7880" protid="17" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19" 
initRateConstant="0.3" mrnadeg="2.78e-3" />
167
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9092" protid="21" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9856" protid="22" 
initRateConstant="0.3" mrnadeg="1.52e-3" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10276" protid="23" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10706" protid="24" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11161" protid="25" 
initRateConstant="0.3" mrnadeg="1.19e-3" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13265" protid="27" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13326" protid="28" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13564" protid="29" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16467" protid="32" 
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17159" protid="34" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17359" protid="35" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17517" protid="36" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37" 
initRateConstant="0.3" mrnadeg="2.78e-3" />
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18507" protid="38" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18859" protid="39" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19131" protid="40" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19531" protid="41" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24818" protid="47" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27226" protid="48" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27723" protid="49" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51" 
initRateConstant="0.3" mrnadeg="0" />
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<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52" 
initRateConstant="0.3" mrnadeg="1.67e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36285" protid="53" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36547" protid="54" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Alternative Degradation Fitst
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500" 
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="no">
<CELL volume="8e-16" polymerase_interaction_model="CUSTOM">
<RIBOSOME initial_number="10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organism_id="2" footprint="15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organism_id="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="0" speed="45" id="4" organism_id="2" footprint="15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id="1" footprint="15" name="gp1" />
<POLYMERASE n="0" speed="230" id="7" organism_id="1" footprint="15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="0" ID="8" organism="1" />
<SPECIES name="gp0.4" n="0" ID="9" organism="1" />
<SPECIES name="gp0.5" n="0" ID="10" organism="1" />
<SPECIES name="gp0.6A" n="0" ID="11" organism="1" />
<SPECIES name="gp0.7" n="0" ID="12" organism="1" />
<SPECIES name="gp1.1" n="0" ID="13" organism="1" />
<SPECIES name="gp1.2" n="0" ID="14" organism="1" />
<SPECIES name="gp1.3" n="0" ID="15" organism="1" />
<SPECIES name="gp1.4" n="0" ID="16" organism="1" />
<SPECIES name="gp1.5" n="0" ID="17" organism="1" />
<SPECIES name="gp1.6" n="0" ID="18" organism="1" />
<SPECIES name="gp1.7" n="0" ID="19" organism="1" />
<SPECIES name="gp1.8" n="0" ID="20" organism="1" />
<SPECIES name="gp2.0" n="0" ID="21" organism="1" />
<SPECIES name="gp2.5" n="0" ID="22" organism="1" />
<SPECIES name="gp2.8" n="0" ID="23" organism="1" />
<SPECIES name="gp3.0" n="0" ID="24" organism="1" />
<SPECIES name="gp3.5" n="0" ID="25" organism="1" />
<SPECIES name="gp3.8" n="0" ID="26" organism="1" />
<SPECIES name="gp4A" n="0" ID="27" organism="1" />
<SPECIES name="gp4.2" n="0" ID="28" organism="1" />
<SPECIES name="gp4.3" n="0" ID="29" organism="1" />
<SPECIES name="gp4.5" n="0" ID="30" organism="1" />
<SPECIES name="gp4.7" n="0" ID="31" organism="1" />
<SPECIES name="gp5.0" n="0" ID="32" organism="1" />
<SPECIES name="gp5.3" n="0" ID="33" organism="1" />
<SPECIES name="gp5.5" n="0" ID="34" organism="1" />
<SPECIES name="gp5.7" n="0" ID="35" organism="1" />
<SPECIES name="gp5.9" n="0" ID="36" organism="1" />
<SPECIES name="gp6.0" n="0" ID="37" organism="1" />
<SPECIES name="gp6.3" n="0" ID="38" organism="1" />
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<SPECIES name="gp6.5" n="0" ID="39" organism="1" />
<SPECIES name="gp6.7" n="0" ID="40" organism="1" />
<SPECIES name="gp7" n="0" ID="41" organism="1" />
<SPECIES name="gp7.3" n="0" ID="42" organism="1" />
<SPECIES name="gp7.7" n="0" ID="43" organism="1" />
<SPECIES name="gp8" n="0" ID="44" organism="1" />
<SPECIES name="gp9" n="0" ID="45" organism="1" />
<SPECIES name="gp10A" n="0" ID="46" organism="1" />
<SPECIES name="gp11" n="0" ID="47" organism="1" />
<SPECIES name="gp12" n="0" ID="48" organism="1" />
<SPECIES name="gp13" n="0" ID="49" organism="1" />
<SPECIES name="gp14" n="0" ID="50" organism="1" />
<SPECIES name="gp15" n="0" ID="51" organism="1" />
<SPECIES name="gp16" n="0" ID="52" organism="1" />
<SPECIES name="gp17" n="0" ID="53" organism="1" />
<SPECIES name="gp17.5" n="0" ID="54" organism="1" />
<SPECIES name="gp18" n="0" ID="55" organism="1" />
<SPECIES name="gp18.5" n="0" ID="56" organism="1" />
<SPECIES name="gp19" n="0" ID="57" organism="1" />
<SPECIES name="gp19.5" n="0" ID="58" organism="1" />
<REACTIONS>
<REACTION>
12+2>3+11;3.8E7
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7 
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1 
</REACTION>
<REACTION>
5>21+3;1.1 
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
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 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="1514" stop="1564" startsite="1558" name="B" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi1.1A" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phi1.1B" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phi1.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start="11180" stop="11203" startsite="11198" name="phi3.8" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop="13364" startsite="13359" name="phi4.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phi17" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="1" />
<POLYMERASE ID="3" efficiency="1" />
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<POLYMERASE ID="4" efficiency="1" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi"  organism="1">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925"  initstepsize="50" elongstepsize="" strength="1e7" stopsite="1278" protid="8" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1433" protid="9" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid="10" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1797" protid="11" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="1e7" stopsite="3100" protid="12" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6" 
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13" 
initRateConstant="0.3" mrnadeg="1.11e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6394" protid="14" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7880" protid="17" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19" 
initRateConstant="0.3" mrnadeg="1.85e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9092" protid="21" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9856" protid="22" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10276" protid="23" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10706" protid="24" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11161" protid="25" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13265" protid="27" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13326" protid="28" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13564" protid="29" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
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<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16467" protid="32" 
initRateConstant="0.3" mrnadeg="2.78e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17159" protid="34" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17359" protid="35" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17517" protid="36" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18507" protid="38" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18859" protid="39" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19131" protid="40" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19531" protid="41" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24818" protid="47" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27226" protid="48" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27723" protid="49" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52" 
initRateConstant="0.3" mrnadeg="1.28e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36285" protid="53" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36547" protid="54" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56" 
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for DownStream Falloff Fits
_________________________________________________________________________________________
<REQUEST>
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<EXECUTE-SIMULATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500" 
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="yes">
<CELL volume="8e-16" polymerase_interaction_model="DOWNSTREAM_FALL_OFF">
<RIBOSOME initial_number="10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organism_id="2" footprint="15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organism_id="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="0" speed="45" id="4" organism_id="2" footprint="15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id="1" footprint="15" name="gp1" />
<POLYMERASE n="0" speed="230" id="7" organism_id="1" footprint="15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="0" ID="8" organism="1" />
<SPECIES name="gp0.4" n="0" ID="9" organism="1" />
<SPECIES name="gp0.5" n="0" ID="10" organism="1" />
<SPECIES name="gp0.6A" n="0" ID="11" organism="1" />
<SPECIES name="gp0.7" n="0" ID="12" organism="1" />
<SPECIES name="gp1.1" n="0" ID="13" organism="1" />
<SPECIES name="gp1.2" n="0" ID="14" organism="1" />
<SPECIES name="gp1.3" n="0" ID="15" organism="1" />
<SPECIES name="gp1.4" n="0" ID="16" organism="1" />
<SPECIES name="gp1.5" n="0" ID="17" organism="1" />
<SPECIES name="gp1.6" n="0" ID="18" organism="1" />
<SPECIES name="gp1.7" n="0" ID="19" organism="1" />
<SPECIES name="gp1.8" n="0" ID="20" organism="1" />
<SPECIES name="gp2.0" n="0" ID="21" organism="1" />
<SPECIES name="gp2.5" n="0" ID="22" organism="1" />
<SPECIES name="gp2.8" n="0" ID="23" organism="1" />
<SPECIES name="gp3.0" n="0" ID="24" organism="1" />
<SPECIES name="gp3.5" n="0" ID="25" organism="1" />
<SPECIES name="gp3.8" n="0" ID="26" organism="1" />
<SPECIES name="gp4A" n="0" ID="27" organism="1" />
<SPECIES name="gp4.2" n="0" ID="28" organism="1" />
<SPECIES name="gp4.3" n="0" ID="29" organism="1" />
<SPECIES name="gp4.5" n="0" ID="30" organism="1" />
<SPECIES name="gp4.7" n="0" ID="31" organism="1" />
<SPECIES name="gp5.0" n="0" ID="32" organism="1" />
<SPECIES name="gp5.3" n="0" ID="33" organism="1" />
<SPECIES name="gp5.5" n="0" ID="34" organism="1" />
<SPECIES name="gp5.7" n="0" ID="35" organism="1" />
<SPECIES name="gp5.9" n="0" ID="36" organism="1" />
<SPECIES name="gp6.0" n="0" ID="37" organism="1" />
<SPECIES name="gp6.3" n="0" ID="38" organism="1" />
<SPECIES name="gp6.5" n="0" ID="39" organism="1" />
<SPECIES name="gp6.7" n="0" ID="40" organism="1" />
<SPECIES name="gp7" n="0" ID="41" organism="1" />
<SPECIES name="gp7.3" n="0" ID="42" organism="1" />
<SPECIES name="gp7.7" n="0" ID="43" organism="1" />
<SPECIES name="gp8" n="0" ID="44" organism="1" />
<SPECIES name="gp9" n="0" ID="45" organism="1" />
<SPECIES name="gp10A" n="0" ID="46" organism="1" />
<SPECIES name="gp11" n="0" ID="47" organism="1" />
<SPECIES name="gp12" n="0" ID="48" organism="1" />
<SPECIES name="gp13" n="0" ID="49" organism="1" />
<SPECIES name="gp14" n="0" ID="50" organism="1" />
<SPECIES name="gp15" n="0" ID="51" organism="1" />
<SPECIES name="gp16" n="0" ID="52" organism="1" />
<SPECIES name="gp17" n="0" ID="53" organism="1" />
<SPECIES name="gp17.5" n="0" ID="54" organism="1" />
<SPECIES name="gp18" n="0" ID="55" organism="1" />
<SPECIES name="gp18.5" n="0" ID="56" organism="1" />
<SPECIES name="gp19" n="0" ID="57" organism="1" />
<SPECIES name="gp19.5" n="0" ID="58" organism="1" />
<REACTIONS>
<REACTION>
12+2>3+11;3.8E7
175
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7 
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1 
</REACTION>
<REACTION>
5>21+3;1.1 
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="1514" stop="1564" startsite="1558" name="B" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
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 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi1.1A" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phi1.1B" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phi1.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="11180" stop="11203" startsite="11198" name="phi3.8" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop="13364" startsite="13359" name="phi4.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
177
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phi17" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="1" />
<POLYMERASE ID="3" efficiency="1" />
<POLYMERASE ID="4" efficiency="1" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi"  organism="1">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925"  initstepsize="50" elongstepsize="" strength="1e7" stopsite="1278" protid="8" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1433" protid="9" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid="10" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1797" protid="11" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
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<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="1e7" stopsite="3100" protid="12" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6" 
initRateConstant="0.3" mrnadeg="2.78e-3" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13" 
initRateConstant="0.3" mrnadeg="1.67e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6394" protid="14" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7880" protid="17" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9092" protid="21" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9856" protid="22" 
initRateConstant="0.3" mrnadeg="1.11e-3" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10276" protid="23" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10706" protid="24" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11161" protid="25" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13265" protid="27" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13326" protid="28" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13564" protid="29" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16467" protid="32" 
initRateConstant="0.3" mrnadeg="2.78e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17159" protid="34" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17359" protid="35" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17517" protid="36" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18507" protid="38" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18859" protid="39" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19131" protid="40" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19531" protid="41" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
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<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24818" protid="47" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27226" protid="48" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27723" protid="49" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52" 
initRateConstant="0.3" mrnadeg="1.11e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36285" protid="53" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36547" protid="54" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56" 
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Traffic Jam Model Fits
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500" 
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="yes">
<CELL volume="8e-16" polymerase_interaction_model="TRAFFIC_JAM">
<RIBOSOME initial_number="10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organism_id="2" footprint="15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organism_id="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="0" speed="45" id="4" organism_id="2" footprint="15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id="1" footprint="15" name="gp1" />
<POLYMERASE n="0" speed="230" id="7" organism_id="1" footprint="15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="0" ID="8" organism="1" />
<SPECIES name="gp0.4" n="0" ID="9" organism="1" />
<SPECIES name="gp0.5" n="0" ID="10" organism="1" />
<SPECIES name="gp0.6A" n="0" ID="11" organism="1" />
<SPECIES name="gp0.7" n="0" ID="12" organism="1" />
<SPECIES name="gp1.1" n="0" ID="13" organism="1" />
<SPECIES name="gp1.2" n="0" ID="14" organism="1" />
<SPECIES name="gp1.3" n="0" ID="15" organism="1" />
<SPECIES name="gp1.4" n="0" ID="16" organism="1" />
<SPECIES name="gp1.5" n="0" ID="17" organism="1" />
<SPECIES name="gp1.6" n="0" ID="18" organism="1" />
<SPECIES name="gp1.7" n="0" ID="19" organism="1" />
<SPECIES name="gp1.8" n="0" ID="20" organism="1" />
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<SPECIES name="gp2.0" n="0" ID="21" organism="1" />
<SPECIES name="gp2.5" n="0" ID="22" organism="1" />
<SPECIES name="gp2.8" n="0" ID="23" organism="1" />
<SPECIES name="gp3.0" n="0" ID="24" organism="1" />
<SPECIES name="gp3.5" n="0" ID="25" organism="1" />
<SPECIES name="gp3.8" n="0" ID="26" organism="1" />
<SPECIES name="gp4A" n="0" ID="27" organism="1" />
<SPECIES name="gp4.2" n="0" ID="28" organism="1" />
<SPECIES name="gp4.3" n="0" ID="29" organism="1" />
<SPECIES name="gp4.5" n="0" ID="30" organism="1" />
<SPECIES name="gp4.7" n="0" ID="31" organism="1" />
<SPECIES name="gp5.0" n="0" ID="32" organism="1" />
<SPECIES name="gp5.3" n="0" ID="33" organism="1" />
<SPECIES name="gp5.5" n="0" ID="34" organism="1" />
<SPECIES name="gp5.7" n="0" ID="35" organism="1" />
<SPECIES name="gp5.9" n="0" ID="36" organism="1" />
<SPECIES name="gp6.0" n="0" ID="37" organism="1" />
<SPECIES name="gp6.3" n="0" ID="38" organism="1" />
<SPECIES name="gp6.5" n="0" ID="39" organism="1" />
<SPECIES name="gp6.7" n="0" ID="40" organism="1" />
<SPECIES name="gp7" n="0" ID="41" organism="1" />
<SPECIES name="gp7.3" n="0" ID="42" organism="1" />
<SPECIES name="gp7.7" n="0" ID="43" organism="1" />
<SPECIES name="gp8" n="0" ID="44" organism="1" />
<SPECIES name="gp9" n="0" ID="45" organism="1" />
<SPECIES name="gp10A" n="0" ID="46" organism="1" />
<SPECIES name="gp11" n="0" ID="47" organism="1" />
<SPECIES name="gp12" n="0" ID="48" organism="1" />
<SPECIES name="gp13" n="0" ID="49" organism="1" />
<SPECIES name="gp14" n="0" ID="50" organism="1" />
<SPECIES name="gp15" n="0" ID="51" organism="1" />
<SPECIES name="gp16" n="0" ID="52" organism="1" />
<SPECIES name="gp17" n="0" ID="53" organism="1" />
<SPECIES name="gp17.5" n="0" ID="54" organism="1" />
<SPECIES name="gp18" n="0" ID="55" organism="1" />
<SPECIES name="gp18.5" n="0" ID="56" organism="1" />
<SPECIES name="gp19" n="0" ID="57" organism="1" />
<SPECIES name="gp19.5" n="0" ID="58" organism="1" />
<REACTIONS>
<REACTION>
12+2>3+11;3.8E7
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7 
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1 
</REACTION>
<REACTION>
5>21+3;1.1 
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
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<DNA_SYSTEM name="phage1" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="1514" stop="1564" startsite="1558" name="B" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi1.1A" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phi1.1B" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phi1.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="11180" stop="11203" startsite="11198" name="phi3.8" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop="13364" startsite="13359" name="phi4.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
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 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phi17" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="1" />
<POLYMERASE ID="3" efficiency="1" />
<POLYMERASE ID="4" efficiency="1" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi"  organism="1">
<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925"  initstepsize="50" elongstepsize="" strength="1e7" stopsite="1278" protid="8" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1433" protid="9" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid="10" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1797" protid="11" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="1e7" stopsite="3100" protid="12" 
initRateConstant="0.3" mrnadeg="1.67e-2" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6" 
initRateConstant="0.3" mrnadeg="1.67e-2" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13" 
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6394" protid="14" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15" 
initRateConstant="0.3" mrnadeg="1.67e-2" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7880" protid="17" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19" 
initRateConstant="0.3" mrnadeg="3.33e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9092" protid="21" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9856" protid="22" 
initRateConstant="0.3" mrnadeg="2.78e-3" />
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<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10276" protid="23" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10706" protid="24" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11161" protid="25" 
initRateConstant="0.3" mrnadeg="1.11e-3" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13265" protid="27" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13326" protid="28" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13564" protid="29" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16467" protid="32" 
initRateConstant="0.3" mrnadeg="2.78e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17159" protid="34" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17359" protid="35" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17517" protid="36" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37" 
initRateConstant="0.3" mrnadeg="4.17e-3" />
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18507" protid="38" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18859" protid="39" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19131" protid="40" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19531" protid="41" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45" 
initRateConstant="0.3" mrnadeg="1.11e-3" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24818" protid="47" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27226" protid="48" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27723" protid="49" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52" 
initRateConstant="0.3" mrnadeg="2.38e-3" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36285" protid="53" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36547" protid="54" 
initRateConstant="0.3" mrnadeg="1.11e-3" />
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<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
_________________________________________________________________________________________
Tabasco Input File for Upstream Falloff Fits
_________________________________________________________________________________________
<REQUEST>
<EXECUTE-SIMULATION runs="1" random_seed="34145" simulation_name="test-1" time_step="5" time_end="1500" 
write_DNA="no" write_InitRNA="yes" write_Energy="yes" compDeg="yes">
<CELL volume="8e-16" polymerase_interaction_model="UPSTREAM_FALL_OFF">
<RIBOSOME initial_number="10000" speed="45" footprint="40" />
<POLYMERASE n="1800" speed="45" id="2" organism_id="2" footprint="15" name="coli Pol" />
<POLYMERASE n="0" speed="45" id="3" organism_id="2" footprint="15" name="coli Pol-P" />
<POLYMERASE n="0" speed="45" id="4" organism_id="2" footprint="15" name="coli Pol-2.0" />
<POLYMERASE n="0" speed="45" id="5" organism_id="2" footprint="15" name="coli Pol-P-2.0" />
<POLYMERASE n="0" speed="230" id="6" organism_id="1" footprint="15" name="gp1" />
<POLYMERASE n="0" speed="230" id="7" organism_id="1" footprint="15" name="gp1-3.5" />
<SPECIES name="gp0.3" n="0" ID="8" organism="1" />
<SPECIES name="gp0.4" n="0" ID="9" organism="1" />
<SPECIES name="gp0.5" n="0" ID="10" organism="1" />
<SPECIES name="gp0.6A" n="0" ID="11" organism="1" />
<SPECIES name="gp0.7" n="0" ID="12" organism="1" />
<SPECIES name="gp1.1" n="0" ID="13" organism="1" />
<SPECIES name="gp1.2" n="0" ID="14" organism="1" />
<SPECIES name="gp1.3" n="0" ID="15" organism="1" />
<SPECIES name="gp1.4" n="0" ID="16" organism="1" />
<SPECIES name="gp1.5" n="0" ID="17" organism="1" />
<SPECIES name="gp1.6" n="0" ID="18" organism="1" />
<SPECIES name="gp1.7" n="0" ID="19" organism="1" />
<SPECIES name="gp1.8" n="0" ID="20" organism="1" />
<SPECIES name="gp2.0" n="0" ID="21" organism="1" />
<SPECIES name="gp2.5" n="0" ID="22" organism="1" />
<SPECIES name="gp2.8" n="0" ID="23" organism="1" />
<SPECIES name="gp3.0" n="0" ID="24" organism="1" />
<SPECIES name="gp3.5" n="0" ID="25" organism="1" />
<SPECIES name="gp3.8" n="0" ID="26" organism="1" />
<SPECIES name="gp4A" n="0" ID="27" organism="1" />
<SPECIES name="gp4.2" n="0" ID="28" organism="1" />
<SPECIES name="gp4.3" n="0" ID="29" organism="1" />
<SPECIES name="gp4.5" n="0" ID="30" organism="1" />
<SPECIES name="gp4.7" n="0" ID="31" organism="1" />
<SPECIES name="gp5.0" n="0" ID="32" organism="1" />
<SPECIES name="gp5.3" n="0" ID="33" organism="1" />
<SPECIES name="gp5.5" n="0" ID="34" organism="1" />
<SPECIES name="gp5.7" n="0" ID="35" organism="1" />
<SPECIES name="gp5.9" n="0" ID="36" organism="1" />
<SPECIES name="gp6.0" n="0" ID="37" organism="1" />
<SPECIES name="gp6.3" n="0" ID="38" organism="1" />
<SPECIES name="gp6.5" n="0" ID="39" organism="1" />
<SPECIES name="gp6.7" n="0" ID="40" organism="1" />
<SPECIES name="gp7" n="0" ID="41" organism="1" />
<SPECIES name="gp7.3" n="0" ID="42" organism="1" />
<SPECIES name="gp7.7" n="0" ID="43" organism="1" />
<SPECIES name="gp8" n="0" ID="44" organism="1" />
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<SPECIES name="gp9" n="0" ID="45" organism="1" />
<SPECIES name="gp10A" n="0" ID="46" organism="1" />
<SPECIES name="gp11" n="0" ID="47" organism="1" />
<SPECIES name="gp12" n="0" ID="48" organism="1" />
<SPECIES name="gp13" n="0" ID="49" organism="1" />
<SPECIES name="gp14" n="0" ID="50" organism="1" />
<SPECIES name="gp15" n="0" ID="51" organism="1" />
<SPECIES name="gp16" n="0" ID="52" organism="1" />
<SPECIES name="gp17" n="0" ID="53" organism="1" />
<SPECIES name="gp17.5" n="0" ID="54" organism="1" />
<SPECIES name="gp18" n="0" ID="55" organism="1" />
<SPECIES name="gp18.5" n="0" ID="56" organism="1" />
<SPECIES name="gp19" n="0" ID="57" organism="1" />
<SPECIES name="gp19.5" n="0" ID="58" organism="1" />
<REACTIONS>
<REACTION>
12+2>3+11;3.8E7
</REACTION>
<REACTION>
12+4>5+11;3.8E7
</REACTION>
<REACTION>
21+2>4;3.8E7 
</REACTION>
<REACTION>
21+3>5;3.8E7
</REACTION>
<REACTION>
4>21+2;1.1 
</REACTION>
<REACTION>
5>21+3;1.1 
</REACTION>
<REACTION>
25+6>7;3.8E7
</REACTION>
<REACTION>
7>6+25;3.5
</REACTION>
</REACTIONS>
<DNA_SYSTEM name="phage1" genome_length="39937" copy_number="3" entry_rate_constant="70" entry_offsite="850">
<PROMOTER start="405" stop="428" startsite="423" name="phi0L" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="498" stop="548" startsite="542" name="A1" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="626" stop="676" startsite="670" name="A2" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="750" stop="800" startsite="794" name="A3" organism_id="2">
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 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="100" aelong="6" arecyc="0"/
>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff=".28" ainiton="0.4" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="1514" stop="1564" startsite="1558" name="B" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="3113" stop="3163" startsite="3157" name="C" organism_id="2">
 <POLYMERASE polymeraseID="2" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="100" aelong="6" 
arecyc="0"/>
 <POLYMERASE polymeraseID="3" aon="1.5e7" aoff="2.8" ainiton="0.19" runoff_percent="70" aelong="6" 
arecyc="0.19"/>
 <POLYMERASE polymeraseID="4" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
 <POLYMERASE polymeraseID="5" aon="0" aoff="0" ainiton="0" runoff_percent="0" aelong="0" arecyc="0"/>
</PROMOTER>
<PROMOTER start="5848" stop="5871" startsite="5866" name="phi1.1A" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6E7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="5923" stop="5946" startsite="5941" name="phi1.1B" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="6409" stop="6432" startsite="6427" name="phi1.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7778" stop="7801" startsite="7796" name="phi1.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="7895" stop="7918" startsite="7913" name="phi1.6" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="9107" stop="9130" startsite="9125" name="phi2.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="11180" stop="11203" startsite="11198" name="phi3.8" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
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</PROMOTER>
<PROMOTER start="12671" stop="12694" startsite="12689" name="phi4c" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13341" stop="13364" startsite="13359" name="phi4.3" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="13915" stop="13938" startsite="13933" name="phi4.7" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="6e7" aoff="18" ainiton="3.5" runoff_percent="50" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="6e7" aoff="18" ainiton="0.875" runoff_percent="18" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="18545" stop="18568" startsite="18563" name="phi6.5" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="21865" stop="21888" startsite="21883" name="phi9" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="22904" stop="22927" startsite="22922" name="phi10" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="27274" stop="27297" startsite="27292" name="phi13" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="34566" stop="34589" startsite="34584" name="phi17" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<PROMOTER start="39229" stop="39252" startsite="39247" name="phiOR" organism_id="1">
 <POLYMERASE polymeraseID="6" aon="1.82e8" aoff="0.2" ainiton="3.5" runoff_percent="100" aelong="5.8" 
arecyc="0.88" />
 <POLYMERASE polymeraseID="7" aon="1.82e8" aoff="0.2" ainiton="0.875" runoff_percent="42" aelong="1.45" 
arecyc="0.22" />
</PROMOTER>
<TERMINATOR start="7546" stop="7610" stopsite="7588" name="TE"  organism="2">
<POLYMERASE ID="2" efficiency="1" />
<POLYMERASE ID="3" efficiency="1" />
<POLYMERASE ID="4" efficiency="1" />
<POLYMERASE ID="5" efficiency="1" />
<POLYMERASE ID="6" efficiency="0" />
<POLYMERASE ID="7" efficiency="0" />
</TERMINATOR>
<TERMINATOR start="24158" stop="24230" stopsite="24209" name="Tphi"  organism="1">
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<POLYMERASE ID="2" efficiency="0" />
<POLYMERASE ID="3" efficiency="0" />
<POLYMERASE ID="4" efficiency="0" />
<POLYMERASE ID="5" efficiency="0" />
<POLYMERASE ID="6" efficiency="0.8" />
<POLYMERASE ID="7" efficiency="0.8" />
</TERMINATOR>
<RBS start="910" stop="925" startsite="925"  initstepsize="50" elongstepsize="" strength="1e7" stopsite="1278" protid="8" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="1262" stop="1277" startsite="1277" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1433" protid="9" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="1454" stop="1469" startsite="1469" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1639" protid="10" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="1621" stop="1636" startsite="1636" initstepsize="50" elongstepsize="" strength="1e7" stopsite="1797" protid="11" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="2006" stop="2021" startsite="2021" initstepsize="50" elongstepsize="" strength="1e7" stopsite="3100" protid="12" 
initRateConstant="0.3" mrnadeg="1.67e-2" />
<RBS start="3156" stop="3171" startsite="3171" initstepsize="50" elongstepsize="" strength="1e7" stopsite="5822" protid="6" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="5992" stop="6007" startsite="6007" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6135" protid="13" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="6119" stop="6134" startsite="6134" initstepsize="50" elongstepsize="" strength="1e7" stopsite="6394" protid="14" 
initRateConstant="0.3" mrnadeg="2.08e-3" />
<RBS start="6460" stop="6475" startsite="6475" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7554" protid="15" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="7593" stop="7608" startsite="7608" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7763" protid="16" 
initRateConstant="0.3" mrnadeg="8.33e-3" />
<RBS start="7776" stop="7791" startsite="7791" initstepsize="50" elongstepsize="" strength="1e7" stopsite="7880" protid="17" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="7891" stop="7906" startsite="7906" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8166" protid="18" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="8150" stop="8165" startsite="8165" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8756" protid="19" 
initRateConstant="0.3" mrnadeg="1.11e-3" />
<RBS start="8734" stop="8749" startsite="8749" initstepsize="50" elongstepsize="" strength="1e7" stopsite="8895" protid="20" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="8879" stop="8894" startsite="8894" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9092" protid="21" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9136" stop="9152" startsite="9158" initstepsize="50" elongstepsize="" strength="1e7" stopsite="9856" protid="22" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="9840" stop="9855" startsite="9855" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10276" protid="23" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="10242" stop="10257" startsite="10257" initstepsize="50" elongstepsize="" strength="1e7" stopsite="10706" protid="24" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="10690" stop="10705" startsite="10705" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11161" protid="25" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="11210" stop="11225" startsite="11225" initstepsize="50" elongstepsize="" strength="1e7" stopsite="11590" protid="26" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="11550" stop="11565" startsite="11565" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13265" protid="27" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="12973" stop="12988" startsite="12988" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13326" protid="28" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="13337" stop="13352" startsite="13352" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13564" protid="29" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="13575" stop="13584" startsite="13584" initstepsize="50" elongstepsize="" strength="1e7" stopsite="13853" protid="30" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="13912" stop="13927" startsite="13927" initstepsize="50" elongstepsize="" strength="1e7" stopsite="14334" protid="31" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="14338" stop="14353" startsite="14353" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16467" protid="32" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="16468" stop="16483" startsite="16483" initstepsize="50" elongstepsize="" strength="1e7" stopsite="16838" protid="33" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="16839" stop="16851" startsite="16851" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17159" protid="34" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
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<RBS start="17124" stop="17149" startsite="17149" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17359" protid="35" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="17343" stop="17358" startsite="17358" initstepsize="50" elongstepsize="" strength="1e7" stopsite="17517" protid="36" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="17489" stop="17504" startsite="17504" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18406" protid="37" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="18379" stop="18394" startsite="18394" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18507" protid="38" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="18590" stop="18605" startsite="18605" initstepsize="50" elongstepsize="" strength="1e7" stopsite="18859" protid="39" 
initRateConstant="0.3" mrnadeg="5.56e-3" />
<RBS start="18860" stop="18864" startsite="18864" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19131" protid="40" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="19114" stop="19129" startsite="19130" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19531" protid="41" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="19515" stop="19530" startsite="19530" initstepsize="50" elongstepsize="" strength="1e7" stopsite="19834" protid="42" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="19835" stop="19848" startsite="19848" initstepsize="50" elongstepsize="" strength="1e7" stopsite="20240" protid="43" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="20224" stop="20239" startsite="20239" initstepsize="50" elongstepsize="" strength="1e7" stopsite="21850" protid="44" 
initRateConstant="0.3" mrnadeg="1.19e-3" />
<RBS start="21935" stop="21950" startsite="21950" initstepsize="50" elongstepsize="" strength="1e7" stopsite="22873" protid="45" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="22942" stop="22967" startsite="22967" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24004" protid="46" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24213" stop="24228" startsite="24228" initstepsize="50" elongstepsize="" strength="1e7" stopsite="24818" protid="47" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="24827" stop="24842" startsite="24842" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27226" protid="48" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="27292" stop="27307" startsite="27307" initstepsize="50" elongstepsize="" strength="1e7" stopsite="27723" protid="49" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="27707" stop="27722" startsite="27728" initstepsize="50" elongstepsize="" strength="1e7" stopsite="28318" protid="50" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="28302" stop="28317" startsite="28325" initstepsize="50" elongstepsize="" strength="1e7" stopsite="30568" protid="51" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="30580" stop="30595" startsite="30595" initstepsize="50" elongstepsize="" strength="1e7" stopsite="34551" protid="52" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="34609" stop="34624" startsite="34624" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36285" protid="53" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="36329" stop="36344" startsite="36344" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36547" protid="54" 
initRateConstant="0.3" mrnadeg="0" />
<RBS start="36531" stop="36546" startsite="36553" initstepsize="50" elongstepsize="" strength="1e7" stopsite="36822" protid="55" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="36902" stop="36917" startsite="36917" initstepsize="50" elongstepsize="" strength="1e7" stopsite="37348" protid="56" 
initRateConstant="0.3" mrnadeg="1.28e-3" />
<RBS start="37355" stop="37370" startsite="37370" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39130" protid="57" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
<RBS start="39374" stop="39389" startsite="39389" initstepsize="50" elongstepsize="" strength="1e7" stopsite="39538" protid="58" 
initRateConstant="0.3" mrnadeg="1.39e-3" />
</DNA_SYSTEM>
</CELL>
</EXECUTE-SIMULATION>
</REQUEST>
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